<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id><journal-id journal-id-type="iso-abbrev">Environ Health Perspect</journal-id><journal-id journal-id-type="pmc-domain-id">253</journal-id><journal-id journal-id-type="pmc-domain">envhper</journal-id><journal-id journal-id-type="publisher-id">EHP</journal-id><journal-title-group><journal-title>Environmental Health Perspectives</journal-title></journal-title-group><issn pub-type="ppub">0091-6765</issn><issn pub-type="epub">1552-9924</issn><publisher><publisher-name>National Institute of Environmental Health Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12180445</article-id><article-id pub-id-type="pmcid-ver">PMC12180445.1</article-id><article-id pub-id-type="pmcaid">12180445</article-id><article-id pub-id-type="pmcaiid">12180445</article-id><article-id pub-id-type="pmid">40344599</article-id><article-id pub-id-type="doi">10.1289/EHP15418</article-id><article-id pub-id-type="publisher-id">EHP15418</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Estimation of Dermal Exposure to Volatile Organic Compounds (VOCs) from Feminine Hygiene Products: Integrating Measurement Data and Physiologically Based Toxicokinetic (PBTK) Model</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="N">Nan</given-names></name><xref rid="a1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="a2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="a3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Z">Zengwei</given-names></name><xref rid="a4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="a5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ding</surname><given-names initials="N">Ning</given-names></name><xref rid="a6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="SK">Sung Kyun</given-names></name><xref rid="a3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="a6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Batterman</surname><given-names initials="S">Stuart</given-names></name><xref rid="a3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Du</surname><given-names initials="W">Wei</given-names></name><xref rid="a7" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dai</surname><given-names initials="J">Jiayin</given-names></name><xref rid="a4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="a5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhu</surname><given-names initials="Y">Ying</given-names></name><xref rid="a4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="a5" ref-type="aff">
<sup>5</sup>
</xref></contrib><aff id="a1">
<label><sup>1</sup></label>Institute of Environment and Ecology, Tsinghua Shenzhen International Graduate School, <institution>Tsinghua University</institution>, Shenzhen, <country>China</country></aff><aff id="a2">
<label><sup>2</sup></label>Department of Environmental Health, School of Public Health, <institution>Shanghai Jiao Tong University</institution>, Shanghai, <country>China</country></aff><aff id="a3">
<label><sup>3</sup></label>Department of Environmental Health Sciences, School of Public Health, <institution>University of Michigan</institution>, Ann Arbor, Michigan, <country>USA</country></aff><aff id="a4">
<label><sup>4</sup></label>State Key Laboratory of Green Papermaking and Resource Recycling, School of Environmental Science and Engineering, <institution>Shanghai Jiao Tong University</institution>, Shanghai, <country>China</country></aff><aff id="a5">
<label><sup>5</sup></label>Key Laboratory of Environmental Health Impact Assessment of Emerging Contaminants, <institution>Ministry of Ecology and Environment of the People&#8217;s Republic of China</institution>, Shanghai, <country>China</country></aff><aff id="a6">
<label><sup>6</sup></label>Department of Epidemiology, School of Public Health, <institution>University of Michigan</institution>, Ann Arbor, Michigan, <country>USA</country></aff><aff id="a7">
<label><sup>7</sup></label>Faculty of Environmental Science &amp; Engineering, <institution>Kunming University of Science &amp; Technology</institution>, Kunming, <country>China</country></aff></contrib-group><author-notes><corresp id="cor1">Address correspondence to Ying Zhu, School of Environmental Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240 China. Email: <email>yzhu16@sjtu.edu.cn</email></corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>6</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>133</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">489736</issue-id><elocation-id>067020</elocation-id><history><date date-type="received"><day>22</day><month>5</month><year>2024</year></date><date date-type="rev-recd"><day>05</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>06</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>20</day><month>06</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>20</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-21 10:25:30.450"><day>21</day><month>06</month><year>2025</year></date></event></pub-history><permissions><license><ali:license_ref>https://ehp.niehs.nih.gov/about-ehp/license</ali:license_ref><license-p><italic toggle="yes">EHP</italic> is a Diamond Open Access journal published with support from the NIEHS, NIH. All content is public domain unless otherwise noted. Contact the corresponding author for permission before any reuse of content. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://ehp.niehs.nih.gov/about-ehp/license">Full licensing information</ext-link> is available online.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ehp15418.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="ehp15418.pdf"/><abstract><sec><title>Background:</title><p>An increasing number of studies have reported noteworthy health risks associated with dermal exposure to volatile organic compounds (VOCs) from feminine hygiene products (FHPs).</p></sec><sec><title>Objectives:</title><p>This study sought to address the gap in understanding the absorption, distribution, metabolism, and excretion dynamics of dermal exposure to VOCs from FHPs and to identify chemicals and products that could cause significant body burden.</p></sec><sec><title>Methods:</title><p>We used measured contents of eight widely present VOCs across five categories of FHPs to estimate dermal exposure, and applied a physiologically based toxicokinetic (PBTK) modeling approach to elucidate VOC toxicokinetics in human body tissues. Inhalation exposure estimates were derived from 20 air samples collected via passive sampling and analyzed using a thermal desorption system coupled with gas chromatography&#8211;mass spectrometry. Predicted urinary VOC concentrations based on dermal and inhalation exposure were validated against 99 measurements from 25 females.</p></sec><sec><title>Results:</title><p>Via skin absorption, the estimated levels of most target VOCs in nearly all tissues, except adipose and the rest of the body, rapidly peaked within an hour of product use. Specifically, <inline-formula><mml:math id="i1a" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene was estimated to reach <inline-formula><mml:math id="i1" display="inline" alttext="approximately 2.23 nanograms per milliliter"><mml:mrow><mml:mo>&#8764;</mml:mo><mml:mn>2.23</mml:mn><mml:mtext>&#8201;ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> in adipose tissue before decreasing over several hours due to efficient excretion pathways, including liver metabolism and exhalation. The model estimated that although the majority of absorbed VOCs (78.9%) were eliminated via liver metabolism, exhalation, and urine excretion, VOCs with <inline-formula><mml:math id="i2" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> higher than 3.5, such as <inline-formula><mml:math id="i1b" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, hexane, and <inline-formula><mml:math id="i1ao" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane, exhibited a potential cumulative trend in adipose tissue. This trend resulted in the estimated VOC concentrations in adipose tissue being 1 to 4 orders of magnitude higher than those estimated in other tissues. In certain cases, <inline-formula><mml:math id="i19ar" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane posed a potential noncancer risk (up to 0.07), and benzene presented a notable cancer risk (up to <inline-formula><mml:math id="i3" display="inline" alttext="1.82 times 10 begin superscript negative 7 end superscript"><mml:mrow><mml:mn>1.82</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>), primarily attributed to washes and moisturizers, respectively.</p></sec><sec><title>Discussion:</title><p>These findings reveal potential significant body burden and health risks associated with dermal exposure to VOCs from FHPs, warranting further research and regulatory measures. Comprehensive assessment of internal exposure by integrating with toxicokinetic modeling to elucidate chemical distribution in various tissues is recommended, rather than by measuring only one type of biomarker, to illustrate exposure variances and ensure accurate risk assessment. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1289/EHP15418" ext-link-type="uri">https://doi.org/10.1289/EHP15418</ext-link></p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="disclaimer"><p>Conclusions and opinions are those of the individual authors and do not necessarily reflect the policies or views of EHP Publishing or the National Institute of Environmental Health Sciences.</p></notes><fn-group><fn fn-type="other" specific-use="pdf-only"><p>Supplemental Material is available online (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.1289/EHP15418" ext-link-type="uri">https://doi.org/10.1289/EHP15418</ext-link>).</p></fn><fn fn-type="financial-disclosure"><p>The authors declare they have no conflicts of interest related to this work to disclose.</p></fn><fn specific-use="pdf-only" fn-type="other"><p><bold>Note to readers with disabilities:</bold>
<italic toggle="yes">EHP</italic> strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in <italic toggle="yes">EHP</italic> articles may not conform to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://ehp.niehs.nih.gov/accessibility/" ext-link-type="uri">508 standards</ext-link> due to the complexity of the information being presented. If you need assistance accessing journal content, please contact <email>ehpsubmissions@niehs.nih.gov</email>. Our staff will work with you to assess and meet your accessibility needs within 3 working days.</p></fn></fn-group></front><body><sec id="s1"><title>Introduction</title><p>Feminine hygiene products (FHPs), including tampons, menstrual pads, washes, wipes, sprays, and powders, are widely used across the world.<sup><xref rid="c1" ref-type="bibr">1</xref></sup> Over the course of the reproductive years, typically spanning from 12&#8211;51 y of age, a woman may use more than 10,000 pads or tampons.<sup><xref rid="c2" ref-type="bibr">2</xref></sup> Up to 40% of women use washes, wipes, and sprays.<sup><xref rid="c3" ref-type="bibr">3</xref></sup> The production of most FHPs typically involves the intentional addition of volatile organic compounds (VOCs) as fragrances, moisture barriers, and binders,<sup><xref rid="c4" ref-type="bibr">4</xref></sup> and VOCs may also be unintentionally introduced as by-products or contaminants from raw materials or during the manufacturing process.<sup><xref rid="c5" ref-type="bibr">5</xref></sup> An increasing number of studies have reported the detection of diverse VOCs in a broad range of FHPs sold in different markets around the world, such as benzene and styrene detected in sanitary napkins and panty liners sold in South Korea<sup><xref rid="c6" ref-type="bibr">6</xref></sup> and styrene and chloroform measured in a wide range of FHPs in the United States.<sup><xref rid="c2" ref-type="bibr">2</xref></sup></p><p>Exposure to VOCs in FHPs mainly occurs through dermal permeation<sup><xref rid="c7" ref-type="bibr">7</xref>,<xref rid="c8" ref-type="bibr">8</xref></sup> and inhalation.<sup><xref rid="c9" ref-type="bibr">9</xref>&#8211;<xref rid="c11" ref-type="bibr">11</xref></sup> Elevated concentrations of certain VOCs such as hexane have been detected in some FHPs in comparison with air, indicating dermal exposure as a potentially dominant route of intake, especially for products used on highly permeable and sensitive vaginal and vulvar tissues with efficient VOCs uptake rates.<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c12" ref-type="bibr">12</xref></sup> A few human studies have substantiated a positive association between chemical concentrations in FHPs, due to the usage, and levels in the body of consumers.<sup><xref rid="c3" ref-type="bibr">3</xref>,<xref rid="c13" ref-type="bibr">13</xref></sup> Long-term exposure, including dermal exposure to high concentrations of certain VOCs, is relevant with various known or suspected health effects such as mucosa and skin irritation, liver and kidney damage, reproductive effects, and carcinogenicity, based on evidence from both animal<sup><xref rid="c14" ref-type="bibr">14</xref>,<xref rid="c15" ref-type="bibr">15</xref></sup> and human studies.<sup><xref rid="c16" ref-type="bibr">16</xref></sup> Benzene, a recognized carcinogen and common contaminant in FHPs due to production residue, has been identified as one of the top 10 chemicals of public health concern by the World Health Organization (WHO).<sup><xref rid="c17" ref-type="bibr">17</xref></sup> It frequently induces high exposure risk in multiple categories of FHPs, surpassing the benchmark level of cancer risk (<inline-formula><mml:math id="i4" display="inline" alttext="10 begin superscript negative 6 end superscript"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>).<sup><xref rid="c2" ref-type="bibr">2</xref></sup> Dermal exposure to <inline-formula><mml:math id="i10p" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane can cause cumulative irritation with inflammation effect, as demonstrated in a rat study.<sup><xref rid="c18" ref-type="bibr">18</xref></sup> In addition, the reported reference dose of <inline-formula><mml:math id="i1aq" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane induced by inhalation can be equivalent to <inline-formula><mml:math id="i5" display="inline" alttext="0.002 milligram per kilogram per day"><mml:mrow><mml:mn>0.002</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mg</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">kg</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">d</mml:mi></mml:mrow></mml:math></inline-formula>,<sup><xref rid="c19" ref-type="bibr">19</xref></sup> significantly higher than that induced by dermal exposure (<inline-formula><mml:math id="i6" display="inline" alttext="0.0003 milligram per kilogram per day"><mml:mrow><mml:mn>0.0003</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mg</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">kg</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">d</mml:mi></mml:mrow></mml:math></inline-formula>),<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c20" ref-type="bibr">20</xref></sup> also supporting the importance of recognizing dermal exposure to VOCs in assessing health risks.<sup><xref rid="c21" ref-type="bibr">21</xref></sup></p><p>An increasing number of studies have explored the exposure and associated health risks posed by VOCs from the use of FHPs. However, the majority have centered on quantifying external exposure levels.<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c6" ref-type="bibr">6</xref>,<xref rid="c22" ref-type="bibr">22</xref></sup> Only a limited number of studies have explored the connections between external exposure levels and internal exposure (measured in urine and blood), as well as the importance of dermal exposure.<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c3" ref-type="bibr">3</xref>,<xref rid="c13" ref-type="bibr">13</xref></sup> There is a scarcity of research depicting the absorption, distribution, metabolism and excretion (ADME) of VOCs within the human body following dermal exposure to FHPs. Consequently, the body burden of VOC exposure stemming from the use of FHPs remains largely uncharted territory. The physiologically based toxicokinetic (PBTK) model is an effective and acknowledged tool for quantifying the ADME process of chemicals, overcoming limitations of single biomarker use in exposure-level quantification.<sup><xref rid="c23" ref-type="bibr">23</xref></sup> It has been used in several similar investigations, e.g., quantifying the exposure of naphthalene via jet propulsion (JP) fuel 8 among members of the US Air Force,<sup><xref rid="c24" ref-type="bibr">24</xref></sup> and evaluating the dermal and air-to-skin exposure routes of diethyl phthalate via using personal care products.<sup><xref rid="c25" ref-type="bibr">25</xref></sup> Such type of models have advantages in the wide applicability to various exposure scenarios and physiological conditions and the achievable visualization of chemical ADME dynamics without <italic toggle="yes">in&#160;vivo</italic> experiments.</p><p>This study integrates measurement data of VOCs in FHPs with a PBTK modeling approach (study design appears in <xref rid="f1" ref-type="fig">Figure 1</xref>), aiming to <italic toggle="yes">a</italic>) estimate the toxicokinetics of VOCs in body tissues resulting from dermal exposure to FHPs by linking the external VOC exposure from FHPs to the internal dose in specific tissues and <italic toggle="yes">b</italic>) identify the specific chemicals and products posing significant health risks. Furthermore, this study validates its estimates by comparing them with measured urinary VOCs levels in a female population.</p><fig position="float" id="f1" orientation="portrait"><label>Figure 1.</label><caption><p>The schematic study design. The image in the figure was taken by the authors, and the graphics were created using Adobe Illustrator 2020 (Adobe Inc.). Note: <inline-formula><mml:math id="i7" display="inline" alttext="uppercase italic c begin subscript uppercase a t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i8" display="inline" alttext="uppercase italic c begin subscript uppercase b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i9" display="inline" alttext="uppercase italic c begin subscript uppercase r b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="i10" display="inline" alttext="uppercase italic c begin subscript urine end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>urine</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, chemical concentration in the adipose tissue, blood, rest of body and urine, respectively; <inline-formula><mml:math id="i11" display="inline" alttext="uppercase italic k begin subscript renal end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>renal</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, the renal excretion coefficient; <inline-formula><mml:math id="i12" display="inline" alttext="uppercase italic p begin subscript adipose or blood end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>adipose</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="i13" display="inline" alttext="uppercase italic p begin subscript rest of body or blood end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>rest&#8201;of&#8201;body</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, partition coefficients of corresponding tissues to blood; <inline-formula><mml:math id="i14" display="inline" alttext="uppercase italic q begin subscript uppercase a t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i15" display="inline" alttext="uppercase italic q begin subscript uppercase k end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="i16" display="inline" alttext="uppercase italic q begin subscript uppercase r b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, blood flow to adipose tissue, kidney and rest of body, respectively; <inline-formula><mml:math id="i17" display="inline" alttext="uppercase italic v begin subscript uppercase a t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="i18" display="inline" alttext="uppercase italic v begin subscript uppercase r b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, volume of adipose tissue and rest of body; <inline-formula><mml:math id="i19" display="inline" alttext="uppercase italic v begin subscript urine end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mtext>urine</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, volume of urine produced per unit time.</p></caption><alt-text>Figure 1 is an illustration flowchart with three steps. Step 1A Exposure: Dermal Exposure: Represented by an image of various feminine hygiene products with the label &#8220;Feminine Hygiene Products.&#8221; Inhalation Exposure: Illustrated by a house icon with a cloud inside, symbolizing indoor air exposure. Step 2B Absorption, Distribution, and Metabolism: A box labeled &#8220;Physiologically based toxicokinetic (P B T K) model&#8221; displays differential equations describing the distribution of chemicals in the body. A graph within the box shows chemical concentration (C) versus time (t), with a peak and subsequent decline, indicating how the chemical is processed by the body. A final equation models the concentration in urine. Step 3C Excretion: A simple icon of a urine collection container labeled &#8220;Urine&#8221; represents the excretion phase.</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_f1.jpg"/></fig></sec><sec id="s2"><title>Methods</title><sec id="s2.1"><title>Selection of FHPs and VOCs</title><p>This study included the five most prevalent categories of FHPs in the United States, i.e., pads, tampons, feminine washes, wipes and moisturizers, as identified in our previous studies.<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c13" ref-type="bibr">13</xref></sup> The measurements of VOCs in these FHPs were also obtained from our previous study, which investigated 74 FHPs (22 pads, 22 tampons, 13 feminine washes, 12 wipes, and 5 moisturizers) covering a variety of types and brands across above categories.<sup><xref rid="c2" ref-type="bibr">2</xref></sup></p><p>We measured VOCs concentrations in urine samples from 25 nonsmoking female participants 22&#8211;25 y of age [interquartile range (IQR)] in our previous study.<sup><xref rid="c13" ref-type="bibr">13</xref></sup> The participants were recruited from the University of Michigan School of Public Health in September 2018 after responding to recruitment emails and completing a brief eligibility survey. Eligibility criteria of participants included ages being between 20 and 49 y, having had a regular menstrual cycle in the past 3 months (menstrual period within 7 d, and an average cycle length of 21&#8211;40 d), and self-identifying as White, Black, or Asian. We excluded women who had a vaginal infection, uterine fibroids, polycystic ovarian syndrome, endometriosis or who were pregnant or breastfeeding. The final study samples included 11 White, 6 Black, and 8 Asian women, all of whom provided written informed consent to participate in the study, which was approved by the institutional review board at the University of Michigan.<sup><xref rid="c13" ref-type="bibr">13</xref></sup> We collected first-morning-void urine samples from participants at four time points: 7 d before menstruation and 3, 7, and 14 d after the first day of menstruation. Finally, from October 2018 to February 2019, we collected 99 urine samples, with one participant failing to collect the first urine sample.<sup><xref rid="c13" ref-type="bibr">13</xref></sup> VOCs in urine samples were collected using a purge and trap method.<sup><xref rid="c13" ref-type="bibr">13</xref></sup> In brief, a <inline-formula><mml:math id="i20" display="inline" alttext="10 milliliters"><mml:mrow><mml:mn>10</mml:mn><mml:mtext>-mL</mml:mtext></mml:mrow></mml:math></inline-formula> aliquot of each urine sample was heated at <inline-formula><mml:math id="i21" display="inline" alttext="40 degrees Celsius"><mml:mrow><mml:mn>40</mml:mn><mml:mo>&#176;</mml:mo><mml:mi mathvariant="normal">C</mml:mi></mml:mrow></mml:math></inline-formula> and purged with <inline-formula><mml:math id="i22" display="inline" alttext="1000 milliliters"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> pure nitrogen gas. The VOCs purged from the urine were collected in a thermal sorbent tube containing <inline-formula><mml:math id="i23" display="inline" alttext="250 milligrams"><mml:mrow><mml:mn>250</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula> of anhydrous sodium sulfate (to remove water vapor) and <inline-formula><mml:math id="i24" display="inline" alttext="160 milligrams"><mml:mrow><mml:mn>160</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula> of Tenax-GR (to trap the VOCs), followed by immediate instrument analysis. The tube preparation and instrument analysis are described in the section below titled &#8220;Field Study of Inhalation Exposure,&#8221; and in our previous studies.<sup><xref rid="c13" ref-type="bibr">13</xref>,<xref rid="c26" ref-type="bibr">26</xref>&#8211;<xref rid="c29" ref-type="bibr">29</xref></sup></p><p>To ensure methodological robustness, we targeted eight VOCs in this study based on their frequency of detection in urine samples (<inline-formula><mml:math id="i25" display="inline" alttext="greater than 40 percent"><mml:mrow><mml:mo>&gt;</mml:mo><mml:mn>40</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula>), availability of necessary parameters for PBTK modeling, and exclusion of substances with endogenous generation in human bodies. These target VOCs [methylene chloride, methyl ethyl ketone, benzene, toluene, styrene, <inline-formula><mml:math id="i1c" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, hexane, and <inline-formula><mml:math id="i1ar" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane (Table S1)<sup><xref rid="c30" ref-type="bibr">30</xref></sup>] were grouped by their chemical structures as halohydrocarbon, ketone, aromatic, and alkane. All eight target VOCs possess the potential to cause skin and mucosal corrosion/irritation, with some being recognized or suspected carcinogens, such as methylene chloride, benzene, toluene, and styrene.<sup><xref rid="c31" ref-type="bibr">31</xref>&#8211;<xref rid="c34" ref-type="bibr">34</xref></sup></p></sec><sec id="s2.2"><title>External Exposure Scenario and Dermal Absorption</title><p>To calculate the external dose of dermal exposure, we conducted a survey of participants to collect parameters regarding the use pattern of FHPs in our previous study, including the number and frequency of use.<sup><xref rid="c13" ref-type="bibr">13</xref></sup> Based on the survey, some females reported using all categories of FHPs. Therefore, to conduct a conservative risk assessment, we assumed that all FHP categories were used except tampons within a 28-d menstrual cycle, because pads and tampons serve similar purposes, with pads generally containing higher VOC levels.<sup><xref rid="c2" ref-type="bibr">2</xref></sup> The specific use pattern is assumed as follows (Figure S1): pads or tampons were used six times daily for 7 d during a 7-d menstrual period, followed by a postmenstrual duration of 21 d, constituting a complete 28-d menstrual cycle. In addition, feminine washes and moisturizers were assumed to be applied once daily, whereas wipes were used six times daily. During the first 0.1 h (6 min) of the day, when the wash was applied, no other products were used. The maximum VOC concentrations in FHPs from our previous study<sup><xref rid="c2" ref-type="bibr">2</xref></sup> (Table S1) were applied to simulate a best-guess exposure scenario, representing the worst case for conservative assessment. The specific parameter values relevant to exposure estimation are shown in Table S2, and the initial exposure amounts input into the model are detailed in Table S3. In addition, we simulated urinary VOC concentration dynamics from the use of a single product category, including tampons, to assess the burden attributed to a single product type. All products were used on vulvar tissues and nearby skin areas, except tampons, which were in contact with vaginal tissues. Farage et al. reviewed previous studies to quantify uncertainty factors for mucosal exposures.<sup><xref rid="c35" ref-type="bibr">35</xref></sup> Two <italic toggle="yes">in&#160;vivo</italic> studies demonstrated that the vulva (labium majus) exhibited a 7-fold increase in permeability to hydrocortisone, a lipophilic substance, in comparison with normal skin.<sup><xref rid="c36" ref-type="bibr">36</xref>,<xref rid="c37" ref-type="bibr">37</xref></sup> Given the lipophilicity of the target VOCs (<xref rid="t1" ref-type="table">Table 1</xref>) and the potential for even greater permeability in vaginal tissue,<sup><xref rid="c35" ref-type="bibr">35</xref></sup> a 10-fold permeability coefficient was reasonably applied to simulate the enhanced absorption of VOCs by mucosa tissue in comparison with normal skin when using tampons. No participants reported discomfort related to these products,<sup><xref rid="c3" ref-type="bibr">3</xref></sup> so we did not consider the potential effects of irritation on product use behavior or any changes in skin physiology.</p><table-wrap position="float" id="t1" orientation="portrait"><label>Table 1</label><caption><p>Values of toxicokinetic parameters of the target VOCs.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/></colgroup><thead><tr><th id="t1c1" rowspan="2" scope="col" align="left" colspan="1">VOC</th><th id="t1c2" rowspan="2" scope="col" align="center" colspan="1">
<inline-formula>
<mml:math id="i26" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</th><th id="t1c3" rowspan="2" scope="col" align="center" colspan="1"><inline-formula><mml:math id="i27" display="inline" alttext="uppercase italic k begin subscript lowercase p end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula><sup><xref rid="c41" ref-type="bibr">41</xref>,<xref rid="c42" ref-type="bibr">42</xref></sup> (cm/h)</th><th id="t1c4" colspan="4" scope="colgroup" align="center" rowspan="1">
<inline-formula>
<mml:math id="i28" display="inline" alttext="uppercase italic p begin subscript tissue or blood end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>tissue</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</th><th id="t1c5" rowspan="2" scope="col" align="center" colspan="1">
<inline-formula>
<mml:math id="i29" display="inline" alttext="uppercase italic p begin subscript blood or air end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>blood</mml:mtext><mml:mo>/</mml:mo><mml:mtext>air</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</th><th id="t1c6" rowspan="2" scope="col" align="center" colspan="1"><inline-formula><mml:math id="i30" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> (ng/mL tissue/h)</th><th id="t1c7" rowspan="2" scope="col" align="center" colspan="1"><inline-formula><mml:math id="i31" display="inline" alttext="uppercase italic k begin subscript lowercase m end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> (ng/mL)</th><th id="t1c8" rowspan="2" scope="col" align="center" colspan="1">
<inline-formula>
<mml:math id="i32" display="inline" alttext="uppercase italic k begin subscript renal end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>renal</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math>
</inline-formula>
<sup>
<xref rid="c38" ref-type="bibr">38</xref>
</sup>
</th></tr><tr><th id="t1c9" headers="t1c4" scope="col" align="center" colspan="1" rowspan="1">Adipose</th><th id="t1c10" headers="t1c4" scope="col" align="center" colspan="1" rowspan="1">Kidney</th><th id="t1c11" headers="t1c4" scope="col" align="center" colspan="1" rowspan="1">Liver</th><th id="t1c12" headers="t1c4" scope="col" align="center" colspan="1" rowspan="1">Rest of body</th></tr></thead><tbody valign="top"><tr><td id="t1c13" headers="t1c1" scope="row" align="left" colspan="1" rowspan="1">Methylene chloride</td><td headers="t1c2 t1c13" align="char" char="." colspan="1" rowspan="1">1.25</td><td headers="t1c3 t1c13" align="char" char="." colspan="1" rowspan="1">0.0045</td><td headers="t1c4 t1c9 t1c13" align="char" char="." colspan="1" rowspan="1">10.43<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c10 t1c13" align="char" char="." colspan="1" rowspan="1">0.71<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c11 t1c13" align="char" char="." colspan="1" rowspan="1">0.88<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c12 t1c13" align="char" char="." colspan="1" rowspan="1">0.59<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c5 t1c13" align="char" char="." colspan="1" rowspan="1">8.15<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c6 t1c13" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i33" display="inline" alttext="2.19 times 10 begin subscript 5 end subscript"><mml:mrow><mml:mn>2.19</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>5</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
<sup>
<xref rid="c60" ref-type="bibr">60</xref>
</sup>
</td><td headers="t1c7 t1c13" align="char" char="." colspan="1" rowspan="1">578<sup><xref rid="c60" ref-type="bibr">60</xref></sup></td><td headers="t1c8 t1c13" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i34" display="inline" alttext="1.78 times 10 begin subscript negative 3 end subscript"><mml:mrow><mml:mn>1.78</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td></tr><tr><td id="t1c14" headers="t1c1" scope="row" align="left" colspan="1" rowspan="1">Methyl ethyl ketone</td><td headers="t1c2 t1c14" align="char" char="." colspan="1" rowspan="1">0.29</td><td headers="t1c3 t1c14" align="char" char="." colspan="1" rowspan="1">0.0011</td><td headers="t1c4 t1c9 t1c14" align="char" char="." colspan="1" rowspan="1">0.88<sup><xref rid="c58" ref-type="bibr">58</xref></sup></td><td headers="t1c4 t1c10 t1c14" align="char" char="." colspan="1" rowspan="1">1.08<sup><xref rid="c58" ref-type="bibr">58</xref></sup></td><td headers="t1c4 t1c11 t1c14" align="char" char="." colspan="1" rowspan="1">0.98<sup><xref rid="c58" ref-type="bibr">58</xref></sup></td><td headers="t1c4 t1c12 t1c14" align="char" char="." colspan="1" rowspan="1">1.16<sup><xref rid="c58" ref-type="bibr">58</xref></sup></td><td headers="t1c5 t1c14" align="center" colspan="1" rowspan="1">183<sup><xref rid="c58" ref-type="bibr">58</xref></sup></td><td headers="t1c6 t1c14" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i35" display="inline" alttext="8.65 times 10 begin subscript 4 end subscript"><mml:mrow><mml:mn>8.65</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
<sup>
<xref rid="c59" ref-type="bibr">59</xref>
</sup>
</td><td headers="t1c7 t1c14" align="char" char="." colspan="1" rowspan="1">144<sup><xref rid="c59" ref-type="bibr">59</xref></sup></td><td headers="t1c8 t1c14" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i36" display="inline" alttext="1.18 times 10 begin subscript negative 2 end subscript"><mml:mrow><mml:mn>1.18</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td></tr><tr><td id="t1c15" headers="t1c1" scope="row" align="left" colspan="1" rowspan="1">Benzene</td><td headers="t1c2 t1c15" align="char" char="." colspan="1" rowspan="1">2.13</td><td headers="t1c3 t1c15" align="char" char="." colspan="1" rowspan="1">0.0207</td><td headers="t1c4 t1c9 t1c15" align="char" char="." colspan="1" rowspan="1">51.49<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c10 t1c15" align="char" char="." colspan="1" rowspan="1">1.64<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c11 t1c15" align="char" char="." colspan="1" rowspan="1">3.07<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c12 t1c15" align="char" char="." colspan="1" rowspan="1">2.23<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c5 t1c15" align="char" char="." colspan="1" rowspan="1">7.37<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c6 t1c15" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i37" display="inline" alttext="9.53 times 10 begin subscript 3 end subscript"><mml:mrow><mml:mn>9.53</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>3</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
<sup>
<xref rid="c60" ref-type="bibr">60</xref>
</sup>
</td><td headers="t1c7 t1c15" align="char" char="." colspan="1" rowspan="1">3,124<sup><xref rid="c60" ref-type="bibr">60</xref></sup></td><td headers="t1c8 t1c15" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i38" display="inline" alttext="1.03 times 10 begin subscript negative 3 end subscript"><mml:mrow><mml:mn>1.03</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td></tr><tr><td id="t1c16" headers="t1c1" scope="row" align="left" colspan="1" rowspan="1">Toluene</td><td headers="t1c2 t1c16" align="char" char="." colspan="1" rowspan="1">2.73</td><td headers="t1c3 t1c16" align="char" char="." colspan="1" rowspan="1">0.0453</td><td headers="t1c4 t1c9 t1c16" align="char" char="." colspan="1" rowspan="1">63.67<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c10 t1c16" align="char" char="." colspan="1" rowspan="1">1.18<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c11 t1c16" align="char" char="." colspan="1" rowspan="1">3.19<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c12 t1c16" align="char" char="." colspan="1" rowspan="1">2.31<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c5 t1c16" align="char" char="." colspan="1" rowspan="1">15.11<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c6 t1c16" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i39" display="inline" alttext="4.65 times 10 begin subscript 4 end subscript"><mml:mrow><mml:mn>4.65</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
<sup>
<xref rid="c60" ref-type="bibr">60</xref>
</sup>
</td><td headers="t1c7 t1c16" align="char" char="." colspan="1" rowspan="1">538<sup><xref rid="c60" ref-type="bibr">60</xref></sup></td><td headers="t1c8 t1c16" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i40" display="inline" alttext="4.18 times 10 begin subscript negative 4 end subscript"><mml:mrow><mml:mn>4.18</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td></tr><tr><td id="t1c17" headers="t1c1" scope="row" align="left" colspan="1" rowspan="1">Styrene</td><td headers="t1c2 t1c17" align="char" char="." colspan="1" rowspan="1">2.95</td><td headers="t1c3 t1c17" align="char" char="." colspan="1" rowspan="1">0.0548</td><td headers="t1c4 t1c9 t1c17" align="char" char="." colspan="1" rowspan="1">57.27<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c10 t1c17" align="char" char="." colspan="1" rowspan="1">1.02<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c11 t1c17" align="char" char="." colspan="1" rowspan="1">2.50<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c12 t1c17" align="char" char="." colspan="1" rowspan="1">1.29<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c5 t1c17" align="char" char="." colspan="1" rowspan="1">55.6<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c6 t1c17" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i41" display="inline" alttext="9.10 times 10 begin subscript 4 end subscript"><mml:mrow><mml:mn>9.10</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
<sup>
<xref rid="c60" ref-type="bibr">60</xref>
</sup>
</td><td headers="t1c7 t1c17" align="char" char="." colspan="1" rowspan="1">360<sup><xref rid="c60" ref-type="bibr">60</xref></sup></td><td headers="t1c8 t1c17" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i42" display="inline" alttext="2.75 times 10 begin subscript negative 4 end subscript"><mml:mrow><mml:mn>2.75</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td></tr><tr><td id="t1c18" headers="t1c1" scope="row" align="left" colspan="1" rowspan="1"><inline-formula><mml:math id="i1d" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-Cymene</td><td headers="t1c2 t1c18" align="char" char="." colspan="1" rowspan="1">4.1</td><td headers="t1c3 t1c18" align="char" char="." colspan="1" rowspan="1">0.2356</td><td headers="t1c4 t1c9 t1c18" align="char" char="." colspan="1" rowspan="1">141.22<sup><xref rid="c38" ref-type="bibr">38</xref></sup></td><td headers="t1c4 t1c10 t1c18" align="char" char="." colspan="1" rowspan="1">5.82<sup><xref rid="c38" ref-type="bibr">38</xref></sup></td><td headers="t1c4 t1c11 t1c18" align="char" char="." colspan="1" rowspan="1">7.88<sup><xref rid="c38" ref-type="bibr">38</xref></sup></td><td headers="t1c4 t1c12 t1c18" align="char" char="." colspan="1" rowspan="1">5.01<sup><xref rid="c38" ref-type="bibr">38</xref></sup></td><td headers="t1c5 t1c18" align="char" char="." colspan="1" rowspan="1">107.2<sup><xref rid="c38" ref-type="bibr">38</xref></sup></td><td headers="t1c6 t1c18" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i43" display="inline" alttext="3.89 times 10 begin subscript 5 end subscript"><mml:mrow><mml:mn>3.89</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>5</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
<sup>
<xref rid="c61" ref-type="bibr">61</xref>
</sup>
</td><td headers="t1c7 t1c18" align="char" char="." colspan="1" rowspan="1">53,554<sup><xref rid="c61" ref-type="bibr">61</xref></sup></td><td headers="t1c8 t1c18" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i44" display="inline" alttext="2.23 times 10 begin subscript negative 5 end subscript"><mml:mrow><mml:mn>2.23</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td></tr><tr><td id="t1c19" headers="t1c1" scope="row" align="left" colspan="1" rowspan="1">Hexane</td><td headers="t1c2 t1c19" align="char" char="." colspan="1" rowspan="1">3.9</td><td headers="t1c3 t1c19" align="char" char="." colspan="1" rowspan="1">0.3336</td><td headers="t1c4 t1c9 t1c19" align="char" char="." colspan="1" rowspan="1">130.00<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c10 t1c19" align="char" char="." colspan="1" rowspan="1">3.75<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c11 t1c19" align="char" char="." colspan="1" rowspan="1">6.50<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c4 t1c12 t1c19" align="char" char="." colspan="1" rowspan="1">6.25<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c5 t1c19" align="char" char="." colspan="1" rowspan="1">0.8<sup><xref rid="c57" ref-type="bibr">57</xref></sup></td><td headers="t1c6 t1c19" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i45" display="inline" alttext="5.79 times 10 begin subscript 4 end subscript"><mml:mrow><mml:mn>5.79</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
<sup>
<xref rid="c54" ref-type="bibr">54</xref>
</sup>
</td><td headers="t1c7 t1c19" align="char" char="." colspan="1" rowspan="1">400<sup><xref rid="c54" ref-type="bibr">54</xref></sup></td><td headers="t1c8 t1c19" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i46" display="inline" alttext="3.51 times 10 begin subscript negative 5 end subscript"><mml:mrow><mml:mn>3.51</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td></tr><tr><td id="t1c20" headers="t1c1" scope="row" align="left" colspan="1" rowspan="1"><inline-formula><mml:math id="i1as" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-Nonane</td><td headers="t1c2 t1c20" align="char" char="." colspan="1" rowspan="1">5.65</td><td headers="t1c3 t1c20" align="char" char="." colspan="1" rowspan="1">3.2295</td><td headers="t1c4 t1c9 t1c20" align="char" char="." colspan="1" rowspan="1">142.45<sup><xref rid="c38" ref-type="bibr">38</xref></sup></td><td headers="t1c4 t1c10 t1c20" align="char" char="." colspan="1" rowspan="1">8.58<sup><xref rid="c38" ref-type="bibr">38</xref></sup></td><td headers="t1c4 t1c11 t1c20" align="char" char="." colspan="1" rowspan="1">8.37<sup><xref rid="c38" ref-type="bibr">38</xref></sup></td><td headers="t1c4 t1c12 t1c20" align="char" char="." colspan="1" rowspan="1">5.30<sup><xref rid="c38" ref-type="bibr">38</xref></sup></td><td headers="t1c5 t1c20" align="char" char="." colspan="1" rowspan="1">75.06<sup><xref rid="c38" ref-type="bibr">38</xref></sup></td><td headers="t1c6 t1c20" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i47" display="inline" alttext="1.06 times 10 begin subscript 8 end subscript"><mml:mrow><mml:mn>1.06</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>8</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
<sup>
<xref rid="c62" ref-type="bibr">62</xref>
</sup>
</td><td headers="t1c7 t1c20" align="char" char="." colspan="1" rowspan="1">8,016<sup><xref rid="c62" ref-type="bibr">62</xref></sup></td><td headers="t1c8 t1c20" align="char" char="." colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i48" display="inline" alttext="6.35 times 10 begin subscript negative 7 end subscript"><mml:mrow><mml:mn>6.35</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>Note: <inline-formula><mml:math id="i49" display="inline" alttext="uppercase italic k begin subscript lowercase m end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, concentration of compound in liver tissue, at which the biotransformation rate is half maximum, also called the Michaelis constant; <inline-formula><mml:math id="i51" display="inline" alttext="uppercase italic k begin subscript lowercase p end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, dermal penetration rate of compound into the skin, <inline-formula><mml:math id="i52" display="inline" alttext="log of uppercase italic k begin subscript lowercase p end subscript equals 0.71 times log of uppercase italic k begin subscript octanol-water end subscript minus 0.0061 times molecular weight minus 2.72"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mn>0.71</mml:mn><mml:mo>&#215;</mml:mo><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>0.0061</mml:mn><mml:mo>&#215;</mml:mo><mml:mi>M</mml:mi><mml:mi>W</mml:mi><mml:mo>&#8722;</mml:mo><mml:mn>2.72</mml:mn></mml:mrow></mml:math></inline-formula><sup><xref rid="c41" ref-type="bibr">41</xref>,<xref rid="c42" ref-type="bibr">42</xref></sup>; <inline-formula><mml:math id="i53" display="inline" alttext="uppercase italic k begin subscript renal end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>renal</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, renal excretion coefficient; <inline-formula><mml:math id="i50" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, logarithm of the octanol-water partition coefficient; <inline-formula><mml:math id="i54" display="inline" alttext="uppercase italic p begin subscript tissue or blood end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>tissure&#8201;</mml:mtext><mml:mo>/</mml:mo><mml:mtext>&#8201;blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, partition coefficient of compound between tissue and blood; <inline-formula><mml:math id="i55" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, the maximum biotransformation rate in liver; VOC, volatile organic compound.</p></fn></table-wrap-foot></table-wrap><p>The dermal absorption through using FHPs was calculated as follows (<xref rid="d1" ref-type="disp-formula">Equations 1</xref>&#8722;<xref rid="d3" ref-type="disp-formula">3</xref>)<sup><xref rid="c38" ref-type="bibr">38</xref>&#8211;<xref rid="c42" ref-type="bibr">42</xref></sup>:
<disp-formula id="d1"><label><x xml:space="preserve">(</x>1<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d1.jpg"/><mml:math id="m1" display="block" alttext="uppercase italic m begin subscript skin end subscript equals uppercase italic k begin subscript lowercase italic p end subscript times uppercase italic m begin subscript product end subscript times uppercase italic r begin subscript uppercase italic t end subscript over lowercase italic l"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>skin</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>&#215;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>product</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>&#215;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mi>l</mml:mi></mml:mfrac></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>
<disp-formula id="d2"><label><x xml:space="preserve">(</x>2<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d2.jpg"/><mml:math id="m2" display="block" alttext="uppercase italic m begin subscript product end subscript equals uppercase italic m begin subscript product, lowercase t equals 0 end subscript times lowercase e minus start fraction uppercase italic k begin subscript lowercase italic p end subscript times uppercase italic r begin subscript uppercase italic t end subscript over lowercase italic l times lowercase t end fraction"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>product</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>product</mml:mtext><mml:mo>,</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mi mathvariant="normal">t</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mo>&#215;</mml:mo><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:msub></mml:mrow><mml:mo>&#215;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mi>l</mml:mi></mml:mfrac></mml:mrow><mml:mo>&#215;</mml:mo><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>and
<disp-formula id="d3"><label><x xml:space="preserve">(</x>3<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d3.jpg"/><mml:math id="m3" display="block" alttext="log of open parenthesis uppercase italic k begin subscript uppercase p end subscript close parenthesis equals 0.71 times log of open parenthesis uppercase italic k begin subscript octanol-water end subscript close parenthesis minus 0.0061 times molecular weight minus 2.72"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mfenced><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0.71</mml:mn><mml:mo>&#215;</mml:mo><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mfenced><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfenced><mml:mo>&#8722;</mml:mo><mml:mn>0.0061</mml:mn><mml:mo>&#215;</mml:mo><mml:mi>M</mml:mi><mml:mi>W</mml:mi><mml:mo>&#8722;</mml:mo><mml:mn>2.72</mml:mn></mml:mrow></mml:math></alternatives></disp-formula>where <inline-formula><mml:math id="i56" display="inline" alttext="uppercase italic m begin subscript skin end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>skin</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the amount of compounds absorbed via skin per hour (ng/h); <inline-formula><mml:math id="i57" display="inline" alttext="uppercase italic k begin subscript lowercase p end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the permeability coefficient (cm/h); <inline-formula><mml:math id="i58" display="inline" alttext="uppercase italic m begin subscript product end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>product</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the amount (ng) of compounds remaining in products at any time during the exposure; <inline-formula><mml:math id="i59" display="inline" alttext="uppercase italic m begin subscript product, lowercase t equals 0 end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>product</mml:mtext><mml:mo>,</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mi mathvariant="normal">t</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the initial VOC mass in FHPs (ng), which is calculated by multiplying the initial chemical concentration in products (<italic toggle="yes">C</italic>, ng/g) by the mass of products (<italic toggle="yes">M</italic>, g) (<xref rid="d2" ref-type="disp-formula">Equation 2</xref>); <inline-formula><mml:math id="i60" display="inline" alttext="uppercase italic r begin subscript lowercase t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the transition rate of chemical from the product to the skin (<inline-formula><mml:math id="i61" display="inline" alttext="uppercase italic r begin subscript lowercase t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, dimensionless),<sup><xref rid="c40" ref-type="bibr">40</xref></sup> which is assumed to be 1 in this study due to the lack of available data on the target VOCs, simulating the maximum potential dermal exposure; <italic toggle="yes">l</italic> is the skin thickness, taking a value of <inline-formula><mml:math id="i62" display="inline" alttext="0.2 centimeter"><mml:mrow><mml:mn>0.2</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">cm</mml:mi></mml:mrow></mml:math></inline-formula><sup><xref rid="c43" ref-type="bibr">43</xref></sup>; <inline-formula><mml:math id="i63" display="inline" alttext="uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the octanol-water partition coefficient; and <italic toggle="yes">MW</italic> is the molecular weight (g/mol). Most previous PBTK studies focused on the inhalation exposure of the target VOCs,<sup><xref rid="c44" ref-type="bibr">44</xref>&#8211;<xref rid="c46" ref-type="bibr">46</xref></sup> resulting in a lack of permeability coefficient data for these VOCs in the literature. Therefore, the permeability coefficient was calculated using <xref rid="d3" ref-type="disp-formula">Equation 3</xref>, as suggested by the US Environmental Protection Agency (US EPA)<sup><xref rid="c41" ref-type="bibr">41</xref></sup> and adapted from Guy and Potts.<sup><xref rid="c42" ref-type="bibr">42</xref></sup> The calculated values are shown in <xref rid="t1" ref-type="table">Table 1</xref>. Based on previous studies, VOCs are rapidly absorbed through the skin.<sup><xref rid="c47" ref-type="bibr">47</xref>,<xref rid="c48" ref-type="bibr">48</xref></sup> In addition, materials such as the waterproof backing of pads can prevent VOCs from evaporating.<sup><xref rid="c40" ref-type="bibr">40</xref></sup> Therefore, we assume no evaporation of VOCs during dermal exposure in this study, which also simulates the worst case for conservative assessment.</p><p>Although inhalation exposure is identified as the main exposure route of VOCs,<sup><xref rid="c2" ref-type="bibr">2</xref></sup> it was not the target exposure route aimed in this study. Therefore, it was only considered in the model validation. VOCs concentrations in outdoor air were much lower than those indoors,<sup><xref rid="c26" ref-type="bibr">26</xref></sup> and given that individuals spend over 80% of their time indoors,<sup><xref rid="c49" ref-type="bibr">49</xref></sup> measured indoor air VOCs concentrations were used to simulate the inhalation exposure. The inhalation absorption dose was calculated as below (<xref rid="d4" ref-type="disp-formula">Equation 4</xref>):
<disp-formula id="d4"><label><x xml:space="preserve">(</x>4<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d4.jpg"/><mml:math id="m4" display="block" alttext="uppercase italic m begin subscript inhalation end subscript equals uppercase italic q begin subscript uppercase p end subscript times uppercase italic c begin subscript air end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>inhalation</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>&#215;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>air</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>where <inline-formula><mml:math id="i64" display="inline" alttext="uppercase italic m begin subscript inhalation end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>inhalation</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the amount of compound absorbed via inhalation per hour (ng/h); <inline-formula><mml:math id="i65" display="inline" alttext="uppercase italic q begin subscript uppercase p end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> (mL/h) represents the alveolar ventilation volume per hour, set at <inline-formula><mml:math id="i66" display="inline" alttext="460, 588 milliliters per hour"><mml:mrow><mml:mn>460</mml:mn><mml:mo>,</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mn>588</mml:mn><mml:mi mathvariant="normal">mL</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">h</mml:mi></mml:mrow></mml:math></inline-formula> in this study for a <inline-formula><mml:math id="i67" display="inline" alttext="74.9 kilogram"><mml:mrow><mml:mn>74.9</mml:mn><mml:mtext>-kg</mml:mtext></mml:mrow></mml:math></inline-formula> female; <inline-formula><mml:math id="i68" display="inline" alttext="uppercase italic c begin subscript air end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>air</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the concentration (ng/mL) of the target VOCs in indoor air. <inline-formula><mml:math id="i69" display="inline" alttext="uppercase italic q begin subscript uppercase p end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> was calculated based on <inline-formula><mml:math id="i70" display="inline" alttext="390000 milliliters per hour"><mml:mrow><mml:mn>390,000</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mL</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">h</mml:mi></mml:mrow></mml:math></inline-formula> for a <inline-formula><mml:math id="i71" display="inline" alttext="60 kilograms"><mml:mrow><mml:mn>60</mml:mn><mml:mtext>-kg</mml:mtext></mml:mrow></mml:math></inline-formula>, seated, awake female<sup><xref rid="c50" ref-type="bibr">50</xref></sup> and adjusted according to the reported correlation between <inline-formula><mml:math id="i72" display="inline" alttext="uppercase italic q begin subscript uppercase p end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and body <inline-formula><mml:math id="i73" display="inline" alttext="weight begin superscript 0.75 end superscript"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>weight</mml:mtext></mml:mrow><mml:mrow><mml:mn>0.75</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="i74" display="inline" alttext="body weight begin superscript 0.75 end superscript"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>BW</mml:mtext></mml:mrow><mml:mrow><mml:mn>0.75</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>).<sup><xref rid="c51" ref-type="bibr">51</xref></sup> Because body weight (BW) was not measured in the studied population,<sup><xref rid="c3" ref-type="bibr">3</xref></sup> we used <inline-formula><mml:math id="i75" display="inline" alttext="74.9 kilograms"><mml:mrow><mml:mn>74.9</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">kg</mml:mi></mml:mrow></mml:math></inline-formula>, the average BW of US females 20&#8211;29 y of age during the period 2015&#8211;2018,<sup><xref rid="c52" ref-type="bibr">52</xref></sup> corresponding to the age range of the studied population (IQR of the age of the female participants in this study being 22&#8211;25).<sup><xref rid="c13" ref-type="bibr">13</xref></sup></p></sec><sec id="s2.3"><title>Field Study of Inhalation Exposure</title><p>To assess the concurrent inhalation exposure, we conducted a field study involving VOC measurements in indoor air samples (<inline-formula><mml:math id="i76" display="inline" alttext="lowercase italic n equals 20"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>20</mml:mn></mml:mrow></mml:math></inline-formula>) from Ann Arbor and Detroit, Michigan, the same cities where the 25 female participants lived, though not from the participants&#8217; residences. We collected these air samples during the same period when we collected urine samples from participants. Sixteen samples were obtained between January and June 2019 from a hotel located in Ann Arbor, and four samples were collected in September 2018 from a house located in Detroit. The concentrations of VOCs detected in these samples are shown in Table S1.</p><p>We collected the air samples using passive sampling with thermal desorption tubes, following establishing protocols.<sup><xref rid="c26" ref-type="bibr">26</xref>,<xref rid="c27" ref-type="bibr">27</xref></sup> These <inline-formula><mml:math id="i77" display="inline" alttext="10 centimeters"><mml:mrow><mml:mn>10</mml:mn><mml:mtext>-cm</mml:mtext></mml:mrow></mml:math></inline-formula>-long stainless sorbent tubes with a <inline-formula><mml:math id="i78" display="inline" alttext="0.4 centimeter"><mml:mrow><mml:mn>0.4</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">cm</mml:mi></mml:mrow></mml:math></inline-formula> inner diameter, were packed with <inline-formula><mml:math id="i79" display="inline" alttext="160 milligrams"><mml:mrow><mml:mn>160</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula> Tenax-GR (60/80 mesh), with a diffusion gap of <inline-formula><mml:math id="i80" display="inline" alttext="0.5 centimeter"><mml:mrow><mml:mn>0.5</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">cm</mml:mi></mml:mrow></mml:math></inline-formula>. Glass wool plugs were placed at both ends to secure the sorbent Tenax-GR (Figure S2). Prior to sampling, the tubes were conditioned at 325&#176;C for 6 h with purging ultrapure nitrogen gas at <inline-formula><mml:math id="i81" display="inline" alttext="30 milliliters per minute"><mml:mrow><mml:mn>30</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mL</mml:mi><mml:mo>/</mml:mo><mml:mtext>min</mml:mtext></mml:mrow></mml:math></inline-formula>. Once conditioned, the tubes were sealed with stainless-steel caps containing prebaked Teflon seals, wrapped in baked aluminum foil, stored in a clean glass jar with activated carbon pack, and placed in a refrigerator kept at <inline-formula><mml:math id="i82" display="inline" alttext="4 degrees Celsius"><mml:mrow><mml:mn>4</mml:mn><mml:mo>&#186;</mml:mo><mml:mi mathvariant="normal">C</mml:mi></mml:mrow></mml:math></inline-formula>. During sampling, the cap was removed and the tube was placed in a stand at breathing height (<inline-formula><mml:math id="i83" display="inline" alttext="approximately 1.5 meters"><mml:mrow><mml:mo>&#8764;</mml:mo><mml:mn>1.5</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:math></inline-formula>; Figure S2) to allow air to passively diffuse. The sampling uptake rate was calculated thorough a diffusion model.<sup><xref rid="c26" ref-type="bibr">26</xref>,<xref rid="c27" ref-type="bibr">27</xref></sup> After sampling, the tubes were resealed and stored under the same conditions as they were under before sampling, followed by instrument analysis.</p><p>Instrument analysis has been well described in our previous studies.<sup><xref rid="c28" ref-type="bibr">28</xref>,<xref rid="c29" ref-type="bibr">29</xref></sup> In brief, each tube was spiked with internal standards (fluorobenzene, <inline-formula><mml:math id="i1e" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-bromofluorobenzene, and <inline-formula><mml:math id="i84" display="inline" alttext="1 2 dichlorobenzene d begin subscript 4 end subscript"><mml:mrow><mml:mn>1,2</mml:mn><mml:msub><mml:mtext>-dichlorobenzene-d</mml:mtext><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) before being analyzed using an automated thermal desorption system (TD; Scientific Instrument Services) coupled to a gas chromatography&#8211;mass spectrometer (GC-MS; Agilent Model 6890/5973), which was equipped with a cryogenic trap. The instrument setting and detailed conditions are presented in Table S4.</p></sec><sec id="s2.4"><title>PBTK Model Configuration</title><p>The PBTK model used in this study (<xref rid="f2" ref-type="fig">Figure 2</xref>) featured five compartments representing various tissues, including blood, liver (the metabolic tissue), adipose tissue (the storage tissue), kidney (the excretory tissue), and other tissues (rest of the body). Absorption via dermal exposure was input into the PBTK model to investigate VOCs dynamics in human tissues from the use of FHPs. Indoor inhalation exposure was included only during the model validation, regarding its significant contribution to internal exposure of the target VOCs, as stated above. Because oral exposure was not the focus of this study, it was not considered in the model, and thus gut tissue was merged into the rest of the body. The major kinetic equations (<xref rid="d5" ref-type="disp-formula">Equations 5</xref>&#8211;<xref rid="d11" ref-type="disp-formula">11</xref>) are provided below to predict the VOCs dynamics in different tissues.<sup><xref rid="c38" ref-type="bibr">38</xref>,<xref rid="c53" ref-type="bibr">53</xref>&#8211;<xref rid="c56" ref-type="bibr">56</xref></sup>
<disp-formula id="d5"><label><x xml:space="preserve">(</x>5<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d5.jpg"/><mml:math id="m5" display="block" alttext="change of concentration begin subscript uppercase b end subscript over change in time equals 1 over uppercase italic v begin subscript uppercase b end subscript open parenthesis uppercase italic q begin subscript uppercase l end subscript uppercase italic c begin subscript uppercase l end subscript over uppercase italic p begin subscript liver or blood end subscript plus uppercase italic q begin subscript uppercase a t end subscript uppercase italic c begin subscript uppercase a t end subscript over uppercase italic p begin subscript adipose or blood end subscript plus uppercase italic q begin subscript uppercase k end subscript uppercase italic c begin subscript uppercase k end subscript over uppercase italic p begin subscript kidney or blood end subscript plus uppercase italic q begin subscript uppercase r b end subscript uppercase italic c begin subscript uppercase r b end subscript over uppercase italic p begin subscript rest of body or blood end subscript minus uppercase italic q begin subscript uppercase c end subscript uppercase italic c begin subscript uppercase c end subscript plus uppercase italic m begin subscript skin end subscript plus uppercase italic m begin subscript inhalation end subscript minus uppercase italic m begin subscript exhalation end subscript close parenthesis"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mfenced><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>liver</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>adipose</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>kidney</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>rest&#8201;of&#8201;body</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>&#8722;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>skin</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>inhalation</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>&#8722;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>exhalation</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula></p><fig position="float" id="f2" orientation="portrait"><label>Figure 2.</label><caption><p>Schematic diagram of PBTK model implemented in this study. Concentrations in skin and lung (in dashed boxes) were not predicted, and they are shown in the schematic diagram to indicate the exposure routes. Note: <inline-formula><mml:math id="i85" display="inline" alttext="uppercase italic c begin subscript uppercase b end subscript"><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, chemical concentration in blood; <inline-formula><mml:math id="i86" display="inline" alttext="uppercase italic k begin subscript lowercase m end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, Michaelis constant; <inline-formula><mml:math id="i87" display="inline" alttext="uppercase italic k begin subscript lowercase p end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, permeability coefficient; <inline-formula><mml:math id="i88" display="inline" alttext="uppercase italic k begin subscript renal end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>renal</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, the renal excretion coefficient; PBTK, physiologically based toxicokinetic; <inline-formula><mml:math id="i89" display="inline" alttext="uppercase italic q begin subscript uppercase a t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i90" display="inline" alttext="uppercase italic q begin subscript uppercase c end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i91" display="inline" alttext="uppercase italic q begin subscript uppercase k end subscript"><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i92" display="inline" alttext="uppercase italic q begin subscript uppercase l end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="i93" display="inline" alttext="uppercase italic q begin subscript uppercase r b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, blood flow to adipose tissue, cardiac output, kidney, liver, lung and rest of body, respectively; <inline-formula><mml:math id="i94" display="inline" alttext="uppercase italic q begin subscript uppercase p end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, alveolar ventilation volume per hour; <inline-formula><mml:math id="i95" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, maximum biotransformation rate in liver.</p></caption><alt-text>Figure 2 is a flowchart with four steps. Step 1: Input Pathways: An arrow with the labels K begin subscript lowercase p end subscript indicates that dermal exposure enters through the skin. The lung, indicated by another arrow with the designation Q begin subscript uppercase p end subscript, is where inhalation exposure enters. An indication of the lung&#8217;s output is exhalation. Step 2: Central Compartment: The blood serves as the central compartment, absorbing substances through the skin and the lungs. The chemical concentrations in blood and the blood flow of cardiac output are marked. Step 3: Distribution Compartments: Chemicals go from the bloodstream to the liver, kidneys, adipose tissue, and the remainder of the body. Each compartment contains two-way arrows indicating blood exchange. Step 4: Metabolism and excretion: The liver is the site of metabolism, as shown by the arrow labeled maximal biotransformation rate in the liver, or Michaelis constant. Kidney: The site of excretion, with an orange arrow indicating the renal excretion coefficient. Exhalation and excretion are the last stages of elimination.</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_f2.jpg"/></fig><disp-formula id="d6"><label><x xml:space="preserve">(</x>6<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d6.jpg"/><mml:math id="m6" display="block" alttext="change of concentration begin subscript uppercase b end subscript over change in time equals uppercase italic q begin subscript uppercase a t end subscript over uppercase italic v begin subscript uppercase a t end subscript open parenthesis uppercase italic c begin subscript uppercase b end subscript minus uppercase italic c begin subscript uppercase a t end subscript over uppercase italic p begin subscript adipose or blood end subscript close parenthesis"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mfenced><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>&#8722;</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>adipose</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula><disp-formula id="d7"><label><x xml:space="preserve">(</x>7<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d7.jpg"/><mml:math id="m7" display="block" alttext="change of concentration begin subscript uppercase r b end subscript over change in time equals uppercase italic q begin subscript uppercase r b end subscript over uppercase italic v begin subscript uppercase r b end subscript open parenthesis uppercase italic c begin subscript uppercase r b end subscript minus uppercase italic c begin subscript uppercase a t end subscript over uppercase italic p begin subscript rest of body or blood end subscript close parenthesis"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mfenced><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>&#8722;</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>rest&#8201;of&#8201;body</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula><disp-formula id="d8"><label><x xml:space="preserve">(</x>8<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d8.jpg"/><mml:math id="m8" display="block" alttext="change of concentration begin subscript uppercase l end subscript over change in time equals uppercase italic q begin subscript uppercase l end subscript over uppercase italic v begin subscript uppercase l end subscript open parenthesis uppercase italic c begin subscript uppercase b end subscript minus uppercase italic c begin subscript uppercase l end subscript over uppercase italic p begin subscript liver or blood end subscript close parenthesis minus lowercase nu begin subscript maximum end subscript uppercase italic c begin subscript uppercase l end subscript divided by uppercase italic p begin subscript liver or blood end subscript over uppercase k begin subscript lowercase m end subscript plus uppercase italic c begin subscript uppercase l end subscript divided by uppercase italic p begin subscript liver or blood end subscript"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mfenced><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>&#8722;</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>liver</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:mfenced><mml:mo>&#8722;</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>liver</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>liver</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula><disp-formula id="d9"><label><x xml:space="preserve">(</x>9<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d9.jpg"/><mml:math id="m9" display="block" alttext="change of concentration begin subscript uppercase k end subscript over change in time equals uppercase italic q begin subscript uppercase k end subscript over uppercase italic v begin subscript uppercase k end subscript open parenthesis uppercase italic c begin subscript uppercase b end subscript minus uppercase italic c begin subscript uppercase k end subscript over uppercase italic p begin subscript kidney or blood end subscript close parenthesis minus uppercase italic q begin subscript uppercase k end subscript uppercase italic c begin subscript uppercase b end subscript uppercase italic k begin subscript renal end subscript over uppercase italic v begin subscript uppercase k end subscript"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mfenced><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>&#8722;</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>kidney</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:mfenced><mml:mo>&#8722;</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>renal</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula><disp-formula id="d10"><label><x xml:space="preserve">(</x>10<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d10.jpg"/><mml:math id="m10" display="block" alttext="uppercase italic m begin subscript exhalation end subscript equals uppercase italic q begin subscript uppercase p end subscript uppercase italic c begin subscript uppercase b end subscript over uppercase italic p begin subscript blood or air end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>exhalation</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mtext>&#8201;</mml:mtext></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>blood</mml:mtext><mml:mo>/</mml:mo><mml:mtext>air</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula><p>and
<disp-formula id="d11"><label><x xml:space="preserve">(</x>11<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d11.jpg"/><mml:math id="m11" display="block" alttext="uppercase italic c begin subscript urine end subscript equals uppercase italic q begin subscript uppercase k end subscript uppercase italic c begin subscript uppercase b end subscript uppercase italic k begin subscript renal end subscript over uppercase italic v begin subscript urine end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>urine</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>renal</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mtext>urine</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>where <inline-formula><mml:math id="i100" display="inline" alttext="uppercase italic c begin subscript uppercase a t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i101" display="inline" alttext="uppercase italic c begin subscript uppercase b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i102" display="inline" alttext="uppercase italic c begin subscript uppercase k end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i103" display="inline" alttext="uppercase italic c begin subscript uppercase l end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i104" display="inline" alttext="uppercase italic c begin subscript uppercase r b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="i105" display="inline" alttext="uppercase italic c begin subscript urine end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mtext>urine</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> are the concentrations (ng/mL) of compounds in the adipose tissue, blood, kidney, liver, rest of body, and urine, respectively; <inline-formula><mml:math id="i106" display="inline" alttext="uppercase italic q begin subscript uppercase c end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the total cardiac output per hour (mL/h); <inline-formula><mml:math id="i107" display="inline" alttext="uppercase italic q begin subscript uppercase a t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i108" display="inline" alttext="uppercase italic q begin subscript uppercase k end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i109" display="inline" alttext="uppercase italic q begin subscript uppercase l end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="i110" display="inline" alttext="uppercase italic q begin subscript uppercase r b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> are the blood flow (mL/h) to adipose tissue, kidney, liver, and rest of body, respectively; <inline-formula><mml:math id="i111" display="inline" alttext="uppercase italic v begin subscript uppercase a t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i112" display="inline" alttext="uppercase italic v begin subscript uppercase b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i113" display="inline" alttext="uppercase italic v begin subscript uppercase k end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i114" display="inline" alttext="uppercase italic v begin subscript uppercase l end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="i115" display="inline" alttext="uppercase italic v begin subscript uppercase r b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mtext>RB</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> are the volumes (mL) of adipose tissue, blood, kidney, liver, and rest of body, respectively; <inline-formula><mml:math id="i116" display="inline" alttext="uppercase italic v begin subscript urine end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mtext>urine</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the volume of urine produced per hour (mL/h); <inline-formula><mml:math id="i117" display="inline" alttext="uppercase italic p begin subscript adipose or blood end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>adipose</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i118" display="inline" alttext="uppercase italic p begin subscript kidney or blood end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>kidney</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i119" display="inline" alttext="uppercase italic p begin subscript liver or blood end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>liver</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i120" display="inline" alttext="uppercase italic p begin subscript rest of body or blood end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>rest&#8201;of&#8201;body</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="i121" display="inline" alttext="uppercase italic p begin subscript blood or air end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>blood</mml:mtext><mml:mo>/</mml:mo><mml:mtext>air</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> are the partition coefficients (dimensionless) of corresponding tissues to blood and blood to air (<xref rid="t1" ref-type="table">Table 1</xref>)<sup><xref rid="c38" ref-type="bibr">38</xref>,<xref rid="c57" ref-type="bibr">57</xref>,<xref rid="c58" ref-type="bibr">58</xref></sup>; <inline-formula><mml:math id="i122" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the maximum biotransformation rate (ng/mL tissue/h) in liver,<sup><xref rid="c54" ref-type="bibr">54</xref>,<xref rid="c59" ref-type="bibr">59</xref>&#8211;<xref rid="c62" ref-type="bibr">62</xref></sup> shown in <xref rid="t1" ref-type="table">Table 1</xref>; <inline-formula><mml:math id="i123" display="inline" alttext="uppercase italic k begin subscript lowercase m end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the Michaelis constant, i.e., the concentration (ng/mL) of a compound in liver tissue when the biotransformation rate of liver reaches half of its maximum (<xref rid="t1" ref-type="table">Table 1</xref>)<sup><xref rid="c54" ref-type="bibr">54</xref>,<xref rid="c59" ref-type="bibr">59</xref>&#8211;<xref rid="c62" ref-type="bibr">62</xref></sup>; <inline-formula><mml:math id="i124" display="inline" alttext="uppercase italic m begin subscript exhalation end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mtext>exhalation</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the amount of compound exhaled per hour (ng/h); and <inline-formula><mml:math id="i125" display="inline" alttext="uppercase italic k begin subscript renal end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>renal</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the renal excretion coefficient (dimensionless, <xref rid="t1" ref-type="table">Table 1</xref>).<sup><xref rid="c38" ref-type="bibr">38</xref></sup></p><p>Physiological values such as blood flow to various tissues and tissue volumes are related to BW, set at <inline-formula><mml:math id="i126" display="inline" alttext="74.9 kilograms"><mml:mrow><mml:mn>74.9</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">kg</mml:mi></mml:mrow></mml:math></inline-formula> in this study, as explained above in the section titled &#8220;External Exposure Scenario and Dermal Absorption.&#8221; According to Brown et al.,<sup><xref rid="c63" ref-type="bibr">63</xref></sup> cardiac output (<inline-formula><mml:math id="i127" display="inline" alttext="uppercase italic q begin subscript uppercase c end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) correlates with <inline-formula><mml:math id="i128" display="inline" alttext="body weight begin superscript 0.75 end superscript"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>BW</mml:mtext></mml:mrow><mml:mrow><mml:mn>0.75</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>. In addition, the International Commission on Radiological Protection (ICRP) reports that a female weighing <inline-formula><mml:math id="i129" display="inline" alttext="60 kilograms"><mml:mrow><mml:mn>60</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">kg</mml:mi></mml:mrow></mml:math></inline-formula> has a cardiac output of <inline-formula><mml:math id="i130" display="inline" alttext="5.9 liters per minute"><mml:mrow><mml:mn>5.9</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">L</mml:mi><mml:mo>/</mml:mo><mml:mtext>min</mml:mtext></mml:mrow></mml:math></inline-formula>.<sup><xref rid="c50" ref-type="bibr">50</xref></sup> Based on this, we applied the relationship: cardiac output <inline-formula><mml:math id="i131" display="inline" alttext="open parenthesis liter per hour close parenthesis equals 16.4 open parenthesis liter per hour per kilogram begin superscript 0.75 end superscript close parenthesis times body weight begin superscript 0.75 end superscript open parenthesis kilogram close parenthesis"><mml:mrow><mml:mfenced><mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">h</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>16.4</mml:mn><mml:mfenced><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">h</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">kg</mml:mi></mml:mrow><mml:mrow><mml:mn>0.75</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:mfenced><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mtext>BW</mml:mtext></mml:mrow><mml:mrow><mml:mn>0.75</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mfenced><mml:mrow><mml:mi mathvariant="normal">kg</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math></inline-formula>, as demonstrated by Smith et al.<sup><xref rid="c51" ref-type="bibr">51</xref></sup> According to the ICRP,<sup><xref rid="c50" ref-type="bibr">50</xref></sup> percentages of blood flow to adipose tissue (<inline-formula><mml:math id="i132" display="inline" alttext="uppercase italic q begin subscript uppercase a t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>), kidney (<inline-formula><mml:math id="i133" display="inline" alttext="uppercase italic q begin subscript uppercase k end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>), and liver (<inline-formula><mml:math id="i134" display="inline" alttext="uppercase italic q begin subscript uppercase l end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) are 8.5%, 17%, and 27% of cardiac output (<inline-formula><mml:math id="i135" display="inline" alttext="uppercase italic q begin subscript uppercase c end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>), respectively. The masses of adipose tissue, blood, kidney, and liver are 30%, 6.8%, 0.458%, and 2.33% of body weight, respectively,<sup><xref rid="c50" ref-type="bibr">50</xref></sup> which were used to determine the tissue volumes (<inline-formula><mml:math id="i136" display="inline" alttext="uppercase italic v begin subscript uppercase a t end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mtext>AT</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i137" display="inline" alttext="uppercase italic v begin subscript uppercase b end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">B</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i138" display="inline" alttext="uppercase italic v begin subscript uppercase k end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="i139" display="inline" alttext="uppercase italic v begin subscript uppercase l end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) in this study (Table S2).</p><p>Partition coefficients between various tissues and blood were primarily derived from the tissue/air partition coefficients reported by Meulenberg and Vijverberg.<sup><xref rid="c57" ref-type="bibr">57</xref></sup> This report consolidated data from multiple previous studies, providing comprehensive data including <inline-formula><mml:math id="i140" display="inline" alttext="uppercase italic p begin subscript kidney or blood end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>kidney</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>. Partition coefficients for methyl ethyl ketone was sourced from a previous PBTK study.<sup><xref rid="c58" ref-type="bibr">58</xref></sup> Because there are no relevant human data for <inline-formula><mml:math id="i1f" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, its partition coefficients were calculated using a generic PBTK model developed by Jongeneelen and Ten Berge.<sup><xref rid="c38" ref-type="bibr">38</xref></sup> The partition coefficient between muscle and blood was used as the coefficient for the rest of the body/blood (<inline-formula><mml:math id="i141" display="inline" alttext="uppercase italic p begin subscript rest of body or blood end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>rest&#8201;of&#8201;body</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>), which was also sourced from these studies, together with <inline-formula><mml:math id="i142" display="inline" alttext="uppercase italic p begin subscript blood or air end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>blood</mml:mtext><mml:mo>/</mml:mo><mml:mtext>air</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>.<sup><xref rid="c38" ref-type="bibr">38</xref>,<xref rid="c57" ref-type="bibr">57</xref>,<xref rid="c58" ref-type="bibr">58</xref></sup></p><p>The maximum biotransformation rates in the liver (<inline-formula><mml:math id="i143" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) were derived from previous PBTK modeling studies and are as below: 2,575; 122; 504; and <inline-formula><mml:math id="i144" display="inline" alttext="874 micromoles per kilogram"><mml:mrow><mml:mn>874</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">&#956;</mml:mi><mml:mtext>mol</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">kg</mml:mi></mml:mrow></mml:math></inline-formula> tissue/h for methylene chloride, benzene, toluene, and styrene, respectively<sup><xref rid="c60" ref-type="bibr">60</xref></sup>; <inline-formula><mml:math id="i145" display="inline" alttext="30 micromoles per minute"><mml:mrow><mml:mn>30</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">&#956;</mml:mi><mml:mtext>mol</mml:mtext><mml:mo>/</mml:mo><mml:mtext>min</mml:mtext></mml:mrow></mml:math></inline-formula> based on <inline-formula><mml:math id="i146" display="inline" alttext="1.5 kilograms"><mml:mrow><mml:mn>1.5</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">kg</mml:mi></mml:mrow></mml:math></inline-formula> of liver for methyl ethyl ketone<sup><xref rid="c59" ref-type="bibr">59</xref></sup>; and <inline-formula><mml:math id="i147" display="inline" alttext="1.35 milligrams per hour per kilogram"><mml:mrow><mml:mn>1.35</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mg</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">h</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">kg</mml:mi></mml:mrow></mml:math></inline-formula> BW for hexane.<sup><xref rid="c54" ref-type="bibr">54</xref></sup> No <italic toggle="yes">in&#160;vivo</italic>
<inline-formula><mml:math id="i148" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> data for <inline-formula><mml:math id="i1g" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene and <inline-formula><mml:math id="i1at" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane in humans are available. An <italic toggle="yes">in vitro</italic> study by Meesters et al. identified the <inline-formula><mml:math id="i149" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="i1h" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene metabolism to three metabolites via four CYP enzymes.<sup><xref rid="c61" ref-type="bibr">61</xref></sup> We averaged the reported <inline-formula><mml:math id="i500" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> values, resulting in <inline-formula><mml:math id="i151" display="inline" alttext="4.372 millimoles per minute per millimole"><mml:mrow><mml:mn>4.372</mml:mn><mml:mtext>&#8201;mmol</mml:mtext><mml:mo>/</mml:mo><mml:mtext>min</mml:mtext><mml:mo>/</mml:mo><mml:mtext>mmol</mml:mtext></mml:mrow></mml:math></inline-formula> CYP enzymes,<sup><xref rid="c61" ref-type="bibr">61</xref></sup> and then multiplied this by the averaged CYP concentration in microsomes (<inline-formula><mml:math id="i152" display="inline" alttext="0.345 nanomole per milligram"><mml:mrow><mml:mn>0.345</mml:mn><mml:mtext>&#8201;nmol</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>) and the microsomal content in the liver (<inline-formula><mml:math id="i153" display="inline" alttext="32 milligrams per gram"><mml:mrow><mml:mn>32</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mg</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>),<sup><xref rid="c64" ref-type="bibr">64</xref>,<xref rid="c65" ref-type="bibr">65</xref></sup> yielding a calculated <inline-formula><mml:math id="i154" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="i1i" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene of <inline-formula><mml:math id="i155" display="inline" alttext="3.89 times 10 begin superscript 5 end superscript nanogram per milliliter"><mml:mrow><mml:mn>3.89</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>5</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> tissue/h. A similar <inline-formula><mml:math id="i156" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> deviation for <inline-formula><mml:math id="i1au" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane was derived from an <italic toggle="yes">in vitro</italic>
<inline-formula><mml:math id="i157" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> of <inline-formula><mml:math id="i158" display="inline" alttext="429 nanomoles per minute per milligram"><mml:mrow><mml:mn>429</mml:mn><mml:mtext>&#8201;nmol</mml:mtext><mml:mo>/</mml:mo><mml:mtext>min</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula> human liver microsomes,<sup><xref rid="c62" ref-type="bibr">62</xref></sup> resulting in a calculated <inline-formula><mml:math id="i159" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> of <inline-formula><mml:math id="i160" display="inline" alttext="1.06 times 10 begin superscript 8 end superscript nanogram per milliliter"><mml:mrow><mml:mn>1.06</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>8</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> tissue/h for <inline-formula><mml:math id="i1aaa" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane. Correspondingly, Michaelis constants (<inline-formula><mml:math id="i161" display="inline" alttext="uppercase italic k begin subscript lowercase m end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) were also obtained from these studies, with values of 6.8, 2.0, 40, 5.84, 3.46, and <inline-formula><mml:math id="i162" display="inline" alttext="6.25 micromoles per liter"><mml:mrow><mml:mn>62.5</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">&#956;</mml:mi><mml:mtext>mol</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula> for methylene chloride,<sup><xref rid="c60" ref-type="bibr">60</xref></sup> methyl ethyl ketone,<sup><xref rid="c59" ref-type="bibr">59</xref></sup> benzene,<sup><xref rid="c60" ref-type="bibr">60</xref></sup> toluene,<sup><xref rid="c60" ref-type="bibr">60</xref></sup> styrene,<sup><xref rid="c60" ref-type="bibr">60</xref></sup> and <inline-formula><mml:math id="i1bbb" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane,<sup><xref rid="c62" ref-type="bibr">62</xref></sup> respectively, and <inline-formula><mml:math id="i163" display="inline" alttext="0.40 milligram per liter"><mml:mrow><mml:mn>0.40</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">mg</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula> for hexane.<sup><xref rid="c54" ref-type="bibr">54</xref></sup> The averaged <inline-formula><mml:math id="i164" display="inline" alttext="uppercase italic k begin subscript lowercase m end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="i1j" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene was <inline-formula><mml:math id="i165" display="inline" alttext="399 micromoles per liter"><mml:mrow><mml:mn>399</mml:mn><mml:mo>&#8196;</mml:mo><mml:mi mathvariant="normal">&#956;</mml:mi><mml:mtext>mol</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula> by different CYP enzymes.<sup><xref rid="c61" ref-type="bibr">61</xref></sup> Because renal excretion coefficients (<inline-formula><mml:math id="i166" display="inline" alttext="uppercase italic k begin subscript renal end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>renal</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) were generally not included in previous PBTK modeling studies, we used a generic method (<xref rid="d12" ref-type="disp-formula">Equation 12</xref>) for their calculation, as developed by Jongeneelen and Ten Berge.<sup><xref rid="c38" ref-type="bibr">38</xref></sup>
<disp-formula id="d12"><label><x xml:space="preserve">(</x>12<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d12.jpg"/><mml:math id="m12" display="block" alttext="uppercase italic k begin subscript renal end subscript equals glomerulus filtrate times fraction of the compound in blood that is dissolved in water begin subscript solution end subscript times open parenthesis 1 minus fraction begin subscript tubular end subscript close parenthesis"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>renal</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mi>G</mml:mi><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>F</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mo>&#215;</mml:mo><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:msub><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mtext>sol</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>&#215;</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>&#8722;</mml:mo><mml:mi>F</mml:mi><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mtext>tubular</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>and
<disp-formula id="d13"><label><x xml:space="preserve">(</x>13<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d13.jpg"/><mml:math id="m13" display="block" alttext="fraction of the compound in blood that is dissolved in water begin subscript solution end subscript equals 0.993 over 0.993 plus 0.007 times 10 begin superscript log of open parenthesis uppercase italic k begin subscript octanol-water end subscript close parenthesis end superscript"><mml:mrow><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:msub><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mtext>sol</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mn>0.993</mml:mn></mml:mrow><mml:mrow><mml:mn>0.993</mml:mn><mml:mo>+</mml:mo><mml:mn>0</mml:mn><mml:mrow><mml:msup><mml:mrow><mml:mo>.</mml:mo><mml:mn>007</mml:mn><mml:mo>&#215;</mml:mo><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mtext>&#8201;</mml:mtext><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mfenced><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>where, <italic toggle="yes">GlomFiltr</italic> is the fraction of glomerulus filtrate (dimensionless), set as 0.2 based on Carlson,<sup><xref rid="c66" ref-type="bibr">66</xref></sup> which is close to the average value of 0.18 derived from the three values (0.08, 0.16, and 0.3) provided by Jongeneelen and Ten Berge<sup><xref rid="c38" ref-type="bibr">38</xref>,<xref rid="c67" ref-type="bibr">67</xref></sup>; <inline-formula><mml:math id="i167" display="inline" alttext="fraction of the compound in blood that is dissolved in water begin subscript solution end subscript"><mml:mrow><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:msub><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mtext>sol</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the fraction of the compound in blood that is dissolved in water (dimensionless), calculated using <xref rid="d13" ref-type="disp-formula">Equation 13</xref><sup><xref rid="c38" ref-type="bibr">38</xref></sup>; <inline-formula><mml:math id="i168" display="inline" alttext="fraction begin subscript tubular end subscript"><mml:mrow><mml:mi>F</mml:mi><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mtext>tubular</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the fraction of tubular resorption (dimensionless), set as 0.94 for methyl ethyl ketone and 0.99 for other target VOCs, as dependent from their <inline-formula><mml:math id="i169" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>.<sup><xref rid="c67" ref-type="bibr">67</xref></sup></p></sec><sec id="s2.5"><title>Model Validation and Uncertainty Analysis</title><p>We validated the model performance by comparing the estimated concentrations with the measurements obtained from urine samples. The urinary VOC concentrations in first-morning-void urine samples, collected from our previous study involving 25 female participants,<sup><xref rid="c13" ref-type="bibr">13</xref></sup> were used as the measured values. Urine samples were collected at four time points: 7 d before menstruation and 3, 7, and 14 d after the first day of menstruation.<sup><xref rid="c13" ref-type="bibr">13</xref></sup> We assumed that the first-morning-void urine represented the previous 8 h [from 2400 hours to 0800 hours (midnight to 8 A.M.)]. Therefore, these four time points corresponded to the 505th to 512th hour, the 73rd to 80th hour, the 169th to 176th hour, and the 337th to 344th hour of the 28-d menstrual cycle in the model, accounting for both dermal exposure to FHPs and inhalation exposure. Consequently, we compared the mean urinary concentrations of the 25 females at each time point with the average estimated concentrations during the corresponding 8-h intervals from the model.</p><p>The target VOCs may also be contained in other non-FHP personal care products,<sup><xref rid="c68" ref-type="bibr">68</xref>,<xref rid="c69" ref-type="bibr">69</xref></sup> which were not included in the current model verification due to the lack of relevant exposure data among the female participants,<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c13" ref-type="bibr">13</xref></sup> potentially leading to underestimation by the PBTK model. Among the target VOCs, benzene, toluene, styrene, and <inline-formula><mml:math id="i1k" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene had the most readily available data in the literature on additional exposure sources.<sup><xref rid="c68" ref-type="bibr">68</xref>,<xref rid="c69" ref-type="bibr">69</xref></sup> To conduct a further model verification by including a more comprehensive range of exposure sources, we incorporated additional exposure data from the literature for these four substances: 48.7, 94.6, and <inline-formula><mml:math id="i170" display="inline" alttext="171 nanograms per kilogram per day"><mml:mrow><mml:mn>171</mml:mn><mml:mtext>&#8201;ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">kg</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">d</mml:mi></mml:mrow></mml:math></inline-formula> for dermal exposure to benzene, toluene, and styrene from sunscreen<sup><xref rid="c69" ref-type="bibr">69</xref></sup> and <inline-formula><mml:math id="i171" display="inline" alttext="42 nanograms per kilogram per day"><mml:mn>42</mml:mn><mml:mtext>&#8201;ng</mml:mtext><mml:mo>/</mml:mo><mml:mi>kg</mml:mi><mml:mo>/</mml:mo><mml:mtext>d</mml:mtext></mml:math></inline-formula> for inhalation and <inline-formula><mml:math id="i172" display="inline" alttext="508 nanograms per kilogram per day"><mml:mrow><mml:mn>508</mml:mn><mml:mtext>&#8201;ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">kg</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">d</mml:mi></mml:mrow></mml:math></inline-formula> for dermal exposure to <inline-formula><mml:math id="i1l" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene from non-FHP fragrance products.<sup><xref rid="c68" ref-type="bibr">68</xref></sup></p><p>For our uncertainty analysis, we adopted probability bounds analysis, which investigated two extreme exposure scenarios beyond the best-guess scenario.<sup><xref rid="c70" ref-type="bibr">70</xref></sup> This method could efficiently capture the full range of potential predictions in a resource-efficient manner. The fifth and 95th percentile values of parameters in the PBTK model were used (Table S5). For the lowest exposure scenario, the 95th percentile BW among females 20&#8211;29 y of age in the United States was used.<sup><xref rid="c52" ref-type="bibr">52</xref></sup> In addition, associated physiological data (e.g., blood flows in tissue and tissue volumes) were considered. To simulate this scenario, the VOC amount in FHPs was reduced to 25% of the original value, reflecting that the mass of a panty liner was only 25% that of a regular pad, as measured in our previous study.<sup><xref rid="c2" ref-type="bibr">2</xref></sup> This adjustment was also applied to other FHPs in the absence of specific data, relying on empirical estimates. Conversely, for the highest exposure scenario, the fifth percentile BW among females 20&#8211;29 y of age in the United States was used,<sup><xref rid="c52" ref-type="bibr">52</xref></sup> along with associated physiological data. The amounts of VOCs in FHPs were doubled (because the mass of the super-size pad was twice that of the regular size) to simulate this scenario.<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c52" ref-type="bibr">52</xref></sup></p></sec><sec id="s2.6"><title>Health Risk Assessment</title><p>We conducted further assessments of noncancer risks [i.e., hazard ratio (HR) for adverse nonneoplastic health effects] and cancer risks (CR) associated with dermal exposure to VOCs from the use of FHPs using <xref rid="d14" ref-type="disp-formula">Equations 14</xref>&#8211;<xref rid="d16" ref-type="disp-formula">16</xref>. These estimations were performed under three exposure scenarios (best-guess, lowest, and highest), as previously mentioned. A noncancer risk is considered notable when the HR exceeds 1 (or 0.1 in a more conservative scenario), and a cancer risk is deemed notable when the CR surpasses <inline-formula><mml:math id="i173" display="inline" alttext="10 begin superscript negative 6 end superscript"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> (or <inline-formula><mml:math id="i174" display="inline" alttext="10 begin superscript negative 7 end superscript"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> in a more conservative scenario).
<disp-formula id="d14"><label><x xml:space="preserve">(</x>14<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d14.jpg"/><mml:math id="m14" display="block" alttext="daily dose equals time minus cumulative absorption times 10 begin superscript negative 6 end superscript times 13 times uppercase italic d begin subscript uppercase italic e end subscript over body weight times 28 times 13 times uppercase italic d begin subscript uppercase italic e end subscript"><mml:mrow><mml:mi>D</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>y</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mi>d</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>i</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mo>-</mml:mo><mml:mi>c</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>u</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mo>&#8196;</mml:mo><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>s</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>p</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msup><mml:mrow><mml:mo>&#215;</mml:mo><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>&#215;</mml:mo><mml:mn>13</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mrow><mml:mi>B</mml:mi><mml:mi>o</mml:mi><mml:mi>d</mml:mi><mml:mi>y</mml:mi><mml:mo>&#8196;</mml:mo><mml:mi>W</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mo>&#215;</mml:mo><mml:mtext>&#8201;</mml:mtext><mml:mn>28</mml:mn><mml:mo>&#215;</mml:mo><mml:mn>13</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>
<disp-formula id="d15"><label><x xml:space="preserve">(</x>15<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d15.jpg"/><mml:math id="m15" display="block" alttext="hazard ratio open parenthesis uppercase h r close parenthesis of dermal exposure equals daily dose over reference dose"><mml:mi>H</mml:mi><mml:mi>a</mml:mi><mml:mi>z</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>d</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mfenced><mml:mrow><mml:mi>H</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:mfenced><mml:mtext>&#8201;</mml:mtext><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mi>D</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>y</mml:mi><mml:mo>&#8196;</mml:mo><mml:mi>d</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>f</mml:mi><mml:mi>D</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>,</mml:mo></mml:math></alternatives></disp-formula>and
<disp-formula id="d16"><label><x xml:space="preserve">(</x>16<x xml:space="preserve">)</x></label><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_d16.jpg"/><mml:math id="m16" display="block" alttext="cancer risk open parenthesis uppercase italic c r close parenthesis of dermal exposure equals daily dose times cancer slope factor"><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>k</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mfenced><mml:mrow><mml:mi>C</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:mfenced><mml:mtext>&#8201;</mml:mtext><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>u</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mo>=</mml:mo><mml:mi>D</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>y</mml:mi><mml:mo>&#8196;</mml:mo><mml:mi>d</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mo>&#215;</mml:mo><mml:mi>C</mml:mi><mml:mi>S</mml:mi><mml:mi>F</mml:mi></mml:math></alternatives></disp-formula>where <italic toggle="yes">time-cumulative absorption</italic> is the cumulative mass (ng) absorbed via skin by using the four categories of FHPs; <italic toggle="yes">Body Weight</italic> is the BW (kg) of the US females 20&#8211;29 y of age<sup><xref rid="c52" ref-type="bibr">52</xref></sup>
<inline-formula><mml:math id="i175" display="inline" alttext="10 begin superscript negative 6 end superscript"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> is to convert ng to mg; <italic toggle="yes">13</italic> is the number of menstrual cycles in 1 y, if a menstrual cycle is 28 d; <inline-formula><mml:math id="i176" display="inline" alttext="uppercase italic d begin subscript uppercase italic e end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> is the exposure duration (year), herein referring to the number of years women experience menstrual cycles; <italic toggle="yes">28</italic> is the days of a menstrual cycle; <italic toggle="yes">RfD</italic> is the reference dose (mg/kg/d), an estimate of a daily exposure, under which there is unlikely an appreciable risk of adverse noncancer health effects<sup><xref rid="c71" ref-type="bibr">71</xref></sup>; and <italic toggle="yes">CSF</italic> is the cancer slope factor (d/kg/mg), which is the upper bound (approximately a 95% confidence limit) for the increased cancer risk from a lifetime exposure expressed as dose (mg/kg/d).<sup><xref rid="c71" ref-type="bibr">71</xref></sup> Herein, we did not average the daily dose into a lifetime to assess the cancer risk as a scenario of an early onset cancer. The evaluation of health risks was conducted using RfDs and CSFs sourced from CalTOX (<xref rid="t2" ref-type="table">Table 2</xref>)<sup><xref rid="c72" ref-type="bibr">72</xref></sup> or alternatively using data from oral exposure combined with gastrointestinal absorption factors (GIABS).<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c20" ref-type="bibr">20</xref></sup></p><table-wrap position="float" id="t2" orientation="portrait"><label>Table 2</label><caption><p>Health risks of estimated skin absorption of VOCs by using feminine hygiene products during a 28-d menstrual cycle in three scenarios.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/><col align="left" valign="top" span="1"/></colgroup><thead><tr><th id="t2c1" rowspan="2" scope="col" align="left" colspan="1">VOC</th><th id="t2c2" rowspan="2" scope="col" align="center" colspan="1">RfD (mg/kg/d)</th><th id="t2c3" rowspan="2" scope="col" align="center" colspan="1">CSF (d/kg/mg)</th><th id="t2c4" colspan="3" scope="colgroup" align="center" rowspan="1">Daily absorption (ng/kg/d)</th><th id="t2c5" colspan="3" scope="colgroup" align="center" rowspan="1">Hazard ratio</th><th id="t2c6" colspan="3" scope="colgroup" align="center" rowspan="1">Cancer risk</th></tr><tr><th id="t2c7" headers="t2c4" scope="col" align="center" colspan="1" rowspan="1">Best-guess</th><th id="t2c8" headers="t2c4" scope="col" align="center" colspan="1" rowspan="1">Lowest</th><th id="t2c9" headers="t2c4" scope="col" align="center" colspan="1" rowspan="1">Highest</th><th id="t2c10" headers="t2c5" scope="col" align="center" colspan="1" rowspan="1">Best-guess</th><th id="t2c11" headers="t2c5" scope="col" align="center" colspan="1" rowspan="1">Lowest</th><th id="t2c12" headers="t2c5" scope="col" align="center" colspan="1" rowspan="1">Highest</th><th id="t2c13" headers="t2c6" scope="col" align="center" colspan="1" rowspan="1">Best-guess</th><th id="t2c14" headers="t2c6" scope="col" align="center" colspan="1" rowspan="1">Lowest</th><th id="t2c15" headers="t2c6" scope="col" align="center" colspan="1" rowspan="1">Highest</th></tr></thead><tbody valign="top"><tr><td id="t2c16" headers="t2c1" scope="row" align="left" colspan="1" rowspan="1">Methylene chloride</td><td headers="t2c2 t2c16" align="char" char="." colspan="1" rowspan="1">0.006<xref rid="TF3" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td headers="t2c3 t2c16" align="char" char="." colspan="1" rowspan="1">0.014</td><td headers="t2c4 t2c7 t2c16" align="char" char="." colspan="1" rowspan="1">0.03</td><td headers="t2c4 t2c8 t2c16" align="char" char="." colspan="1" rowspan="1">0.00</td><td headers="t2c4 t2c9 t2c16" align="char" char="." colspan="1" rowspan="1">0.08</td><td headers="t2c5 t2c10 t2c16" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i177" display="inline" alttext="4.30 times 10 begin subscript negative 6 end subscript"><mml:mrow><mml:mn>4.30</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c11 t2c16" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i178" display="inline" alttext="6.81 times 10 begin subscript negative 7 end subscript"><mml:mrow><mml:mn>6.81</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c12 t2c16" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i179" display="inline" alttext="1.33 times 10 begin subscript negative 5 end subscript"><mml:mrow><mml:mn>1.33</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c13 t2c16" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i180" display="inline" alttext="3.62 times 10 begin subscript negative 10 end subscript"><mml:mrow><mml:mn>3.62</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c14 t2c16" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i181" display="inline" alttext="5.72 times 10 begin subscript negative 11 end subscript"><mml:mrow><mml:mn>5.72</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>11</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c15 t2c16" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i182" display="inline" alttext="1.12 times 10 begin subscript negative 9 end subscript"><mml:mrow><mml:mn>1.12</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>9</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td></tr><tr><td id="t2c17" headers="t2c1" scope="row" align="left" colspan="1" rowspan="1">Methyl ethyl ketone</td><td headers="t2c2 t2c17" align="char" char="." colspan="1" rowspan="1">0.6</td><td headers="t2c3 t2c17" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c4 t2c7 t2c17" align="char" char="." colspan="1" rowspan="1">0.95</td><td headers="t2c4 t2c8 t2c17" align="char" char="." colspan="1" rowspan="1">0.15</td><td headers="t2c4 t2c9 t2c17" align="char" char="." colspan="1" rowspan="1">2.93</td><td headers="t2c5 t2c10 t2c17" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i183" display="inline" alttext="1.58 times 10 begin subscript negative 6 end subscript"><mml:mrow><mml:mn>1.58</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c11 t2c17" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i184" display="inline" alttext="2.50 times 10 begin subscript negative 7 end subscript"><mml:mrow><mml:mn>2.50</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c12 t2c17" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i185" display="inline" alttext="4.89 times 10 begin subscript negative 6 end subscript"><mml:mrow><mml:mn>4.89</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c13 t2c17" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c14 t2c17" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c15 t2c17" align="center" colspan="1" rowspan="1">&#8212;</td></tr><tr><td id="t2c18" headers="t2c1" scope="row" align="left" colspan="1" rowspan="1">Benzene</td><td headers="t2c2 t2c18" align="char" char="." colspan="1" rowspan="1">0.004<xref rid="TF3" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td headers="t2c3 t2c18" align="char" char="." colspan="1" rowspan="1">0.1</td><td headers="t2c4 t2c7 t2c18" align="char" char="." colspan="1" rowspan="1">0.59</td><td headers="t2c4 t2c8 t2c18" align="char" char="." colspan="1" rowspan="1">0.09</td><td headers="t2c4 t2c9 t2c18" align="char" char="." colspan="1" rowspan="1">1.82</td><td headers="t2c5 t2c10 t2c18" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i186" display="inline" alttext="1.48 times 10 begin subscript negative 4 end subscript"><mml:mrow><mml:mn>1.48</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c11 t2c18" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i187" display="inline" alttext="2.33 times 10 begin subscript negative 5 end subscript"><mml:mrow><mml:mn>2.33</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c12 t2c18" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i188" display="inline" alttext="4.56 times 10 begin subscript negative 4 end subscript"><mml:mrow><mml:mn>4.56</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c13 t2c18" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i189" display="inline" alttext="5.90 times 10 begin subscript negative 8 end subscript"><mml:mrow><mml:mn>5.90</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c14 t2c18" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i190" display="inline" alttext="9.34 times 10 begin subscript negative 9 end subscript"><mml:mrow><mml:mn>9.34</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>9</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c15 t2c18" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i191" display="inline" alttext="1.82 times 10 begin subscript negative 7 end subscript"><mml:mrow><mml:mn>1.82</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td></tr><tr><td id="t2c19" headers="t2c1" scope="row" align="left" colspan="1" rowspan="1">Toluene</td><td headers="t2c2 t2c19" align="char" char="." colspan="1" rowspan="1">0.08<xref rid="TF3" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td headers="t2c3 t2c19" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c4 t2c7 t2c19" align="char" char="." colspan="1" rowspan="1">2.75</td><td headers="t2c4 t2c8 t2c19" align="char" char="." colspan="1" rowspan="1">0.43</td><td headers="t2c4 t2c9 t2c19" align="char" char="." colspan="1" rowspan="1">8.48</td><td headers="t2c5 t2c10 t2c19" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i192" display="inline" alttext="3.43 times 10 begin subscript negative 5 end subscript"><mml:mrow><mml:mn>3.43</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c11 t2c19" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i193" display="inline" alttext="5.43 times 10 begin subscript negative 6 end subscript"><mml:mrow><mml:mn>5.43</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c12 t2c19" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i194" display="inline" alttext="1.06 times 10 begin subscript negative 4 end subscript"><mml:mrow><mml:mn>1.06</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c13 t2c19" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c14 t2c19" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c15 t2c19" align="center" colspan="1" rowspan="1">&#8212;</td></tr><tr><td id="t2c20" headers="t2c1" scope="row" align="left" colspan="1" rowspan="1">Styrene</td><td headers="t2c2 t2c20" align="char" char="." colspan="1" rowspan="1">0.2</td><td headers="t2c3 t2c20" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c4 t2c7 t2c20" align="char" char="." colspan="1" rowspan="1">1.86</td><td headers="t2c4 t2c8 t2c20" align="char" char="." colspan="1" rowspan="1">0.29</td><td headers="t2c4 t2c9 t2c20" align="char" char="." colspan="1" rowspan="1">5.73</td><td headers="t2c5 t2c10 t2c20" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i195" display="inline" alttext="9.28 times 10 begin subscript negative 6 end subscript"><mml:mrow><mml:mn>9.28</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c11 t2c20" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i196" display="inline" alttext="1.47 times 10 begin subscript negative 6 end subscript"><mml:mrow><mml:mn>1.47</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c12 t2c20" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i197" display="inline" alttext="2.87 times 10 begin subscript negative 5 end subscript"><mml:mrow><mml:mn>2.87</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c13 t2c20" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c14 t2c20" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c15 t2c20" align="center" colspan="1" rowspan="1">&#8212;</td></tr><tr><td id="t2c21" headers="t2c1" scope="row" align="left" colspan="1" rowspan="1"><inline-formula><mml:math id="i1m" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-Cymene</td><td headers="t2c2 t2c21" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c3 t2c21" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c4 t2c7 t2c21" align="char" char="." colspan="1" rowspan="1">76.26</td><td headers="t2c4 t2c8 t2c21" align="char" char="." colspan="1" rowspan="1">12.06</td><td headers="t2c4 t2c9 t2c21" align="char" char="." colspan="1" rowspan="1">235.55</td><td headers="t2c5 t2c10 t2c21" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c5 t2c11 t2c21" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c5 t2c12 t2c21" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c13 t2c21" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c14 t2c21" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c15 t2c21" align="center" colspan="1" rowspan="1">&#8212;</td></tr><tr><td id="t2c22" headers="t2c1" scope="row" align="left" colspan="1" rowspan="1">Hexane</td><td headers="t2c2 t2c22" align="char" char="." colspan="1" rowspan="1">0.06</td><td headers="t2c3 t2c22" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c4 t2c7 t2c22" align="char" char="." colspan="1" rowspan="1">9.44</td><td headers="t2c4 t2c8 t2c22" align="char" char="." colspan="1" rowspan="1">1.49</td><td headers="t2c4 t2c9 t2c22" align="char" char="." colspan="1" rowspan="1">29.15</td><td headers="t2c5 t2c10 t2c22" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i198" display="inline" alttext="1.57 times 10 begin subscript negative 4 end subscript"><mml:mrow><mml:mn>1.57</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c11 t2c22" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i199" display="inline" alttext="2.49 times 10 begin subscript negative 5 end subscript"><mml:mrow><mml:mn>2.49</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c12 t2c22" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i200" display="inline" alttext="4.86 times 10 begin subscript negative 4 end subscript"><mml:mrow><mml:mn>4.86</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c13 t2c22" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c14 t2c22" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c15 t2c22" align="center" colspan="1" rowspan="1">&#8212;</td></tr><tr><td id="t2c23" headers="t2c1" scope="row" align="left" colspan="1" rowspan="1"><inline-formula><mml:math id="i1ccc" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-Nonane</td><td headers="t2c2 t2c23" align="char" char="." colspan="1" rowspan="1">0.0003<xref rid="TF3" ref-type="table-fn"><sup><italic toggle="yes">a</italic></sup></xref></td><td headers="t2c3 t2c23" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c4 t2c7 t2c23" align="char" char="." colspan="1" rowspan="1">7.09</td><td headers="t2c4 t2c8 t2c23" align="char" char="." colspan="1" rowspan="1">1.12</td><td headers="t2c4 t2c9 t2c23" align="char" char="." colspan="1" rowspan="1">21.89</td><td headers="t2c5 t2c10 t2c23" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i201" display="inline" alttext="2.36 times 10 begin subscript negative 2 end subscript"><mml:mrow><mml:mn>2.36</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c11 t2c23" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i202" display="inline" alttext="3.74 times 10 begin subscript negative 3 end subscript"><mml:mrow><mml:mn>3.74</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c5 t2c12 t2c23" align="center" colspan="1" rowspan="1">
<inline-formula>
<mml:math id="i203" display="inline" alttext="7.30 times 10 begin subscript negative 2 end subscript"><mml:mrow><mml:mn>7.30</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math>
</inline-formula>
</td><td headers="t2c6 t2c13 t2c23" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c14 t2c23" align="center" colspan="1" rowspan="1">&#8212;</td><td headers="t2c6 t2c15 t2c23" align="center" colspan="1" rowspan="1">&#8212;</td></tr></tbody></table><table-wrap-foot><fn id="TF2"><p>Note: RfD and CSF were sourced from CalTOX,<sup><xref rid="c72" ref-type="bibr">72</xref></sup> or alternatively using data from oral exposure and GIABS.<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c20" ref-type="bibr">20</xref></sup> The best-guess scenario is the general scenario using the mean value of body weight of females 20&#8211;29 y of age in the United States, along with the corresponding kinetic and physiological data based on body weight. The 95th and fifth percentile body weights of females 20&#8211;29 y of age in the United States were applied to simulate the lowest and highest exposure scenarios, respectively, along with the corresponding kinetic and physiological data based on body weight. One-fourth and double the dermal exposure amounts from the best-guess scenario were used to simulate the lowest and highest exposure scenarios, respectively. &#8212;, no data; CFS, cancer slope factor; GIABS, gastrointestinal absorption factors; RfD, reference dose; VOC, volatile organic compound.</p></fn><fn id="TF3"><label>
<sup>
<italic toggle="yes">a</italic>
</sup>
</label><p>Derived from oral exposure and GIABS.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2.7"><title>Software and Statistical Analysis Methods</title><p>The modeling was performed using R (version 4.4.0; R Foundation for Statistical Computing; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.R-project.org/" ext-link-type="uri">https://www.R-project.org/</ext-link>), and the source code is provided in the Supplemental Materials, &#8220;Model Code in R Software.&#8221; Internal VOC levels stabilized quickly with regular FHP use, typically reaching equilibrium by the sixth menstrual cycle (Figure S3). Therefore, most results below, except for the distribution in the &#8220;Results&#8221; section titled, &#8220;Distribution of VOCs in Different Tissues Based on PBTK Model,&#8221; are based on the modeling outcomes of the sixth menstrual cycle. The distribution results in section titled, &#8220;Distribution of VOCs in Different Tissues Based on PBTK Model,&#8221; in the &#8220;Results&#8221; section of this article focus on the first menstrual cycle to simulate the accumulation process.</p><p>Measurements (VOCs in air, FHPs, and urine) below the MDL (listed in Table S1) were recorded as 0 and labeled as ND (not detected). A single missing urine sample was excluded from the analysis. The descriptive statistics provided in the main text and tables included the median, mean, standard deviation (SD), and range. Group differences were assessed using the Mann-Whitney <italic toggle="yes">U</italic>-test. Spearman correlation analysis was conducted to examine the relationship between <inline-formula><mml:math id="i204" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and the partition proportion in adipose tissue. All statistical tests were two-sided, with a type-I error rate set at 0.05. Analyses were performed using SPSS (SPSS, Inc.), and the results were visualized using Origin 2024b (OriginLab Corporation) and R (version 4.4.0).</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3.1"><title>Estimated Skin Absorption Amounts of VOCs by Using FHPs</title><p>The skin absorption amounts of VOCs from four FHP categories over a 28-d menstrual cycle were estimated using <xref rid="d1" ref-type="disp-formula">Equations 1</xref>&#8211;<xref rid="d3" ref-type="disp-formula">3</xref>, based on measured VOC concentrations in FHPs. The estimated skin absorption of most VOCs, except for methylene chloride, exhibited a consistent increase throughout the duration of one menstrual cycle (<xref rid="f3" ref-type="fig">Figure 3A</xref>). Methylene chloride, mainly existing in pads rather than other target FHPs,<sup><xref rid="c2" ref-type="bibr">2</xref></sup> was estimated to reach its peak absorption on the seventh day of the menstrual period. Overall, the cumulative estimated skin absorption of all target VOCs amounted to <inline-formula><mml:math id="i205" display="inline" alttext="2.08 times 10 begin superscript 5 end superscript nanograms"><mml:mrow><mml:mn>2.08</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>5</mml:mn></mml:msup></mml:mrow><mml:mtext>&#8201;ng</mml:mtext></mml:mrow></mml:math></inline-formula> during one menstrual cycle of 28 d, with individual VOCs ranging from <inline-formula><mml:math id="i206" display="inline" alttext="54.2 nanograms"><mml:mrow><mml:mn>54.2</mml:mn><mml:mtext>&#8201;ng</mml:mtext></mml:mrow></mml:math></inline-formula> (methylene chloride) to <inline-formula><mml:math id="i207" display="inline" alttext="1.60 times 10 begin superscript 5 end superscript nanograms"><mml:mrow><mml:mn>1.60</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>5</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="i1azwe" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene) (Table S6).</p><fig position="float" id="f3" orientation="portrait"><label>Figure 3.</label><caption><p>(A) The estimated skin absorption amount dynamics of eight target VOCs from four categories of feminine hygiene products during a 28-d menstrual cycle. (B) Contribution dynamics of four categories of feminine hygiene products to the estimated skin absorption amounts of eight target VOCs during a 28-d menstrual cycle. All the data are shown in Supplemental Excel Tables S2&#8211;S3. Note: VOC, volatile organic compound.</p></caption><alt-text>Figure 3A is a set of eight area graphs titled methylene chloride, methyl ethyl ketone, benzene, toluene, Styrene, p-Cymene, Hexane, n-Nonane, plotting cumulative skin absorption (nanogram), ranging from 0 to 100 in increments of 50, 0 to 2000 in increments of 500, 0 to 1500 in increments of 500, 0 to 6000 in increments of 2000, 0 to 4000 in increments of 1000, 0 to 200000 in increments of 50000, 0 to 20000 in increments of 5000, 0 to 15000 in increments of 5000 (y-axis) across time (day), ranging from 0 to 28 in increments of 7 (x-axis) for pad, wash, wipe, and moisturizer, respectively. Figure 3B is a set of eight area graphs titled methylene chloride, methyl ethyl ketone, benzene, toluene, Styrene, p-Cymene, Hexane, n-Nonane, plotting contribution (percentage), ranging from 0 to 100 in increments of 20 (y-axis) across time (day), ranging from 0 to 28 in increments of 7 (x-axis) for pad, wash, wipe, and moisturizer, respectively.</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_f3.jpg"/></fig><p>In a 28-d menstrual cycle, all methylene chloride exposure was estimated to be attributed to pad usage. Pads also contributed to more than half of the estimated exposure to toluene (50.0%) and hexane (51.4%) (<xref rid="f3" ref-type="fig">Figure 3B</xref>). Feminine wash products were estimated to contribute predominantly to the absorption of the total target VOCs (84.1%, <inline-formula><mml:math id="i208" display="inline" alttext="1.75 times 10 begin superscript 5 end superscript nanograms"><mml:mrow><mml:mn>1.75</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>5</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula>; <xref rid="f4" ref-type="fig">Figure 4</xref>), especially styrene (73.4%, <inline-formula><mml:math id="i209" display="inline" alttext="2858 nanograms"><mml:mrow><mml:mn>2,858</mml:mn><mml:mtext>&#8201;ng</mml:mtext></mml:mrow></mml:math></inline-formula>), <inline-formula><mml:math id="i1n" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene (95.1%, <inline-formula><mml:math id="i210" display="inline" alttext="1.52 times 10 begin superscript 5 end superscript nanograms"><mml:mrow><mml:mn>1.52</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>5</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula>), and <inline-formula><mml:math id="i1ddd" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane (82.8%, <inline-formula><mml:math id="i211" display="inline" alttext="1.23 times 10 begin superscript 4 end superscript nanograms"><mml:mrow><mml:mn>1.23</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula>) (Table S6). Feminine wipes were estimated to account for 87.0% of the total absorption of methyl ethyl ketone (<inline-formula><mml:math id="i212" display="inline" alttext="1732 nanograms"><mml:mrow><mml:mn>1,732</mml:mn><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula>), whereas moisturizers contributed 82.5% of benzene (<inline-formula><mml:math id="i213" display="inline" alttext="2370 nanograms"><mml:mrow><mml:mn>2,370</mml:mn><mml:mtext>&#8201;ng</mml:mtext></mml:mrow></mml:math></inline-formula>).</p><fig position="float" id="f4" orientation="portrait"><label>Figure 4.</label><caption><p>(A) Sankey diagram illustrating the relative contributions of VOCs absorbed from four categories of feminine hygiene products during the first 28-d menstrual cycle and their distribution in human body at the end of a menstrual cycle based on PBTK model. (B) Scatter diagram between <inline-formula><mml:math id="i266" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> and proportion in adipose after skin absorption of VOCs from four categories of feminine hygiene products during the first 28-d menstrual cycle and the trend line based on PBTK model. The correlation was tested by Spearman analysis. All the data are shown in Supplemental Excel Tables S4&#8211;S5. Note: <inline-formula><mml:math id="i267" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>, logarithm of the octanol-water partition coefficient; PBTK, physiologically based toxicokinetic; VOC, volatile organic compound.</p></caption><alt-text>Figure 4A is a Sankey diagram that depicts the volatile organic compound pathways from feminine hygiene products to human distribution and elimination. Feminine Hygiene Products Sources: Categories of Feminine Hygiene Products: Wash (dominant source), Wipe, Moisturizer, and Pad. Volatile organic compounds: Emitted volatile organic compounds include p-cymene (most abundant), n-Nonane, styrene, hexane, methyl ethyl ketone, toluene, methylene chloride, and benzene. Each volatile organic compound is linked to specific feminine hygiene product sources via bands, indicating relative contribution amounts. Distribution: liver metabolism, adipose tissue, rest of body, kidney, liver, blood, exhalation, and urine excretion. The flow lines may vary in width, representing the quantity or intensity of chemical transfer. Figure 4B is a scatter dot plot, plotting proportion in adipose (percentage), ranging from 0 to 4 in unit increments and 20 to 30 in increments of 10 (y-axis) across log of uppercase italic k begin subscript octanol-water end subscript, ranging from 0 to 6 in unit increments (x-axis) for spearman analysis, p-cymene, n-Nonane, styrene, hexane, methyl ethyl ketone, toluene, methylene chloride, and benzene.</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_f4.jpg"/></fig></sec><sec id="s3.2"><title>VOC Concentration Dynamics in Different Tissues Based on PBTK Model</title><p>During a 28-d menstrual cycle, the highest estimated concentration was <inline-formula><mml:math id="i214" display="inline" alttext="2.23 nanograms per milliliter"><mml:mrow><mml:mn>2.23</mml:mn><mml:mtext>&#8201;ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> of <inline-formula><mml:math id="i1o" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene in the adipose tissue, estimated 395 min after the end of menstrual period. Across different tissues, adipose tissue generally exhibited higher VOC levels than other tissues, whereas the urine showed the lowest estimated concentrations for most target VOCs (<xref rid="f5" ref-type="fig">Figure 5A</xref>). The exception to this trend was methyl ethyl ketone, which was estimated to have the highest levels in urine and the lowest in liver.</p><fig position="float" id="f5" orientation="portrait"><label>Figure 5.</label><caption><p>(A) VOC concentration dynamics in different tissues using four categories of feminine hygiene products in the first 8 h of a menstrual cycle based on PBTK model. (B) VOC concentration dynamics in different tissues using four categories of feminine hygiene products during 28 d of a menstrual cycle based on PBTK model. All the data are shown in Supplemental Excel Table S6. Note: PBTK, physiologically based toxicokinetic; VOC, volatile organic compound.</p></caption><alt-text>Figure 5A is a set of eight line graphs titled methylene chloride, methyl ethyl ketone, benzene, toluene, Styrene, p-Cymene, Hexane, n-Nonane, plotting concentration (nanogram per milliliter), ranging as 10 begin superscript negative 9 end superscript, 10 begin superscript negative 8 end superscript, 10 begin superscript negative 7 end superscript, 10 begin superscript negative 6 end superscript, 10 begin superscript negative 5 end superscript, 10 begin superscript negative 4 end superscript; 10 begin superscript negative 6 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 2 end superscript; 10 begin superscript negative 5 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 3 end superscript, 10 begin superscript negative 2 end superscript; 10 begin superscript negative 5 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 3 end superscript, 10 begin superscript negative 2 end superscript; 10 begin superscript negative 6 end superscript, 10 begin superscript negative 5 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 3 end superscript, 10 begin superscript negative 2 end superscript; 10 begin superscript negative 4 end superscript, 10 begin superscript negative 3 end superscript, 10 begin superscript negative 2 end superscript, 10 begin superscript negative 1 end superscript, 1 to 10 in increments of 9; 10 begin superscript negative 7 end superscript, 10 begin superscript negative 5 end superscript, 10 begin superscript negative 3 end superscript, 10 begin superscript negative 1 end superscript; 10 begin superscript negative 8 end superscript, 10 begin superscript negative 6 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 2 end superscript, and 1 (y-axis) across time (hour), ranging from 0 to 8 in unit increments (x-axis) for blood, adipose, rest of body, liver, kidney, and urine, respectively. Figure 5B is a set of eight line graphs titled methylene chloride, methyl ethyl ketone, benzene, toluene, Styrene, p-Cymene, Hexane, n-Nonane, plotting concentration (nanogram per milliliter), ranging as 10 begin superscript negative 34 end superscript, 10 begin superscript negative 24 end superscript, 10 begin superscript negative 14 end superscript, 10 begin superscript negative 4 end superscript; 10 begin superscript negative 6 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 2 end superscript; 10 begin superscript negative 6 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 2 end superscript; 10 begin superscript negative 6 end superscript, 10 begin superscript negative 5 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 3 end superscript, 10 begin superscript negative 2 end superscript, 10 begin superscript negative 1 end superscript; 10 begin superscript negative 6 end superscript, 10 begin superscript negative 5 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 3 end superscript, 10 begin superscript negative 2 end superscript, 10 begin superscript negative 1 end superscript; 10 begin superscript negative 6 end superscript, 10 begin superscript negative 5 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 3 end superscript, 10 begin superscript negative 2 end superscript, 10 begin superscript negative 1 end superscript; 10 begin superscript negative 5 end superscript, 10 begin superscript negative 3 end superscript, 10 begin superscript negative 1 end superscript, 10; 10 begin superscript negative 8 end superscript, 10 begin superscript negative 6 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 2 end superscript, and 10 begin superscript negative 9 end superscript, 10 begin superscript negative 6 end superscript, 10 begin superscript negative 3 end superscript, and 1 (y-axis) across time (day), ranging from 0 to 28 in increments of 7 (x-axis) for blood, adipose, rest of body, liver, kidney, and urine, respectively.</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_f5.jpg"/></fig><p>Given that pads are almost exclusively used during menstruation,<sup><xref rid="c73" ref-type="bibr">73</xref></sup> the model estimated that VOCs such as hexane, which exhibited significant proportions of dermal absorption through pads (<xref rid="f3" ref-type="fig">Figure 3</xref>), showed increased concentrations in tissues (excluding adipose) and urine during menstruation in comparison with the postmenstrual period (<xref rid="f5" ref-type="fig">Figure 5B</xref>). Methylene chloride experienced a dramatic increase at the beginning of the menstrual period and then maintained stable but slow increases and decreases in tissues along with the pad use during the menstrual period, followed by a large decrease during the postmenstrual period.</p><p>For the VOCs present in the wash, the estimated concentrations in the blood, liver, kidney, and urine exhibited a sharp rise after wash use, usually peaking at 6 min before rapidly declining as the wash application stopped (<xref rid="f5" ref-type="fig">Figure 5A</xref>). Afterward, the estimated concentrations of all target VOCs increased again due to the use of other FHPs, but the subsequent rises were less pronounced. For example, after the use of other FHPs, hexane and <inline-formula><mml:math id="i1fff" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane peaked within 2 min, whereas benzene and <inline-formula><mml:math id="i1p" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene peaked within 8&#8211;14 min (Table S7). Other VOCs showed a more gradual increase, with their peak times ranging from 37 to 50 min. In the rest of the body, concentrations rose more slowly, peaking 9&#8211;49 min later than those in the blood. After peaking, concentrations of styrene, <inline-formula><mml:math id="i1q" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, hexane, and <inline-formula><mml:math id="i1iii" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane were estimated to decrease to <inline-formula><mml:math id="i215" display="inline" alttext="approximately 10 percent"><mml:mrow><mml:mo>&#8764;</mml:mo><mml:mn>10</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> or even lower until the next FHP use, whereas the concentrations of other target VOCs declined at a slower rate (<xref rid="f5" ref-type="fig">Figure 5A</xref>).</p><p>In contrast to the significant fluctuations estimated in other tissues and urine, the estimated levels of VOCs in adipose tissue displayed a very small undulation, with some VOCs, including methylene chloride, benzene, toluene, and hexane, maintaining a gradual upward trend through the end of the menstrual period. Even after 7 d of the menstrual period, the levels of VOCs in adipose tissue were estimated to experience only a slight decrease, with methylene chloride being the exception (<xref rid="f5" ref-type="fig">Figure 5B</xref>). Throughout the subsequent 21-d postmenstrual period, most VOC concentrations in adipose tissue exhibited a more pronounced, yet still minor, pattern of increase and decrease.</p></sec><sec id="s3.3"><title>Distribution of VOCs in Different Tissues Based on PBTK Model</title><p>After exposure from using FHPs during the first 28-d menstrual cycle, the PBTK model predicted that 53.1% of the total target VOCs (<inline-formula><mml:math id="i216" display="inline" alttext="1.10 times 10 begin superscript 5 end superscript nanograms"><mml:mrow><mml:mn>1.10</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>5</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula>) were metabolized via liver. In addition, 25.8% (<inline-formula><mml:math id="i217" display="inline" alttext="5.35 times 10 begin superscript 4 end superscript nanograms"><mml:mrow><mml:mn>5.35</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula>) were estimated to be exhaled, and 0.02% (<inline-formula><mml:math id="i218" display="inline" alttext="31.7 nanograms"><mml:mrow><mml:mn>31.7</mml:mn><mml:mtext>&#8201;ng</mml:mtext></mml:mrow></mml:math></inline-formula>) were excreted via urine, as illustrated in <xref rid="f4" ref-type="fig">Figure 4A</xref>. The remaining VOCs were primarily distributed in adipose tissue, although constituting only 20.1% of the total target VOCs (<inline-formula><mml:math id="i219" display="inline" alttext="4.18 times 10 begin superscript 4 end superscript nanograms"><mml:mrow><mml:mn>4.18</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula>). The estimated adipose distribution primarily comprised <inline-formula><mml:math id="i1r" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene (<inline-formula><mml:math id="i220" display="inline" alttext="4.11 times 10 begin superscript 4 end superscript nanograms"><mml:mrow><mml:mn>4.11</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula>), <inline-formula><mml:math id="i1jjj" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane (<inline-formula><mml:math id="i221" display="inline" alttext="538 nanograms"><mml:mrow><mml:mn>538</mml:mn><mml:mtext>&#8201;ng</mml:mtext></mml:mrow></mml:math></inline-formula>), and hexane (<inline-formula><mml:math id="i222" display="inline" alttext="53.7 nanograms"><mml:mrow><mml:mn>53.7</mml:mn><mml:mtext>&#8201;ng</mml:mtext></mml:mrow></mml:math></inline-formula>). These distribution disparities may explain the higher estimated concentrations of most target VOCs in adipose tissue. In addition, the model predicted that the accumulation typically peaked within hours after the end of the menstrual period, echoing the peak concentration of <inline-formula><mml:math id="i1s" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene occurring about 395 min post menstruation, as discussed above.</p><p>Regarding individual VOCs, their estimated proportions in adipose tissue varied widely, ranging from 0% (<inline-formula><mml:math id="i223" display="inline" alttext="0 nanogram"><mml:mrow><mml:mn>0</mml:mn><mml:mtext>&#8201;ng</mml:mtext></mml:mrow></mml:math></inline-formula> out of <inline-formula><mml:math id="i224" display="inline" alttext="54.2 nanograms"><mml:mrow><mml:mn>54.2</mml:mn><mml:mtext>&#8201;ng</mml:mtext></mml:mrow></mml:math></inline-formula> for methylene chloride) to 25.7% (<inline-formula><mml:math id="i225" display="inline" alttext="4.11 times 10 begin superscript 4 end superscript nanograms"><mml:mrow><mml:mn>4.11</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula> out of <inline-formula><mml:math id="i226" display="inline" alttext="1.60 times 10 begin superscript 5 end superscript nanograms"><mml:mrow><mml:mn>1.60</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>5</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="i1t" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene). We further examined the logarithm of the octanol-water partition coefficient (<inline-formula><mml:math id="i227" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) of the individual VOCs and their estimated relative mass proportions in adipose tissue in relation to total skin absorption (<xref rid="f4" ref-type="fig">Figure 4B</xref>), revealing a significantly positive correlation (<inline-formula><mml:math id="i228" display="inline" alttext="lowercase italic p equals 0.037"><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.037</mml:mn></mml:mrow></mml:math></inline-formula>, Spearman analysis).</p></sec><sec id="s3.4"><title>Urinary VOCs Attributed to the Use of FHPs Based on PBTK Model</title><p>Throughout the 28-d menstrual cycle involving four categories of FHPs, the PBTK model estimated that VOC concentrations in urine were relatively low. <inline-formula><mml:math id="i1u" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-Cymene presented the highest estimated level among all targeted VOCs (<xref rid="f5" ref-type="fig">Figure 5</xref>), which was merely up to <inline-formula><mml:math id="i229" display="inline" alttext="0.005 nanogram per milliliter"><mml:mrow><mml:mn>0.005</mml:mn><mml:mtext>&#8201;ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> and primarily resulted from using a wash product (<inline-formula><mml:math id="i230" display="inline" alttext="3053 nanograms per gram"><mml:mrow><mml:mn>3,053</mml:mn><mml:mtext>&#8201;ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula> of <inline-formula><mml:math id="i1v" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene in wash). The estimated urinary dynamics of all VOCs mirrored those in most tissues, exhibiting similar peak times and percentage changes (Table S7). For example, the urinary concentration of <inline-formula><mml:math id="i1w" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene was estimated to rapidly increase to the peak of <inline-formula><mml:math id="i231" display="inline" alttext="0.005 nanogram per milliliter"><mml:mrow><mml:mn>0.005</mml:mn><mml:mtext>&#8201;ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> after using FHPs, then decline to about <inline-formula><mml:math id="i232" display="inline" alttext="2.73 times 10 begin superscript negative 4 end superscript nanograms per milliliter"><mml:mrow><mml:mn>2.73</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> over the next 24 h before the subsequent use cycle of wash products, with minor increases from using other FHPs like pads and wipes in between (<xref rid="f5" ref-type="fig">Figure 5</xref>).</p><p>As for the difference between VOCs, the estimated urinary concentrations of hexane and <inline-formula><mml:math id="i1kkk" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane were consistently the lowest across all FHP categories (<xref rid="f6" ref-type="fig">Figure 6</xref>; Figure S4), despite their significant skin absorption amounts (<inline-formula><mml:math id="i233" display="inline" alttext="1.98 times 10 begin superscript 4 end superscript"><mml:mrow><mml:mn>1.98</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="i234" display="inline" alttext="1.49 times 10 begin superscript 4 end superscript"><mml:mrow><mml:mn>1.49</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> ng, respectively). Although the estimated dynamics of these urinary VOCs aligned with those in most tissues, showing increases and decreases (<xref rid="f5" ref-type="fig">Figure 5</xref>), the changes in methyl ethyl ketone were less pronounced, attributed to its lower dermal penetration rate of <inline-formula><mml:math id="i235" display="inline" alttext="0.0011 centimeter per hour"><mml:mrow><mml:mn>0.0011</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">cm</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">h</mml:mi></mml:mrow></mml:math></inline-formula>. This difference was particularly evident when using wipes and moisturizers (<xref rid="f6" ref-type="fig">Figure 6</xref>), because the low dermal absorption allowed the residue to remain on the skin and then to continue the skin absorption until next use. A similar situation applied to methyl ethyl ketone in pads, because we assumed that the pads were always in contact with the skin, inducing the absorption to continue to occur. A 10 times of absorption coefficient was employed for using a tampon, to simulate the easy penetration of mucosa, so there was a small increase in methyl ethyl ketone when using tampons.</p><fig position="float" id="f6" orientation="portrait"><label>Figure 6.</label><caption><p>VOC concentration dynamics in urine using individual feminine hygiene products during first 8 h of menstrual period based on PBTK model. All the data are shown in Supplemental Excel Table S7. Note: PBTK, physiologically based toxicokinetic; VOC, volatile organic compound.</p></caption><alt-text>Figure 6 is a set of five line graphs titled pad, tampon, wash, wipe, and moisturizer, plotting urinary concentration (nanogram per milliliter), ranging as 10 begin superscript negative 10 end superscript, 10 begin superscript negative 8 end superscript, 10 begin superscript negative 6 end superscript, 10 begin superscript negative 4 end superscript; 10 begin superscript negative 10 end superscript, 10 begin superscript negative 8 end superscript, 10 begin superscript negative 6 end superscript, 10 begin superscript negative 4 end superscript; 10 begin superscript negative 8 end superscript, 10 begin superscript negative 6 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 2 end superscript; 10 begin superscript negative 10 end superscript, 10 begin superscript negative 9 end superscript, 10 begin superscript negative 8 end superscript, 10 begin superscript negative 7 end superscript, 10 begin superscript negative 6 end superscript, 10 begin superscript negative 5 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 3 end superscript; and 10 begin superscript negative 9 end superscript, 10 begin superscript negative 8 end superscript, 10 begin superscript negative 7 end superscript, 10 begin superscript negative 6 end superscript, 10 begin superscript negative 5 end superscript, 10 begin superscript negative 4 end superscript (y-axis) across time (hour), ranging from 0 to 8 in unit increments (x-axis) for methylene chloride, methyl ethyl ketone, benzene, toluene, styrene, p-Cymene, hexane, and n-Nonane.</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_f6.jpg"/></fig></sec><sec id="s3.5"><title>Model Validation and Uncertainty Analysis</title><p>As indicated above, inhalation exposure was additionally considered when validating the modeling. The detection frequency (DF) of the target VOCs was measured to be low in indoor air samples (Table S1). Only benzene and toluene had DFs above 50%, with the highest measured concentrations at 1.38 and <inline-formula><mml:math id="i236" display="inline" alttext="14.6 micrograms per meter cubed"><mml:mrow><mml:mn>14.6</mml:mn><mml:mrow><mml:msup><mml:mrow><mml:mtext>&#8201;</mml:mtext><mml:mi mathvariant="normal">&#956;</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>, respectively. The measured indoor VOC levels in the Detroit samples were not significantly different from those sampled from a hotel in Ann Arbor, except for <inline-formula><mml:math id="i1x" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, which was significantly higher in Detroit samples than that in Ann Arbor samples (<inline-formula><mml:math id="i237" display="inline" alttext="0.23 plus or minus 0.09 microgram per meter cubed greater than 0.009 plus or minus 0.037 microgram per meter cubed"><mml:mrow><mml:mn>0.23</mml:mn><mml:mo>&#177;</mml:mo><mml:mn>0.09</mml:mn><mml:mrow><mml:msup><mml:mrow><mml:mtext>&#8201;</mml:mtext><mml:mi mathvariant="normal">&#956;</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msup></mml:mrow><mml:mo>&gt;</mml:mo><mml:mn>0.009</mml:mn><mml:mo>&#177;</mml:mo><mml:mn>0.037</mml:mn><mml:mrow><mml:msup><mml:mrow><mml:mtext>&#8201;</mml:mtext><mml:mi mathvariant="normal">&#956;</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="i238" display="inline" alttext="lowercase italic p equals 0.001"><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula>), as shown in Figure S5. Over a 28-d menstrual cycle, inhalation was estimated to account for over 96% to the total intake for most target VOCs (Table S6), except for <inline-formula><mml:math id="i1y" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, where inhalation contributed only 22.4%. These estimates assume complete absorption of inhaled VOCs.</p><p>A comparison between the estimated and measured urinary concentrations is shown in <xref rid="f7" ref-type="fig">Figure 7A</xref>. The predictions of the model tended to slightly underestimate concentrations, typically within 1 order of magnitude. For example, estimates for methylene chloride, benzene, toluene, and styrene ranged from 22.1% to 33.7% of the measured values, with some cases reaching up to 48.3%. Methyl ethyl ketone estimates were lower at only 7.70% of the measured concentrations. This finding suggests that inhalation exposure to indoor air and dermal absorption from FHPs together contributed only about 8%&#8211;34% (up to 49% in some cases) of the overall internal exposure levels of VOCs. The underestimation of <inline-formula><mml:math id="i1z" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, hexane, and <inline-formula><mml:math id="i1lll" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane by the model was more significant than that of the other VOCs. Even though <inline-formula><mml:math id="i1aa" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene estimates were only 1.82% of measured concentrations, hexane and <inline-formula><mml:math id="i1mmm" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane estimates were approximately 3 orders of magnitude lower than the measurements for other VOCs. These discrepancies indicate the presence of other, potentially larger, sources, especially for <inline-formula><mml:math id="i1ab" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, hexane, and <inline-formula><mml:math id="i1nnn" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane, such as the potential use of other wide ranges of personal care products and gasoline exposure, etc., for which relevant data were not available among the studied female participants.<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c13" ref-type="bibr">13</xref></sup> Benzene, toluene, styrene, and <inline-formula><mml:math id="i1ac" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene had available additional external exposure estimates in the literature as impurities or fragrance ingredients in non-FHP personal care products.<sup><xref rid="c68" ref-type="bibr">68</xref>,<xref rid="c69" ref-type="bibr">69</xref></sup> As stated above, these exposure source estimates were additionally added into the PBTK modeling for further model validation on these substances. It was found that the updated urinary predictions aligned better with the measurements in comparison with when these non-FHP personal care product exposure sources were not considered (Figure S6). The slight overestimation of <inline-formula><mml:math id="i1ad" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene is due to the combined effects of the conservative exposure assumptions in this study and the broader exposure assessment reported in the literature.<sup><xref rid="c72" ref-type="bibr">72</xref></sup> This finding not only reinforces the likelihood of other significant exposure sources but also supports the reliability of the PBTK model in estimating the VOC toxicokinetics.</p><p>The results of the uncertainty analysis are shown in <xref rid="f7" ref-type="fig">Figure 7B</xref>. The difference in urinary concentrations between the best-guess exposure scenario and the lowest or highest exposure scenarios ranged from 11.7% (methylene chloride and hexane) to 19.5% (<inline-formula><mml:math id="i1afgfgf" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane), with the exception of <inline-formula><mml:math id="i1ae" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene. For <inline-formula><mml:math id="i1af" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, the disparities in estimates were 65.9% for the best-guess exposure scenario in comparison with the lowest exposure scenario and 170% in comparison with the highest exposure scenario. Comparable concentration differences were observed in other tissues as well (Figure S7).</p><fig position="float" id="f7" orientation="portrait"><label>Figure 7.</label><caption><p>(A) Comparison of the estimated and measured VOC concentrations in urine. The estimates were derived from using best-guess exposure scenario with both dermal exposure from using feminine hygiene products and inhalation exposure from indoor air, with the error bars showing the highest and lowest exposure scenarios. These estimates correspond to the mean levels in 505th to 512th h, the 73rd to 80th h, the 169th to 176th h, and the 337th to 344th h of the 28-d menstrual cycle in the model. The measurements (<inline-formula><mml:math id="i255" display="inline" alttext="lowercase italic n equals 25"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>25</mml:mn></mml:mrow></mml:math></inline-formula> for each mean value, except <inline-formula><mml:math id="i256" display="inline" alttext="lowercase italic n equals 24"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>24</mml:mn></mml:mrow></mml:math></inline-formula> for the first time point) were from the urine of 25 females collected at four time points: 7 d before menstruation and 3, 7, and 14 d after the first day of menstruation. Each dot (mean with SD) in the comparison represents the value at each time point. (B) Uncertainty analysis results of urinary concentrations using probability bounds analysis based on PBTK model. The column is the estimated concentration using best-guess exposure scenario with both dermal exposure from using feminine hygiene products and inhalation exposure from indoor air. The minus bar indicates the lowest exposure scenario when using 95th body weight value among the US females 20&#8211;29 y of age, the associated kinetic and physiological data, and only one-fourth exposure dose. The plus bar indicates the highest exposure scenario when using fifth body weight value among the US females 20&#8211;29 y of age, the associated kinetic and physiological data, and double exposure dose. All the data are shown in Supplemental Excel Tables S9&#8211;S10. Note: PBTK, physiologically based toxicokinetic; SD, standard deviation; VOC, volatile organic compounds.</p></caption><alt-text>Figure 7A is a graph, plotting estimated urinary concentration (nanogram per milliliter), ranging as 10 begin superscript negative 6 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 2 end superscript, 1 to 100 in increments of 9 (y-axis) across measure urinary concentration (nanogram per milliliter), ranging as 10 begin superscript negative 6 end superscript, 10 begin superscript negative 4 end superscript, 10 begin superscript negative 2 end superscript, 1 to 100 in increments of 9 (x-axis) for methylene chloride, methyl ethyl ketone, benzene, toluene, styrene, p-Cymene, hexane, and n-Nonane. Figure 7B is a horizontal bar graph, plotting methylene chloride, methyl ethyl ketone, benzene, toluene, styrene, p-Cymene, hexane, and n-Nonane (y-axis) across estimated urinary concentration (nanogram per milliliter), ranging as 0, 1 times 10 begin superscript negative 3 end superscript, 2 times 10 begin superscript negative 3 end superscript; 0.02 to 0.04 in increments of 0.02; 0.2 to 0.3 in increments of 0.1 (x-axis) for best-guess scenario, lowest exposure, highest exposure.</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ehp15418_f7.jpg"/></fig></sec><sec id="s3.6"><title>Health Risks</title><p>We used the time-averaged daily absorption amount as the dermal exposure dose to assess the health risks (<xref rid="t2" ref-type="table">Table 2</xref>). Under the best-guess exposure scenario, both HRs (noncancer risk) and CRs (cancer risks) were much lower than 1 and <inline-formula><mml:math id="i239" display="inline" alttext="10 begin superscript negative 6 end superscript"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> (the recommended levels of noncancer and cancer risks), respectively, even lower than 0.1 and <inline-formula><mml:math id="i240" display="inline" alttext="10 begin superscript negative 7 end superscript"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula> (more conservative recommended levels of noncancer and cancer risks). Therefore, normal use of the FHPs was determined as unlikely to pose significant noncancer risks, such as skin and mucosal irritation, or cancer risks attributed to exposure to the target VOCs, whereas, under the highest exposure scenario, the HRs of <inline-formula><mml:math id="i1qqq" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane were 0.07, approaching 0.1, and the cancer risk of benzene exceeded <inline-formula><mml:math id="i241" display="inline" alttext="10 begin superscript negative 7 end superscript"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>, reaching <inline-formula><mml:math id="i242" display="inline" alttext="1.82 times 10 begin superscript negative 7 end superscript"><mml:mrow><mml:mn>1.82</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>. <inline-formula><mml:math id="i1rrr" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-Nonane and benzene originated mainly from washes and moisturizers, respectively (<xref rid="f4" ref-type="fig">Figure 4</xref>; Table S6).</p></sec></sec><sec id="s4"><title>Discussion</title><p>In this study, we integrated measurement data and PBTK modeling to reveal VOC toxicokinetics in FHP users. The modeling results suggest that FHPs can contribute to increasing levels of VOCs in all body tissues via dermal exposure, but mostly at low levels and decreasing within hours. However, it is worth noting that certain VOCs, especially <inline-formula><mml:math id="i1ag" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene and <inline-formula><mml:math id="i1sss" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane, were estimated to present a cumulative trend in adipose, which led to several orders of magnitude higher concentrations predicted in adipose than those in other tissues. Regarding the health risks, <inline-formula><mml:math id="i1ttt" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane occasionally contributed a potential noteworthy noncancer risk when using wash products, and benzene showed a significant cancer risk when using moisturizers.</p><p>The estimated dynamics of VOCs in most body tissues including blood were characterized by an increase within minutes to one hour, followed by a significant decline of over 90% within hours (for most target VOCs). This pattern was consistent with findings from previous studies. Animal studies have shown that blood concentrations of benzene, toluene, styrene, and hexane rise quickly, often peaking within the first hour or even within 15 min after exposure.<sup><xref rid="c74" ref-type="bibr">74</xref>&#8211;<xref rid="c76" ref-type="bibr">76</xref></sup> These levels drop rapidly in the absence of continued exposure<sup><xref rid="c71" ref-type="bibr">71</xref></sup>; for example, toluene concentrations can decrease to 15% of their peak within 2 h.<sup><xref rid="c77" ref-type="bibr">77</xref></sup> Georgopoulos et al. used a PBTK model to simulate human exposure to benzene in a household setting and found a sharp increase in skin absorption during a shower, followed by a rapid decrease.<sup><xref rid="c78" ref-type="bibr">78</xref></sup> However, a benzene exhalation study on a female rhesus monkey exposed to benzene through whole-hand immersion in a solution showed peak exhalation occurring approximately 2 h post exposure.<sup><xref rid="c79" ref-type="bibr">79</xref></sup> Other VOCs exhibited similar dynamics. Studies on chloroform absorption during showers showed that exhaled concentrations peaked within 20&#8211;30 min, as confirmed by both human monitoring and PBTK models.<sup><xref rid="c80" ref-type="bibr">80</xref>,<xref rid="c81" ref-type="bibr">81</xref></sup> Kim et al. combined <italic toggle="yes">in&#160;vivo</italic> studies with PBTK modeling to investigate dermal exposure to naphthalene among US Air Force personnel, showing an increase in blood concentrations during the first hour and peaking at around 62 min.<sup><xref rid="c24" ref-type="bibr">24</xref>,<xref rid="c82" ref-type="bibr">82</xref></sup></p><p>The estimated dynamics of rapid fluctuation are primarily attributed to the physicochemical properties and kinetic values of target VOCs.<sup><xref rid="c83" ref-type="bibr">83</xref></sup> Most target VOCs possess a skin absorption rate <inline-formula><mml:math id="i243" display="inline" alttext="uppercase italic k begin subscript lowercase p end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> exceeding <inline-formula><mml:math id="i244" display="inline" alttext="0.01 centimeter per hour"><mml:mrow><mml:mn>0.01</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">cm</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">h</mml:mi></mml:mrow></mml:math></inline-formula> (<xref rid="t1" ref-type="table">Table 1</xref>), facilitating rapid absorption through the skin upon FHP use, particularly for <inline-formula><mml:math id="i1ah" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, hexane, and <inline-formula><mml:math id="i1uuu" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane. The absorption rates, combined with high partition coefficients between tissues and blood, resulted in sharp increases across various tissues (<xref rid="f5" ref-type="fig">Figure 5</xref>; Table S7). We found it notable that both skin absorption rates and partition coefficients of substances correlated with their <inline-formula><mml:math id="i245" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> (Figure S8).<sup><xref rid="c38" ref-type="bibr">38</xref>,<xref rid="c41" ref-type="bibr">41</xref></sup> The subsequent rapid decline, especially for certain VOCs, was attributed to highly efficient metabolization by the liver, as seen with <inline-formula><mml:math id="i1ai" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene and <inline-formula><mml:math id="i1tuv" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane (<xref rid="t1" ref-type="table">Table 1</xref>) and partitioning into exhaled air, as in the case of hexane. The maximum reaction velocities (<inline-formula><mml:math id="i246" display="inline" alttext="lowercase nu begin subscript maximum end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mtext>max</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) of target VOCs are notably high, ranging from <inline-formula><mml:math id="i247" display="inline" alttext="9.53 times 10 begin superscript 3 end superscript nanogram per milliliter"><mml:mrow><mml:mn>9.53</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>3</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> tissue/h for benzene to <inline-formula><mml:math id="i248" display="inline" alttext="1.06 times 10 begin superscript 8 end superscript nanogram per milliliter"><mml:mrow><mml:mn>1.06</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>8</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> tissue/h for <inline-formula><mml:math id="i150" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane (<xref rid="t1" ref-type="table">Table 1</xref>).<sup><xref rid="c54" ref-type="bibr">54</xref>,<xref rid="c59" ref-type="bibr">59</xref>&#8211;<xref rid="c62" ref-type="bibr">62</xref></sup> In addition, the Michaelis constants (<inline-formula><mml:math id="i249" display="inline" alttext="uppercase italic k begin subscript lowercase m end subscript"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula>) even range from <inline-formula><mml:math id="i250" display="inline" alttext="144 nanograms per milliliter"><mml:mrow><mml:mn>144</mml:mn><mml:mtext>&#8201;ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> (methyl ethyl ketone) to <inline-formula><mml:math id="i251" display="inline" alttext="53554 nanograms per milliliter"><mml:mrow><mml:mn>53,554</mml:mn><mml:mtext>&#8201;ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="i1vvv" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane).<sup><xref rid="c54" ref-type="bibr">54</xref>,<xref rid="c59" ref-type="bibr">59</xref>&#8211;<xref rid="c62" ref-type="bibr">62</xref></sup> In comparison with other target VOCs, methyl ethyl ketone has a lower skin permeability coefficient (<inline-formula><mml:math id="i252" display="inline" alttext="0.0011 centimeter per hour"><mml:mrow><mml:mn>0.0011</mml:mn><mml:mspace width="0.3em"/><mml:mi mathvariant="normal">cm</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">h</mml:mi></mml:mrow></mml:math></inline-formula>)<sup><xref rid="c41" ref-type="bibr">41</xref>,<xref rid="c42" ref-type="bibr">42</xref></sup>; lower tissue partition coefficients, particularly in adipose tissue (<inline-formula><mml:math id="i253" display="inline" alttext="uppercase italic p begin subscript adipose or blood end subscript equals 0.88"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mtext>adipose</mml:mtext><mml:mo>/</mml:mo><mml:mtext>blood</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mn>0.88</mml:mn></mml:mrow></mml:math></inline-formula>)<sup><xref rid="c58" ref-type="bibr">58</xref></sup>; and higher renal excretion coefficient of <inline-formula><mml:math id="i254" display="inline" alttext="1.18 times 10 begin superscript negative 2 end superscript"><mml:mrow><mml:mn>1.18</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>.<sup><xref rid="c57" ref-type="bibr">57</xref></sup> These properties led to its relatively slower skin absorption and greater urine excretion rather than accumulation in body tissues, as reflected by a later peak time (Table S7) and consistently higher levels in urine (<xref rid="f5" ref-type="fig">Figures 5</xref> and <xref rid="f6" ref-type="fig">6</xref>).</p><p>In adipose tissue, the estimated dynamics of VOCs showed much smaller fluctuations and even a gradual increase during the whole menstrual period. The estimated levels in adipose were 1&#8211;4 orders of magnitude higher than those estimated in other tissues (<xref rid="f5" ref-type="fig">Figure 5</xref>). Furthermore, several VOCs such as <inline-formula><mml:math id="i1aj" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene and <inline-formula><mml:math id="i1xxx" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane were estimated to have significantly larger distribution in adipose (<xref rid="f4" ref-type="fig">Figure 4</xref>), suggesting a potential accumulation. A similar accumulation phenomenon was observed in rats exposed to <inline-formula><mml:math id="i1601" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane in a closed chamber.<sup><xref rid="c84" ref-type="bibr">84</xref></sup> The concentration in fat decreased only slightly during nonexposure periods and increased to higher levels with subsequent exposures, indicating significant accumulation.<sup><xref rid="c84" ref-type="bibr">84</xref></sup> These results are attributed to the <inline-formula><mml:math id="i257" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> values of substances. Most of the target VOCs possess <inline-formula><mml:math id="i258" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> values higher than 1 (<xref rid="t1" ref-type="table">Table 1</xref>), indicating a preference for partitioning in lipid-rich tissues such as adipose tissue. Consequently, the partition coefficients between adipose and blood for target VOCs were correlated with <inline-formula><mml:math id="i259" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="i260" display="inline" alttext="lowercase italic p less than 0.001"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula>, Spearman analysis; Figure S8) and much higher than those between other tissues and blood, such as liver and kidney (<xref rid="t1" ref-type="table">Table 1</xref>).<sup><xref rid="c38" ref-type="bibr">38</xref>,<xref rid="c58" ref-type="bibr">58</xref></sup> The phenomena of higher levels and larger distribution estimated in adipose tissues were particularly significant for VOCs with <inline-formula><mml:math id="i261" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> values exceeding 3.5, such as <inline-formula><mml:math id="i1ak" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, hexane, and <inline-formula><mml:math id="i1yyy" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane. Hamelin et al. also observed hexane accumulation in adipose tissue among occupational populations using physiologically based pharmacokinetic (PBPK) modeling and attributed this to its high lipophilicity.<sup><xref rid="c85" ref-type="bibr">85</xref></sup></p><p>The phenomena, including differences in distribution between tissues within the human body, as discussed above, extend beyond VOCs. Many chemicals have lipophilic properties, such as organochlorine pesticides (OCPs) and polycyclic aromatic hydrocarbons (PAHs). As a result, these chemicals tend to distribute more in body tissues such as adipose tissue rather than in blood or urine.<sup><xref rid="c86" ref-type="bibr">86</xref>,<xref rid="c87" ref-type="bibr">87</xref></sup> However, we usually collect urine or blood for quantifying the internal levels of chemicals in human body, given the ethical challenges and operational difficulties in obtaining samples from other body tissues.<sup><xref rid="c88" ref-type="bibr">88</xref>,<xref rid="c89" ref-type="bibr">89</xref></sup> Moreover, such quantification is typically based on a single type of biological sample. All these limitations may result in a bias of the quantification of internal chemical levels in the human body, especially when considering individual variations in body composition. Our study proposes a promising solution by integrating measurements with a PBTK modeling, offering a more comprehensive understanding of chemical distribution and accumulation within the body. This approach could yield a more precise evaluation of exposure levels and facilitate more thorough investigations into potential health effects.</p><p>We have identified <inline-formula><mml:math id="i1zzz" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane and benzene to induce potential notable noncancer (<inline-formula><mml:math id="i262" display="inline" alttext="approximately 0.07"><mml:mrow><mml:mo>&#8764;</mml:mo><mml:mn>0.07</mml:mn></mml:mrow></mml:math></inline-formula>) and cancer risks (<inline-formula><mml:math id="i263" display="inline" alttext="approximately 1.82 times 10 begin superscript negative 2 end superscript"><mml:mrow><mml:mo>&#8764;</mml:mo><mml:mn>1.82</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></inline-formula>), respectively, in certain cases by the use of FHPs (<xref rid="t2" ref-type="table">Table 2</xref>). <inline-formula><mml:math id="i1abc" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-Nonane is an alkane usually included in products as solvents and lubricants.<sup><xref rid="c26" ref-type="bibr">26</xref></sup> An extremely high level of <inline-formula><mml:math id="i1701" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane, <inline-formula><mml:math id="i264" display="inline" alttext="1.44 times 10 begin superscript 4 end superscript nanogram per gram"><mml:mrow><mml:mn>1.44</mml:mn><mml:mo>&#215;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow><mml:mo>&#8196;</mml:mo><mml:mtext>ng</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, was detected in personal care products.<sup><xref rid="c2" ref-type="bibr">2</xref></sup> Prolonged exposure to <inline-formula><mml:math id="i1801" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane has the potential to cause irritation to the skin and mucous membranes,<sup><xref rid="c90" ref-type="bibr">90</xref></sup> whereas short-term exposure can result in neurotoxic effects.<sup><xref rid="c33" ref-type="bibr">33</xref></sup> Benzene, which usually undergoes rapid metabolism in the liver after absorption, resulting in low levels in all tissues and in urine, is a well-known carcinogen in humans that is associated with genetic defects.<sup><xref rid="c91" ref-type="bibr">91</xref></sup> A range of reactive species such as benzene oxide, benzoquinones, and benzene diolepoxide are produced after metabolism<sup><xref rid="c92" ref-type="bibr">92</xref></sup> and tend to distribute to lipid-rich tissues like bone marrow, based on their fat content and perfusion rate by blood, thereby causing multiple adverse health effects.<sup><xref rid="c93" ref-type="bibr">93</xref></sup> In previous studies, the external exposure doses of both <inline-formula><mml:math id="i1def" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane and benzene from the use of various personal care products have been estimated to yield significant noncancer and cancer risks.<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c94" ref-type="bibr">94</xref></sup> In addition, both of these substances have shown significant positive associations between the measured levels in menstrual products and urinary concentrations in women in our previous study.<sup><xref rid="c13" ref-type="bibr">13</xref></sup> The results from the current study further reenforce the importance of reducing the existence and controlling the exposure to <inline-formula><mml:math id="i1ghi" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane and benzene via using FHPs.</p><p>The underestimation of urinary concentrations could have occurred for several reasons. First, there might be other important sources of exposure.<sup><xref rid="c68" ref-type="bibr">68</xref>,<xref rid="c69" ref-type="bibr">69</xref></sup> Epidemiological studies have shown that females typically encounter higher levels of chemicals than males, primarily because they use a greater variety of personal care products,<sup><xref rid="c95" ref-type="bibr">95</xref>&#8211;<xref rid="c97" ref-type="bibr">97</xref></sup> which were not quantified or considered in this study due to absence of data.<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c13" ref-type="bibr">13</xref></sup>
<inline-formula><mml:math id="i1al" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-Cymene is a widely used fragrance additive in personal and household care products and is even ubiquitous in food.<sup><xref rid="c2" ref-type="bibr">2</xref>,<xref rid="c26" ref-type="bibr">26</xref>,<xref rid="c68" ref-type="bibr">68</xref>,<xref rid="c98" ref-type="bibr">98</xref>,<xref rid="c99" ref-type="bibr">99</xref></sup> Hexane and <inline-formula><mml:math id="i1jkl" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane are both alkanes and usually included in many products as solvents and lubricants, including detergent and floor cleaners,<sup><xref rid="c26" ref-type="bibr">26</xref></sup> and have also been detected in food.<sup><xref rid="c100" ref-type="bibr">100</xref></sup> As indicated above, when additional exposure to non-FHP personal care products was considered in the modeling, the model performance was significantly improved (Figure S6). Second, the underestimation particularly existed among the chemicals with higher partition coefficients between adipose and blood, i.e., <inline-formula><mml:math id="i1am" display="inline" alttext="lowercase italic p"><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>-cymene, hexane, and <inline-formula><mml:math id="i1mno" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane. This factor suggests that the disparities in distribution may result in the bias of estimation. Furthermore, we cannot obviate the possible limitations of PBTK model. A refined model compartment and structure that better simulates the actual physiological environment of human bodies would ensure a more accurate model prediction. However, the increasing number of parameters, stemming from the rise in the quantity of tissues and complexity of the model, would also introduce higher uncertainties. Due to the limitation of data, it is often difficult to carry out calibration and verification.</p><p>The current study had several limitations. We were unable to fully evaluate each participant&#8217;s complete exposure profile when conducting model validation, including personal inhalation exposure due to sampling condition limitations and potential exposure from other sources due to lack of available data. For example, using other personal care products may increase the exposure; however, the lack of relevant data makes it difficult to consider this in the current study. Future research could validate the model by conducting a comprehensive assessment of aggregate exposure across more complete exposure sources and pathways and by employing longitudinal data derived from population-based controlled exposure studies. However, the current scenario has considered the most important routes with available data for model evaluation. The assignment of exposure parameters introduces uncertainty, e.g., variations in BW and the frequency of product usage, which were modeled using extreme exposure scenarios rather than actual measurements from the study population. Assumptions were made to simulate the worst-case scenario for a conservative assessment, including the assumed 10-fold increase in permeability to the target VOCs for vaginal tissue in comparison with normal skin and the complete transition of chemicals from products to the skin. Interactions between chemicals in mixture exposure scenarios and their potential impact on toxicokinetics were not explored due to insufficient data for parameterization. The metabolites of VOCs were not included in the simulation. Nonetheless, to the best of our knowledge, this study represents the most comprehensive research conducted under these specific conditions and is the first investigation to unveil a comprehensive assessment of VOC exposure in FHPs, spanning from product composition to urinary excretion levels in population. Although ADME processes in humans of these VOCs have been assessed in previous studies, a majority of them considered only inhalation exposure.<sup><xref rid="c44" ref-type="bibr">44</xref>&#8211;<xref rid="c46" ref-type="bibr">46</xref>,<xref rid="c101" ref-type="bibr">101</xref>,<xref rid="c102" ref-type="bibr">102</xref></sup> This study, novelly focusing on dermal exposure through using FHPs, benefits from the availability of relevant parameters from the previous publications.</p><p>Our study also boasts several other notable strengths. We integrated actual measurements with model simulations to elucidate the dynamics of internal VOC exposure from the use of FHPs. Leveraging the PBTK model, we simulated the dermal exposure and the distribution of VOCs in the body by incorporating data from population surveys on FHP categories and usage, along with chemical concentration measurements in FHPs. We also included individual exposure data such as measured urinary concentrations to validate the model. Furthermore, uncertainty analyses were introduced to test the robustness of the model. These strengths underscore the significance of further, more comprehensive follow-up studies.</p><p>In conclusion, our study using the PBTK modeling approach elucidates that, through skin absorption, FHPs can lead to elevated levels of VOCs in all body tissues, primarily at low concentrations and for short durations. In certain cases, benzene and <inline-formula><mml:math id="i1pqr" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane in products could pose significant health risks. It was surprising that our findings also reveal distribution disparities characterized by high levels of VOCs estimated in adipose tissue but low urinary levels, particularly for substances with high <inline-formula><mml:math id="i265" display="inline" alttext="log of uppercase italic k begin subscript octanol-water end subscript"><mml:mrow><mml:mi mathvariant="normal">log</mml:mi><mml:mtext>&#8201;</mml:mtext><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mtext>ow</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> values like <inline-formula><mml:math id="i2001" display="inline" alttext="lowercase italic n"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:math></inline-formula>-nonane. Expanding our findings to other substances, it becomes clear that relying solely on one type of biological samples like urine, blood, or hair to characterize internal exposure in population studies may introduce a quantification bias, particularly for lipophilic chemicals. Evaluating tissue distribution in conjunction with PBTK modeling offers a promising avenue. Therefore, we recommend further studies employing comprehensive assessments that integrate exposure measurement with toxicokinetic modeling to yield more accurate results and inform regulatory measures. Future research should also incorporate extensive data to address comprehensive exposure routes and mixture chemical exposure scenarios in the model, which could enhance the model&#8217;s functionality to better address extending scientific issues and risk assessment related to VOC exposure.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ehp15418.smcontents.508.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ehp15418.s001.acco.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ehp15418.s002.codeanddata.acco.zip" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>Support for this research was provided by grants 42307545, 41977359, and 42377362 from the National Natural Science Foundation of China, grant P30ES017885 from the National Institute of Environmental Health Sciences, National Institutes of Health of the United States, and grant 22YF1420900 of the Science and Technology Commission of Shanghai Municipality.</p><p>Supplemental Material is available online.</p></ack><ref-list><title>References</title><ref id="c1"><label>1.</label><mixed-citation publication-type="webpage"><collab>Statista Inc</collab>. <year>2020</year>. <article-title>Feminine Hygiene &#8211; United States</article-title>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.statista.com/outlook/80040000/109/feminine-hygiene/united-states" ext-link-type="uri">https://www.statista.com/outlook/80040000/109/feminine-hygiene/united-states</ext-link> [accessed <date-in-citation content-type="access-date">15 December 2023</date-in-citation>].</mixed-citation></ref><ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lin</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Meza-Wilson</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Devasurendra</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Godwin</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>SK</given-names></string-name>, <etal>et al.</etal></person-group><year>2020</year>. <article-title>Volatile organic compounds in feminine hygiene products sold in the US market: a survey of products and health risks</article-title>. <source>Environ Int</source><volume>144</volume>:<elocation-id>105740</elocation-id>, PMID: 32866732, <pub-id pub-id-type="doi">10.1016/j.envint.2020.105740</pub-id>.<pub-id pub-id-type="pmid">32866732</pub-id><pub-id pub-id-type="pmcid">PMC7958867</pub-id></mixed-citation></ref><ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ding</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Batterman</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>SK</given-names></string-name></person-group>. <year>2020</year>. <article-title>Exposure to volatile organic compounds and use of feminine hygiene products among reproductive-aged women in the United States</article-title>. <source>J Womens Health (Larchmt)</source><volume>29</volume>(<issue>1</issue>):<fpage>65</fpage>&#8211;<lpage>73</lpage>, PMID: 31532304, <pub-id pub-id-type="doi">10.1089/jwh.2019.7785</pub-id>.<pub-id pub-id-type="pmid">31532304</pub-id><pub-id pub-id-type="pmcid">PMC6998054</pub-id></mixed-citation></ref><ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Marroquin</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kiomourtzoglou</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Scranton</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pollack</surname><given-names>AZ</given-names></string-name></person-group>. <year>2024</year>. <article-title>Chemicals in menstrual products: a systematic review</article-title>. <source>BJOG</source><volume>131</volume>(<issue>5</issue>):<fpage>655</fpage>&#8211;<lpage>664</lpage>, PMID: 37743685, <pub-id pub-id-type="doi">10.1111/1471-0528.17668</pub-id>.<pub-id pub-id-type="pmid">37743685</pub-id></mixed-citation></ref><ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Even</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Girard</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Rich</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hutzler</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Luch</surname><given-names>A</given-names></string-name></person-group>. <year>2019</year>. <article-title>Emissions of VOCs from polymer-based consumer products: from emission data of real samples to the assessment of inhalation exposure</article-title>. <source>Front Public Health</source><volume>7</volume>:<fpage>202</fpage>, PMID: 31475125, <pub-id pub-id-type="doi">10.3389/fpubh.2019.00202</pub-id>.<pub-id pub-id-type="pmid">31475125</pub-id><pub-id pub-id-type="pmcid">PMC6707103</pub-id></mixed-citation></ref><ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Park</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Barakat</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ulanov</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>P-C</given-names></string-name>, <string-name name-style="western"><surname>Chiu</surname><given-names>K</given-names></string-name>, <etal>et al.</etal></person-group><year>2019</year>. <article-title>Sanitary pads and diapers contain higher phthalate contents than those in common commercial plastic products</article-title>. <source>Reprod Toxicol</source><volume>84</volume>:<fpage>114</fpage>&#8211;<lpage>121</lpage>, PMID: 30659930, <pub-id pub-id-type="doi">10.1016/j.reprotox.2019.01.005</pub-id>.<pub-id pub-id-type="pmid">30659930</pub-id><pub-id pub-id-type="pmcid">PMC6504186</pub-id></mixed-citation></ref><ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Weisel</surname><given-names>CP</given-names></string-name>, <string-name name-style="western"><surname>Jo</surname><given-names>WK</given-names></string-name></person-group>. <year>1996</year>. <article-title>Ingestion, inhalation, and dermal exposures to chloroform and trichloroethene from tap water</article-title>. <source>Environ Health Perspect</source><volume>104</volume>(<issue>1</issue>):<fpage>48</fpage>&#8211;<lpage>51</lpage>, PMID: 8834861, <pub-id pub-id-type="doi">10.2307/3432759</pub-id>.<pub-id pub-id-type="pmid">8834861</pub-id><pub-id pub-id-type="pmcid">PMC1469238</pub-id></mixed-citation></ref><ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Xu</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Weisel</surname><given-names>CP</given-names></string-name></person-group>. <year>2005</year>. <article-title>Dermal uptake of chloroform and haloketones during bathing</article-title>. <source>J Expo Anal Environ Epidemiol</source><volume>15</volume>(<issue>4</issue>):<fpage>289</fpage>&#8211;<lpage>296</lpage>, PMID: 15316574, <pub-id pub-id-type="doi">10.1038/sj.jea.7500404</pub-id>.<pub-id pub-id-type="pmid">15316574</pub-id></mixed-citation></ref><ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bridges</surname><given-names>B</given-names></string-name></person-group>. <year>2002</year>. <article-title>Fragrance: emerging health and environmental concerns</article-title>. <source>Flavour &amp; Fragrance J</source><volume>17</volume>(<issue>5</issue>):<fpage>361</fpage>&#8211;<lpage>371</lpage>, <pub-id pub-id-type="doi">10.1002/ffj.1106</pub-id>.</mixed-citation></ref><ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bello</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Quinn</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Perry</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Milton</surname><given-names>DK</given-names></string-name></person-group>. <year>2009</year>. <article-title>Characterization of occupational exposures to cleaning products used for common cleaning tasks - a pilot study of hospital cleaners</article-title>. <source>Environ Health</source><volume>8</volume>:<fpage>11</fpage>, PMID: 19327131, <pub-id pub-id-type="doi">10.1186/1476-069X-8-11</pub-id>.<pub-id pub-id-type="pmid">19327131</pub-id><pub-id pub-id-type="pmcid">PMC2678109</pub-id></mixed-citation></ref><ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Singer</surname><given-names>BC</given-names></string-name>, <string-name name-style="western"><surname>Destaillats</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hodgson</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Nazaroff</surname><given-names>WW</given-names></string-name></person-group>. <year>2006</year>. <article-title>Cleaning products and air fresheners: emissions and resulting concentrations of glycol ethers and terpenoids</article-title>. <source>Indoor Air</source><volume>16</volume>(<issue>3</issue>):<fpage>179</fpage>&#8211;<lpage>191</lpage>, PMID: 16683937, <pub-id pub-id-type="doi">10.1111/j.1600-0668.2005.00414.x</pub-id>.<pub-id pub-id-type="pmid">16683937</pub-id></mixed-citation></ref><ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Farage</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Maibach</surname><given-names>HI</given-names></string-name></person-group>. <year>2004</year>. <article-title>The vulvar epithelium differs from the skin: implications for cutaneous testing to address topical vulvar exposures</article-title>. <source>Contact Dermatitis</source><volume>51</volume>(<issue>4</issue>):<fpage>201</fpage>&#8211;<lpage>209</lpage>, PMID: 15500670, <pub-id pub-id-type="doi">10.1111/j.0105-1873.2004.00444.x</pub-id>.<pub-id pub-id-type="pmid">15500670</pub-id></mixed-citation></ref><ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ding</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Batterman</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>SK</given-names></string-name></person-group>. <year>2022</year>. <article-title>Feminine hygiene products and volatile organic compounds in reproductive-aged women across the menstrual cycle: a longitudinal pilot study</article-title>. <source>J Womens Health (Larchmt)</source><volume>31</volume>(<issue>2</issue>):<fpage>210</fpage>&#8211;<lpage>218</lpage>, PMID: 34491105, <pub-id pub-id-type="doi">10.1089/jwh.2021.0153</pub-id>.<pub-id pub-id-type="pmid">34491105</pub-id><pub-id pub-id-type="pmcid">PMC8864434</pub-id></mixed-citation></ref><ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Anderson</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Wells</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Fedorowicz</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Butterworth</surname><given-names>LF</given-names></string-name>, <string-name name-style="western"><surname>Meade</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Munson</surname><given-names>AE</given-names></string-name></person-group>. <year>2007</year>. <article-title>Evaluation of the contact and respiratory sensitization potential of volatile organic compounds generated by simulated indoor air chemistry</article-title>. <source>Toxicol Sci</source><volume>97</volume>(<issue>2</issue>):<fpage>355</fpage>&#8211;<lpage>363</lpage>, PMID: 17347135, <pub-id pub-id-type="doi">10.1093/toxsci/kfm043</pub-id>.<pub-id pub-id-type="pmid">17347135</pub-id></mixed-citation></ref><ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wolkoff</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Clausen</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Wilkins</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>Nielsen</surname><given-names>GD</given-names></string-name></person-group>. <year>2000</year>. <article-title>Formation of strong airway irritants in terpene/ozone mixtures</article-title>. <source>Indoor Air</source><volume>10</volume>(<issue>2</issue>):<fpage>82</fpage>&#8211;<lpage>91</lpage>, PMID: 11980106, <pub-id pub-id-type="doi">10.1034/j.1600-0668.2000.010002082.x</pub-id>.<pub-id pub-id-type="pmid">11980106</pub-id></mixed-citation></ref><ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wolkoff</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Wilkins</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>Clausen</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Nielsen</surname><given-names>GD</given-names></string-name></person-group>. <year>2006</year>. <article-title>Organic compounds in office environments - sensory irritation, odor, measurements and the role of reactive chemistry</article-title>. <source>Indoor Air</source><volume>16</volume>(<issue>1</issue>):<fpage>7</fpage>&#8211;<lpage>19</lpage>, PMID: 16420493, <pub-id pub-id-type="doi">10.1111/j.1600-0668.2005.00393.x</pub-id>.<pub-id pub-id-type="pmid">16420493</pub-id></mixed-citation></ref><ref id="c17"><label>17.</label><mixed-citation publication-type="webpage"><collab>WHO (World Health Organization)</collab>. <year>2020</year>. <article-title>10 Chemicals of Public Health Concern</article-title>. <comment>2020</comment>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/news-room/photo-story/photo-story/detail/10-chemicals-of-public-health-concern" ext-link-type="uri">https://www.who.int/news-room/photo-story/photo-story/detail/10-chemicals-of-public-health-concern</ext-link> [accessed <date-in-citation content-type="access-date">10 April 2023</date-in-citation>].</mixed-citation></ref><ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Babu</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Chatterjee</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>M</given-names></string-name></person-group>. <year>2004</year>. <article-title>Assessment of skin irritation and molecular responses in rat skin exposed to nonane, dodecane and tetradecane</article-title>. <source>Toxicol Lett</source><volume>153</volume>(<issue>2</issue>):<fpage>255</fpage>&#8211;<lpage>266</lpage>, PMID: 15451557, <pub-id pub-id-type="doi">10.1016/j.toxlet.2004.04.036</pub-id>.<pub-id pub-id-type="pmid">15451557</pub-id></mixed-citation></ref><ref id="c19"><label>19.</label><mixed-citation publication-type="webpage"><collab>US EPA (US Environmental Protection Agency)</collab>. <year>2019</year>. <article-title>Regional Screening Levels (RSLS) - User&#8217;s Guide</article-title>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.epa.gov/risk/regional-screening-levels-rsls-users-guide" ext-link-type="uri">https://www.epa.gov/risk/regional-screening-levels-rsls-users-guide</ext-link> [accessed <date-in-citation content-type="access-date">24 April 2020</date-in-citation>].</mixed-citation></ref><ref id="c20"><label>20.</label><mixed-citation publication-type="other"><collab>North Carolina Department of Environmental Quality</collab>. <year>2017</year>. <article-title>Risk evaluation equations and calculations</article-title>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://files.nc.gov/ncdeq/Waste%20Management/DWM/SF/RiskBasedRemediation/20171024_RiskEvalEqnsandCalcs.pdf" ext-link-type="uri">https://files.nc.gov/ncdeq/Waste%20Management/DWM/SF/RiskBasedRemediation/20171024_RiskEvalEqnsandCalcs.pdf</ext-link> [accessed <date-in-citation content-type="access-date">10 April 2023</date-in-citation>].</mixed-citation></ref><ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lin</surname><given-names>N</given-names></string-name></person-group>. <year>2023</year>. <article-title>Chemicals in personal care products: an important but understudied exposure source for both the human body and ecosystems</article-title>. <source>J Environ Expo Assess</source><volume>2</volume>(<issue>4</issue>):<fpage>19</fpage>, <pub-id pub-id-type="doi">10.20517/jeea.2023.31</pub-id>.</mixed-citation></ref><ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>HY</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>J-Y</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Bae</surname><given-names>O-N</given-names></string-name>, <string-name name-style="western"><surname>Choi</surname><given-names>Y-K</given-names></string-name>, <etal>et al.</etal></person-group><year>2019</year>. <article-title>Risk assessment of volatile organic compounds (VOCs) detected in sanitary pads</article-title>. <source>J Toxicol Environ Health A</source><volume>82</volume>(<issue>11</issue>):<fpage>678</fpage>&#8211;<lpage>695</lpage>, PMID: 31328663, <pub-id pub-id-type="doi">10.1080/15287394.2019.1642607</pub-id>.<pub-id pub-id-type="pmid">31328663</pub-id></mixed-citation></ref><ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Georgopoulos</surname><given-names>PG</given-names></string-name>, <string-name name-style="western"><surname>Sasso</surname><given-names>AF</given-names></string-name>, <string-name name-style="western"><surname>Isukapalli</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Lioy</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Vallero</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Okino</surname><given-names>M</given-names></string-name>, <etal>et al.</etal></person-group><year>2009</year>. <article-title>Reconstructing population exposures to environmental chemicals from biomarkers: challenges and opportunities</article-title>. <source>J Expo Sci Environ Epidemiol</source><volume>19</volume>(<issue>2</issue>):<fpage>149</fpage>&#8211;<lpage>171</lpage>, PMID: 18368010, <pub-id pub-id-type="doi">10.1038/jes.2008.9</pub-id>.<pub-id pub-id-type="pmid">18368010</pub-id><pub-id pub-id-type="pmcid">PMC3068528</pub-id></mixed-citation></ref><ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Chao</surname><given-names>Y-CE</given-names></string-name>, <string-name name-style="western"><surname>Egeghy</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Rappaport</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Nylander-French</surname><given-names>LA</given-names></string-name></person-group>. <year>2007</year>. <article-title>PBTK modeling demonstrates contribution of dermal and inhalation exposure components to end-exhaled breath concentrations of naphthalene</article-title>. <source>Environ Health Perspect</source><volume>115</volume>(<issue>6</issue>):<fpage>894</fpage>&#8211;<lpage>901</lpage>, PMID: 17589597, <pub-id pub-id-type="doi">10.1289/ehp.9778</pub-id>.<pub-id pub-id-type="pmid">17589597</pub-id><pub-id pub-id-type="pmcid">PMC1892111</pub-id></mixed-citation></ref><ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>YN</given-names></string-name>, <string-name name-style="western"><surname>Zhan</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Qu</surname><given-names>WD</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></string-name></person-group>. <year>2022</year>. <article-title>Physiologically-based toxicokinetic modeling of human dermal exposure to diethyl phthalate: application to health risk assessment</article-title>. <source>Chemosphere</source><volume>307</volume>(<issue>pt 2</issue>):<elocation-id>135931</elocation-id>, PMID: 35940406, <pub-id pub-id-type="doi">10.1016/j.chemosphere.2022.135931</pub-id>.<pub-id pub-id-type="pmid">35940406</pub-id></mixed-citation></ref><ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lin</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Rosemberg</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Meza-Wilson</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Godwin</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Batterman</surname><given-names>S</given-names></string-name></person-group>. <year>2021</year>. <article-title>Occupational exposure and health risks of volatile organic compounds of hotel housekeepers: field measurements of exposure and health risks</article-title>. <source>Indoor Air</source><volume>31</volume>(<issue>1</issue>):<fpage>26</fpage>&#8211;<lpage>39</lpage>, PMID: 32609907, <pub-id pub-id-type="doi">10.1111/ina.12709</pub-id>.<pub-id pub-id-type="pmid">32609907</pub-id><pub-id pub-id-type="pmcid">PMC8020495</pub-id></mixed-citation></ref><ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lin</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Zhong</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Godwin</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Batterman</surname><given-names>S</given-names></string-name></person-group>. <year>2022</year>. <article-title>Be alert for vapor intrusion of 1,4-dioxane from contaminated groundwater</article-title>. <source>Sci Total Environ</source><volume>825</volume>:<elocation-id>153713</elocation-id>, PMID: 35149073, <pub-id pub-id-type="doi">10.1016/j.scitotenv.2022.153713</pub-id>.<pub-id pub-id-type="pmid">35149073</pub-id><pub-id pub-id-type="pmcid">PMC9845134</pub-id></mixed-citation></ref><ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lin</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Kwarteng</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Godwin</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Warner</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Robins</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Arko-Mensah</surname><given-names>J</given-names></string-name>, <etal>et al.</etal></person-group><year>2021</year>. <article-title>Airborne volatile organic compounds at an e-waste site in Ghana: source apportionment, exposure and health risks</article-title>. <source>J Hazard Mater</source><volume>419</volume>:<elocation-id>126353</elocation-id>, PMID: 34175701, <pub-id pub-id-type="doi">10.1016/j.jhazmat.2021.126353</pub-id>.<pub-id pub-id-type="pmid">34175701</pub-id><pub-id pub-id-type="pmcid">PMC9925107</pub-id></mixed-citation></ref><ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jia</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Batterman</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chernyak</surname><given-names>S</given-names></string-name></person-group>. <year>2006</year>. <article-title>Development and comparison of methods using MS scan and selective ion monitoring modes for a wide range of airborne VOCs</article-title>. <source>J Environ Monit</source><volume>8</volume>(<issue>10</issue>):<fpage>1029</fpage>&#8211;<lpage>1042</lpage>, PMID: 17240909, <pub-id pub-id-type="doi">10.1039/b607042f</pub-id>.<pub-id pub-id-type="pmid">17240909</pub-id></mixed-citation></ref><ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Orhan</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>van Holland</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Krab</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Moeken</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Vermeulen</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Hollander</surname><given-names>P</given-names></string-name>, <etal>et al.</etal></person-group><year>2004</year>. <article-title>Evaluation of a multi-parameter biomarker set for oxidative damage in man: increased urinary excretion of lipid, protein and DNA oxidation products after one hour of exercise</article-title>. <source>Free Radic Res</source><volume>38</volume>(<issue>12</issue>):<fpage>1269</fpage>&#8211;<lpage>1279</lpage>, PMID: 15763951, <pub-id pub-id-type="doi">10.1080/10715760400013763</pub-id>.<pub-id pub-id-type="pmid">15763951</pub-id></mixed-citation></ref><ref id="c31"><label>31.</label><mixed-citation publication-type="book"><collab>IARC (International Agency for Research on Cancer)</collab>. <year>2018</year>. <article-title>Benzene</article-title>. vol. <volume>120</volume>. <publisher-loc>Lyon, France</publisher-loc>: <publisher-name>IARC</publisher-name>.</mixed-citation></ref><ref id="c32"><label>32.</label><mixed-citation publication-type="webpage"><collab>ILO (International Labour Organization), WHO</collab>. <year>2023</year>. <article-title>N-hexane</article-title>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ilo.org/dyn/icsc/showcard.display?p_version=2&amp;p_card_id=0279" ext-link-type="uri">http://www.ilo.org/dyn/icsc/showcard.display?p_version=2&amp;p_card_id=0279</ext-link> [accessed <date-in-citation content-type="access-date">10 April 2023</date-in-citation>].</mixed-citation></ref><ref id="c33"><label>33.</label><mixed-citation publication-type="webpage"><collab>ILO, WHO</collab>. <year>2023</year>. <article-title>Nonane</article-title>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ilo.org/dyn/icsc/showcard.display?p_version=2&amp;p_card_id=1245" ext-link-type="uri">http://www.ilo.org/dyn/icsc/showcard.display?p_version=2&amp;p_card_id=1245</ext-link> [accessed <date-in-citation content-type="access-date">10 April 2023</date-in-citation>].</mixed-citation></ref><ref id="c34"><label>34.</label><mixed-citation publication-type="webpage"><collab>ILO, WHO</collab>. <year>2023</year>. <article-title>Benzene</article-title>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ilo.org/dyn/icsc/showcard.display?p_version=2&amp;p_card_id=0015" ext-link-type="uri">http://www.ilo.org/dyn/icsc/showcard.display?p_version=2&amp;p_card_id=0015</ext-link> [accessed <date-in-citation content-type="access-date">10 April 2023</date-in-citation>].</mixed-citation></ref><ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Farage</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Bjerke</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Mahony</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Blackburn</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Gerberick</surname><given-names>GF</given-names></string-name></person-group>. <year>2003</year>. <article-title>Quantitative risk assessment for the induction of allergic contact dermatitis: uncertainty factors for mucosal exposures</article-title>. <source>Contact Dermatitis</source><volume>49</volume>(<issue>3</issue>):<fpage>140</fpage>&#8211;<lpage>147</lpage>, PMID: 14678210, <pub-id pub-id-type="doi">10.1111/j.0105-1873.2003.00192.x</pub-id>.<pub-id pub-id-type="pmid">14678210</pub-id></mixed-citation></ref><ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Britz</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Maibach</surname><given-names>HI</given-names></string-name>, <string-name name-style="western"><surname>Anjo</surname><given-names>DM</given-names></string-name></person-group>. <year>1980</year>. <article-title>Human percutaneous penetration of hydrocortisone - the vulva</article-title>. <source>Arch Dermatol Res</source><volume>267</volume>(<issue>3</issue>):<fpage>313</fpage>&#8211;<lpage>316</lpage>, PMID: 7406539, <pub-id pub-id-type="doi">10.1007/BF00403852</pub-id>.<pub-id pub-id-type="pmid">7406539</pub-id></mixed-citation></ref><ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Oriba</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Bucks</surname><given-names>DAW</given-names></string-name>, <string-name name-style="western"><surname>Maibach</surname><given-names>HI</given-names></string-name></person-group>. <year>1996</year>. <article-title>Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of the menopause and site</article-title>. <source>Br J Dermatol</source><volume>134</volume>(<issue>2</issue>):<fpage>229</fpage>&#8211;<lpage>233</lpage>, PMID: 8746334.<pub-id pub-id-type="pmid">8746334</pub-id></mixed-citation></ref><ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jongeneelen</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Ten Berge</surname><given-names>WF</given-names></string-name></person-group>. <year>2011</year>. <article-title>A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results</article-title>. <source>Ann Occup Hyg</source><volume>55</volume>(<issue>8</issue>):<fpage>841</fpage>&#8211;<lpage>864</lpage>, PMID: 21998005, <pub-id pub-id-type="doi">10.1093/annhyg/mer075</pub-id>.<pub-id pub-id-type="pmid">21998005</pub-id></mixed-citation></ref><ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mattie</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Grabau</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>McDougal</surname><given-names>JN</given-names></string-name></person-group>. <year>1994</year>. <article-title>Significance of the dermal route of exposure to risk assessment</article-title>. <source>Risk Anal</source><volume>14</volume>(<issue>3</issue>):<fpage>277</fpage>&#8211;<lpage>284</lpage>, PMID: 8029499, <pub-id pub-id-type="doi">10.1111/j.1539-6924.1994.tb00242.x</pub-id>.<pub-id pub-id-type="pmid">8029499</pub-id></mixed-citation></ref><ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bae</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kwon</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>J</given-names></string-name></person-group>. <year>2018</year>. <article-title>Safety evaluation of absorbent hygiene pads: a review on assessment framework and test methods</article-title>. <source>Sustainability</source><volume>10</volume>(<issue>11</issue>):<fpage>4146</fpage>, <pub-id pub-id-type="doi">10.3390/su10114146</pub-id>.</mixed-citation></ref><ref id="c41"><label>41.</label><mixed-citation publication-type="book"><collab>US EPA</collab>. <year>2007</year>. <article-title>Dermal Exposure Assessment: A Summary of EPA Approaches.</article-title><comment>EPA/600/R-07/040F</comment>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>US EPA</publisher-name>.</mixed-citation></ref><ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Guy</surname><given-names>RH</given-names></string-name>, <string-name name-style="western"><surname>Potts</surname><given-names>RO</given-names></string-name></person-group>. <year>1993</year>. <article-title>Penetration of industrial chemicals across the skin: a predictive model</article-title>. <source>Am J Ind Med</source><volume>23</volume>(<issue>5</issue>):<fpage>711</fpage>&#8211;<lpage>719</lpage>, PMID: 8506849, <pub-id pub-id-type="doi">10.1002/ajim.4700230505</pub-id>.<pub-id pub-id-type="pmid">8506849</pub-id></mixed-citation></ref><ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yazdi</surname><given-names>SJM</given-names></string-name>, <string-name name-style="western"><surname>Baqersad</surname><given-names>J</given-names></string-name></person-group>. <year>2022</year>. <article-title>Mechanical modeling and characterization of human skin: a review</article-title>. <source>J Biomech</source><volume>130</volume>:<elocation-id>110864</elocation-id>, PMID: 34844034, <pub-id pub-id-type="doi">10.1016/j.jbiomech.2021.110864</pub-id>.<pub-id pub-id-type="pmid">34844034</pub-id></mixed-citation></ref><ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yokley</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Tran</surname><given-names>HT</given-names></string-name>, <string-name name-style="western"><surname>Pekari</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Rappaport</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Riihimaki</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Rothman</surname><given-names>N</given-names></string-name>, <etal>et al.</etal></person-group><year>2006</year>. <article-title>Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach</article-title>. <source>Risk Anal</source><volume>26</volume>(<issue>4</issue>):<fpage>925</fpage>&#8211;<lpage>943</lpage>, PMID: 16948686, <pub-id pub-id-type="doi">10.1111/j.1539-6924.2006.00789.x</pub-id>.<pub-id pub-id-type="pmid">16948686</pub-id></mixed-citation></ref><ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bois</surname><given-names>FY</given-names></string-name>, <string-name name-style="western"><surname>Jackson</surname><given-names>ET</given-names></string-name>, <string-name name-style="western"><surname>Pekari</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>MT</given-names></string-name></person-group>. <year>1996</year>. <article-title>Population toxicokinetics of benzene</article-title>. <source>Environ Health Perspect</source><volume>104</volume>(<issue>suppl 6</issue>):<fpage>1405</fpage>&#8211;<lpage>1411</lpage>, PMID: 9118927, <pub-id pub-id-type="doi">10.1289/ehp.961041405</pub-id>.<pub-id pub-id-type="pmid">9118927</pub-id><pub-id pub-id-type="pmcid">PMC1469729</pub-id></mixed-citation></ref><ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tardif</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lapar&#233;</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Charest-Tardif</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Brodeur</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Krishnan</surname><given-names>K</given-names></string-name></person-group>. <year>1995</year>. <article-title>Physiologically-based pharmacokinetic modeling of a mixture of toluene and xylene in humans</article-title>. <source>Risk Anal</source><volume>15</volume>(<issue>3</issue>):<fpage>335</fpage>&#8211;<lpage>342</lpage>, PMID: 7604167, <pub-id pub-id-type="doi">10.1111/j.1539-6924.1995.tb00326.x</pub-id>.<pub-id pub-id-type="pmid">7604167</pub-id></mixed-citation></ref><ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Frasch</surname><given-names>HF</given-names></string-name>, <string-name name-style="western"><surname>Barbero</surname><given-names>AM</given-names></string-name></person-group>. <year>2018</year>. <article-title>Human skin permeation of benzene in gasoline: effects of concentration, multiple dosing and skin preparation</article-title>. <source>J Expo Sci Environ Epidemiol</source><volume>28</volume>(<issue>2</issue>):<fpage>193</fpage>&#8211;<lpage>201</lpage>, PMID: 28792002, <pub-id pub-id-type="doi">10.1038/jes.2017.10</pub-id>.<pub-id pub-id-type="pmid">28792002</pub-id><pub-id pub-id-type="pmcid">PMC6531855</pub-id></mixed-citation></ref><ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Thrall</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Woodstock</surname><given-names>AD</given-names></string-name></person-group>. <year>2002</year>. <article-title>Evaluation of the dermal absorption of aqueous toluene in f344 rats using real-time breath analysis and physiologically based pharmacokinetic modeling</article-title>. <source>J Toxicol Environ Health A</source><volume>65</volume>(<issue>24</issue>):<fpage>2087</fpage>&#8211;<lpage>2100</lpage>, PMID: 12515588, <pub-id pub-id-type="doi">10.1080/00984100290071540</pub-id>.<pub-id pub-id-type="pmid">12515588</pub-id></mixed-citation></ref><ref id="c49"><label>49.</label><mixed-citation publication-type="book"><collab>US EPA</collab>. <year>2011</year>. <source>Exposure Factors Handbook: 2011 Edition</source>. <comment>EPA/600/r-09/052f</comment>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>US Environmental Protection Agency</publisher-name>.</mixed-citation></ref><ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Valentin</surname><given-names>J</given-names></string-name></person-group>. <year>2002</year>. <article-title>Basic anatomical and physiological data for use in radiological protection: reference values: ICRP Publication 89</article-title>. <source>Ann ICRP</source><volume>32</volume>(<issue>3&#8211;4</issue>):<fpage>1</fpage>&#8211;<lpage>277</lpage>, <pub-id pub-id-type="doi">10.1016/S0146-6453(03)00002-2</pub-id>.<pub-id pub-id-type="pmid">14506981</pub-id></mixed-citation></ref><ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Smith</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Tyrrell</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Weitz</surname><given-names>KK</given-names></string-name>, <string-name name-style="western"><surname>Faber</surname><given-names>W</given-names></string-name></person-group>. <year>2020</year>. <article-title>Linking internal dosimetries of the propyl metabolic series in rats and humans using physiologically based pharmacokinetic (PBPK) modeling</article-title>. <source>Regul Toxicol Pharmacol</source><volume>110</volume>:<elocation-id>104507</elocation-id>, PMID: 31669189, <pub-id pub-id-type="doi">10.1016/j.yrtph.2019.104507</pub-id>.<pub-id pub-id-type="pmid">31669189</pub-id></mixed-citation></ref><ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Fryar</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Carroll</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Gu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Afful</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ogden</surname><given-names>CL</given-names></string-name></person-group>. <year>2021</year>. <article-title>Anthropometric reference data for children and adults: United States, 2015&#8211;2018</article-title>. <source>Vital Health Stat 3</source><volume>3</volume>(<issue>36</issue>):<fpage>1</fpage>&#8211;<lpage>44</lpage>, PMID: 33541517.<pub-id pub-id-type="pmid">33541517</pub-id></mixed-citation></ref><ref id="c53"><label>53.</label><mixed-citation publication-type="book"><string-name name-style="western"><surname>Gupta</surname><given-names>A.</given-names></string-name><year>2020</year>. <article-title>Chapter 44 - Toxicokinetics, pharmacokinetics, and absorption, distribution, metabolism, and excretion</article-title>. In: <source>Information Resources in Toxicology</source>. <person-group person-group-type="editor"><string-name name-style="western"><surname>Wexler</surname><given-names>P</given-names></string-name></person-group>, <role>ed.</role><edition>5th ed.</edition><publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>Academic Press</publisher-name>, <fpage>483</fpage>&#8211;<lpage>488</lpage>.</mixed-citation></ref><ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ali</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Tardif</surname><given-names>R</given-names></string-name></person-group>. <year>1999</year>. <article-title>Toxicokinetic modeling of the combined exposure to toluene and n-hexane in rats and humans</article-title>. <source>J Occup Health</source><volume>41</volume>(<issue>2</issue>):<fpage>95</fpage>&#8211;<lpage>103</lpage>, <pub-id pub-id-type="doi">10.1539/joh.41.95</pub-id>.</mixed-citation></ref><ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Edginton</surname><given-names>AN</given-names></string-name>, <string-name name-style="western"><surname>Ritter</surname><given-names>L</given-names></string-name></person-group>. <year>2009</year>. <article-title>Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic model</article-title>. <source>Environ Health Perspect</source><volume>117</volume>(<issue>4</issue>):<fpage>645</fpage>&#8211;<lpage>652</lpage>, PMID: 19440506, <pub-id pub-id-type="doi">10.1289/ehp.0800073</pub-id>.<pub-id pub-id-type="pmid">19440506</pub-id><pub-id pub-id-type="pmcid">PMC2679611</pub-id></mixed-citation></ref><ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Emond</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Sanders</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Wikoff</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Birnbaum</surname><given-names>LS</given-names></string-name></person-group>. <year>2013</year>. <article-title>Proposed mechanistic description of dose-dependent BDE-47 urinary elimination in mice using a physiologically based pharmacokinetic model</article-title>. <source>Toxicol Appl Pharmacol</source><volume>273</volume>(<issue>2</issue>):<fpage>335</fpage>&#8211;<lpage>344</lpage>, PMID: 24055880, <pub-id pub-id-type="doi">10.1016/j.taap.2013.09.007</pub-id>.<pub-id pub-id-type="pmid">24055880</pub-id><pub-id pub-id-type="pmcid">PMC3913262</pub-id></mixed-citation></ref><ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Meulenberg</surname><given-names>CJW</given-names></string-name>, <string-name name-style="western"><surname>Vijverberg</surname><given-names>HPM</given-names></string-name></person-group>. <year>2000</year>. <article-title>Empirical relations predicting human and rat tissue: air partition coefficients of volatile organic compounds</article-title>. <source>Toxicol Appl Pharmacol</source><volume>165</volume>(<issue>3</issue>):<fpage>206</fpage>&#8211;<lpage>216</lpage>, PMID: 10873711, <pub-id pub-id-type="doi">10.1006/taap.2000.8929</pub-id>.<pub-id pub-id-type="pmid">10873711</pub-id></mixed-citation></ref><ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Perbellini</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Brugnone</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Mozzo</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Cocheo</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Caretta</surname><given-names>D</given-names></string-name></person-group>. <year>1984</year>. <article-title>Methyl ethyl ketone exposure in industrial-workers - uptake and kinetics</article-title>. <source>Int Arch Occup Environ Health</source><volume>54</volume>(<issue>1</issue>):<fpage>73</fpage>&#8211;<lpage>81</lpage>, PMID: 6724704, <pub-id pub-id-type="doi">10.1007/BF00378730</pub-id>.<pub-id pub-id-type="pmid">6724704</pub-id></mixed-citation></ref><ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Liira</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Johanson</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Riihimaki</surname><given-names>V</given-names></string-name></person-group>. <year>1990</year>. <article-title>Dose-dependent kinetics of inhaled methylethylketone in man</article-title>. <source>Toxicol Lett</source><volume>50</volume>(<issue>2&#8211;3</issue>):<fpage>195</fpage>&#8211;<lpage>201</lpage>, PMID: 2309238, <pub-id pub-id-type="doi">10.1016/0378-4274(90)90011-a</pub-id>.<pub-id pub-id-type="pmid">2309238</pub-id></mixed-citation></ref><ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Olie</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Bessems</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Clewell</surname><given-names>HJ</given-names><suffix>3rd</suffix></string-name>, <string-name name-style="western"><surname>Meulenbelt</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hunault</surname><given-names>CC</given-names></string-name></person-group>. <year>2015</year>. <article-title>Evaluation of semi-generic PBTK modeling for emergency risk assessment after acute inhalation exposure to volatile hazardous chemicals</article-title>. <source>Chemosphere</source><volume>132</volume>:<fpage>47</fpage>&#8211;<lpage>55</lpage>, PMID: 25794648, <pub-id pub-id-type="doi">10.1016/j.chemosphere.2015.02.048</pub-id>.<pub-id pub-id-type="pmid">25794648</pub-id></mixed-citation></ref><ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Meesters</surname><given-names>RJW</given-names></string-name>, <string-name name-style="western"><surname>Duisken</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hollender</surname><given-names>J</given-names></string-name></person-group>. <year>2009</year>. <article-title>Cytochrome P450-catalysed arene-epoxidation of the bioactive tea tree oil ingredient p-cymene: indication for the formation of a reactive allergenic intermediate?</article-title><source>Xenobiotica</source><volume>39</volume>(<issue>9</issue>):<fpage>663</fpage>&#8211;<lpage>671</lpage>, PMID: 19480554, <pub-id pub-id-type="doi">10.1080/00498250902989094</pub-id>.<pub-id pub-id-type="pmid">19480554</pub-id></mixed-citation></ref><ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Edwards</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Rose</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Hodgson</surname><given-names>E</given-names></string-name></person-group>. <year>2005</year>. <article-title>The metabolism of nonane, a JP-8 jet fuel component, by human liver microsomes, P450 isoforms and alcohol dehydrogenase and inhibition of human P450 isoforms by JP-8</article-title>. <source>Chem Biol Interact</source><volume>151</volume>(<issue>3</issue>):<fpage>203</fpage>&#8211;<lpage>211</lpage>, PMID: 15733541, <pub-id pub-id-type="doi">10.1016/j.cbi.2004.12.003</pub-id>.<pub-id pub-id-type="pmid">15733541</pub-id></mixed-citation></ref><ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Brown</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Delp</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Lindstedt</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Rhomberg</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Beliles</surname><given-names>RP</given-names></string-name></person-group>. <year>1997</year>. <article-title>Physiological parameter values for physiologically based pharmacokinetic models</article-title>. <source>Toxicol Ind Health</source><volume>13</volume>(<issue>4</issue>):<fpage>407</fpage>&#8211;<lpage>484</lpage>, PMID: 9249929, <pub-id pub-id-type="doi">10.1177/074823379701300401</pub-id>.<pub-id pub-id-type="pmid">9249929</pub-id></mixed-citation></ref><ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shimada</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Yamazaki</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Mimura</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Inui</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Guengerich</surname><given-names>FP</given-names></string-name></person-group>. <year>1994</year>. <article-title>Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians</article-title>. <source>J Pharmacol Exp Ther</source><volume>270</volume>(<issue>1</issue>):<fpage>414</fpage>&#8211;<lpage>423</lpage>, PMID: 8035341.<pub-id pub-id-type="pmid">8035341</pub-id></mixed-citation></ref><ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chiu</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>Ginsberg</surname><given-names>GL</given-names></string-name></person-group>. <year>2011</year>. <article-title>Development and evaluation of a harmonized physiologically based pharmacokinetic (PBPK) model for perchloroethylene toxicokinetics in mice, rats, and humans</article-title>. <source>Toxicol Appl Pharmacol</source><volume>253</volume>(<issue>3</issue>):<fpage>203</fpage>&#8211;<lpage>234</lpage>, PMID: 21466818, <pub-id pub-id-type="doi">10.1016/j.taap.2011.03.020</pub-id>.<pub-id pub-id-type="pmid">21466818</pub-id></mixed-citation></ref><ref id="c66"><label>66.</label><mixed-citation publication-type="book"><string-name name-style="western"><surname>Carlson</surname><given-names>BM.</given-names></string-name><year>2019</year>. <article-title>Chapter 13 - The urinary system</article-title>. In: <source>The Human Body</source>. <person-group person-group-type="editor"><string-name name-style="western"><surname>Carlson</surname><given-names>BM</given-names></string-name></person-group>, ed. <publisher-loc>Cambridge, MA</publisher-loc>: <publisher-name>Academic Press</publisher-name>, <fpage>357</fpage>&#8211;<lpage>372</lpage>.</mixed-citation></ref><ref id="c67"><label>67.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Jongeneelen</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>ten Berge</surname><given-names>WF</given-names></string-name></person-group>. <year>2011</year>. <source>IndusChemFate, A Multi-Chemical PBTK-Model in MS-Excel Applicable for Workers, Consumers and Experimental Animals: User Manual, Version 2.00</source>. <publisher-loc>Nijmegen, Netherlands</publisher-loc>: <publisher-name>IndusTox, European Chemical Industry Council Long-Range Research Initiative (Cefic LRI)</publisher-name>.</mixed-citation></ref><ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Api</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Belsito</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Biserta</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Botelho</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Bruze</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Burton</surname><given-names>GA</given-names></string-name>, <etal>et al.</etal></person-group><year>2021</year>. <article-title>RIFM fragrance ingredient safety assessment, <italic toggle="yes">p</italic>-cymene, CAS Registry Number 99-87-6</article-title>. <source>Food Chem Toxicol</source><volume>149 Suppl 1</volume>:<elocation-id>112051</elocation-id>, PMID: 33571609, <pub-id pub-id-type="doi">10.1016/j.fct.2021.112051</pub-id>.<pub-id pub-id-type="pmid">33571609</pub-id></mixed-citation></ref><ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pal</surname><given-names>VK</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kannan</surname><given-names>K</given-names></string-name></person-group>. <year>2023</year>. <article-title>Occurrence of and dermal exposure to benzene, toluene and styrene in sunscreen products marketed in the United States</article-title>. <source>Sci Total Environ</source><volume>888</volume>:<elocation-id>164196</elocation-id>, PMID: 37201845, <pub-id pub-id-type="doi">10.1016/j.scitotenv.2023.164196</pub-id>.<pub-id pub-id-type="pmid">37201845</pub-id><pub-id pub-id-type="pmcid">PMC10330564</pub-id></mixed-citation></ref><ref id="c70"><label>70.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Troy</surname><given-names>TW</given-names></string-name>, <string-name name-style="western"><surname>Scott</surname><given-names>F</given-names></string-name></person-group>. <year>2003</year>. <source>Probability Bounds Analysis in Environmental Risk Assessments</source>. <publisher-loc>Setauket, New York</publisher-loc>: <publisher-name>Applied Biomathematics</publisher-name>.</mixed-citation></ref><ref id="c71"><label>71.</label><mixed-citation publication-type="webpage"><collab>US EPA</collab>. <year>2011</year>. <article-title>Community-Based Air Pollution Projects Glossary: Vocabulary Catalog</article-title>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://sor.epa.gov/sor_internet/registry/termreg/searchandretrieve/glossariesandkeywordlists/search.do?details=&amp;glossaryName=Community-Based%20Air%20Pollution" ext-link-type="uri">https://sor.epa.gov/sor_internet/registry/termreg/searchandretrieve/glossariesandkeywordlists/search.do?details=&amp;glossaryName=Community-Based%20Air%20Pollution</ext-link> [accessed <date-in-citation content-type="access-date">23 April 2023</date-in-citation>].</mixed-citation></ref><ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McKone</surname><given-names>TE</given-names></string-name>, <string-name name-style="western"><surname>Maddalena</surname><given-names>RL</given-names></string-name></person-group>. <year>2002</year>. <article-title>Eight years of model evaluation: the CalTOX experience</article-title>. <source>Epidemiology</source><volume>13</volume>:<fpage>S118</fpage>&#8211;<lpage>S118</lpage>.</mixed-citation></ref><ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Woo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Jeong</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Ha</surname><given-names>E</given-names></string-name></person-group>. <year>2019</year>. <article-title>Systematic review on sanitary pads and female health</article-title>. <source>Ewha Med J</source><volume>42</volume>(<issue>3</issue>):<fpage>25</fpage>&#8211;<lpage>38</lpage>, <pub-id pub-id-type="doi">10.12771/emj.2019.42.3.25</pub-id>.</mixed-citation></ref><ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Morgan</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Cooper</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Carlock</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Sykora</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Sutton</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Mattie</surname><given-names>DR</given-names></string-name>, <etal>et al.</etal></person-group><year>1991</year>. <article-title>Dermal absorption of neat and aqueous volatile organic-chemicals in the Fischer 344 rat</article-title>. <source>Environ Res</source><volume>55</volume>(<issue>1</issue>):<fpage>51</fpage>&#8211;<lpage>63</lpage>, PMID: 1855490, <pub-id pub-id-type="doi">10.1016/s0013-9351(05)80140-9</pub-id>.<pub-id pub-id-type="pmid">1855490</pub-id></mixed-citation></ref><ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McDougal</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Jepson</surname><given-names>GW</given-names></string-name>, <string-name name-style="western"><surname>Clewell</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Gargas</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname><given-names>ME</given-names></string-name></person-group>. <year>1990</year>. <article-title>Dermal absorption of organic-chemical vapors in rats and humans</article-title>. <source>Fundam Appl Toxicol</source><volume>14</volume>(<issue>2</issue>):<fpage>299</fpage>&#8211;<lpage>308</lpage>, PMID: 2318354, <pub-id pub-id-type="doi">10.1016/0272-0590(90)90209-3</pub-id>.<pub-id pub-id-type="pmid">2318354</pub-id></mixed-citation></ref><ref id="c76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Susten</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Niemeier</surname><given-names>RW</given-names></string-name>, <string-name name-style="western"><surname>Simon</surname><given-names>SD</given-names></string-name></person-group>. <year>1990</year>. <article-title>In vivo percutaneous absorption studies of volatile organic solvents in hairless mice. II. Toluene, ethylbenzene and aniline</article-title>. <source>J Appl Toxicol</source><volume>10</volume>(<issue>3</issue>):<fpage>217</fpage>&#8211;<lpage>225</lpage>, PMID: 2380484, <pub-id pub-id-type="doi">10.1002/jat.2550100313</pub-id>.<pub-id pub-id-type="pmid">2380484</pub-id></mixed-citation></ref><ref id="c77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Heinrich-Ramm</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Jakubowski</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Heinzow</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Christensen</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Olsen</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Hertel</surname><given-names>O</given-names></string-name></person-group>. <year>2000</year>. <article-title>Biological monitoring for exposure to volatile organic compounds (VOCs) (IUPAC Recommendations 2000)</article-title>. <source>Pure Appl Chem</source><volume>72</volume>(<issue>3</issue>):<fpage>385</fpage>&#8211;<lpage>436</lpage>, <pub-id pub-id-type="doi">10.1351/pac200072030385</pub-id>.</mixed-citation></ref><ref id="c78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lazaridis</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Broday</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Hov</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Georgopoulos</surname><given-names>PG</given-names></string-name></person-group>. <year>2001</year>. <article-title>Integrated exposure and dose modeling and analysis system. 3. Deposition of inhaled particles in the human respiratory tract</article-title>. <source>Environ Sci Technol</source><volume>35</volume>(<issue>18</issue>):<fpage>3727</fpage>&#8211;<lpage>3734</lpage>, PMID: 11783652, <pub-id pub-id-type="doi">10.1021/es001545w</pub-id>.<pub-id pub-id-type="pmid">11783652</pub-id></mixed-citation></ref><ref id="c79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Thrall</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Poet</surname><given-names>TS</given-names></string-name>, <string-name name-style="western"><surname>Corley</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Tanojo</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Edwards</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Weitz</surname><given-names>KK</given-names></string-name>, <etal>et al.</etal></person-group><year>2000</year>. <article-title>A real-time in-vivo method for studying the percutaneous absorption of volatile chemicals</article-title>. <source>Int J Occup Environ Health</source><volume>6</volume>(<issue>2</issue>):<fpage>96</fpage>&#8211;<lpage>103</lpage>, PMID: 10828137, <pub-id pub-id-type="doi">10.1179/oeh.2000.6.2.96</pub-id>.<pub-id pub-id-type="pmid">10828137</pub-id></mixed-citation></ref><ref id="c80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gordon</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Wallace</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Callahan</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Kenny</surname><given-names>DV</given-names></string-name>, <string-name name-style="western"><surname>Brinkman</surname><given-names>MC</given-names></string-name></person-group>. <year>1998</year>. <article-title>Effect of water temperature on dermal exposure to chloroform</article-title>. <source>Environ Health Perspect</source><volume>106</volume>(<issue>6</issue>):<fpage>337</fpage>&#8211;<lpage>345</lpage>, PMID: 9618350, <pub-id pub-id-type="doi">10.1289/ehp.98106337</pub-id>.<pub-id pub-id-type="pmid">9618350</pub-id><pub-id pub-id-type="pmcid">PMC1532999</pub-id></mixed-citation></ref><ref id="c81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Corley</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Gordon</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Wallace</surname><given-names>LA</given-names></string-name></person-group>. <year>2000</year>. <article-title>Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures</article-title>. <source>Toxicol Sci</source><volume>53</volume>(<issue>1</issue>):<fpage>13</fpage>&#8211;<lpage>23</lpage>, PMID: 10653516, <pub-id pub-id-type="doi">10.1093/toxsci/53.1.13</pub-id>.<pub-id pub-id-type="pmid">10653516</pub-id></mixed-citation></ref><ref id="c82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Nylander-French</surname><given-names>LA</given-names></string-name></person-group>. <year>2006</year>. <article-title>Dermal absorption and penetration of jet fuel components in humans</article-title>. <source>Toxicol Lett</source><volume>165</volume>(<issue>1</issue>):<fpage>11</fpage>&#8211;<lpage>21</lpage>, PMID: 16497449, <pub-id pub-id-type="doi">10.1016/j.toxlet.2006.01.009</pub-id>.<pub-id pub-id-type="pmid">16497449</pub-id></mixed-citation></ref><ref id="c83"><label>83.</label><mixed-citation publication-type="book"><string-name name-style="western"><surname>Kim</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Nylander-French</surname><given-names>LA.</given-names></string-name><year>2009</year>. <article-title>Physiologically based toxicokinetic models and their application in human exposure and internal dose assessment</article-title>. In: <source>Molecular, Clinical and Environmental Toxicology</source>. <person-group person-group-type="editor"><string-name name-style="western"><surname>Luch</surname><given-names>A</given-names></string-name></person-group>, <role>ed.</role><comment>Experientia Supplementum, vol. 99</comment>. <publisher-loc>Basel, Switzerland</publisher-loc>: <publisher-name>Birkh&#228;user Verlag</publisher-name>, <fpage>37</fpage>&#8211;<lpage>55</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-7643-8336-7_2</pub-id><pub-id pub-id-type="pmid">19157057</pub-id></mixed-citation></ref><ref id="c84"><label>84.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Robinson</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Merrill</surname><given-names>EA</given-names></string-name></person-group>. <year>2007</year>. <article-title>A Harmonized Physiologically-Based Pharmacokinetic Model for Nonane as a Component of Jet Fuel</article-title>. <publisher-loc>Wright-Patterson AFB OH, USA</publisher-loc>: <publisher-name>Henry M. Jackson Foundation for the Advancement of Military Medicine</publisher-name>.</mixed-citation></ref><ref id="c85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hamelin</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Charest-Tardif</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Truchon</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Tardif</surname><given-names>R</given-names></string-name></person-group>. <year>2005</year>. <article-title>Physiologically based modeling of n-hexane kinetics in humans following inhalation exposure at rest and under physical exertion: impact on free 2,5-hexanedione in urine and on n-hexane in alveolar air</article-title>. <source>J Occup Environ Hyg</source><volume>2</volume>(<issue>2</issue>):<fpage>86</fpage>&#8211;<lpage>97</lpage>, PMID: 15764529, <pub-id pub-id-type="doi">10.1080/15459620590909673</pub-id>.<pub-id pub-id-type="pmid">15764529</pub-id></mixed-citation></ref><ref id="c86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Quintana</surname><given-names>PJE</given-names></string-name>, <string-name name-style="western"><surname>Delfino</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Korrick</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ziogas</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kutz</surname><given-names>FW</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>EL</given-names></string-name>, <etal>et al.</etal></person-group><year>2004</year>. <article-title>Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin&#8217;s lymphoma</article-title>. <source>Environ Health Perspect</source><volume>112</volume>(<issue>8</issue>):<fpage>854</fpage>&#8211;<lpage>861</lpage>, PMID: 15175172, <pub-id pub-id-type="doi">10.1289/ehp.6726</pub-id>.<pub-id pub-id-type="pmid">15175172</pub-id><pub-id pub-id-type="pmcid">PMC1242012</pub-id></mixed-citation></ref><ref id="c87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mlyczy&#324;ska</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bongrani</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rame</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>W&#281;giel</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ma&#347;lanka</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Major</surname><given-names>P</given-names></string-name>, <etal>et al.</etal></person-group><year>2023</year>. <article-title>Concentration of polycyclic aromatic hydrocarbons (PAHs) in human serum and adipose tissues and stimulatory effect of naphthalene in adipogenesis in 3T3-L1 cells</article-title>. <source>Int J Mol Sci</source><volume>24</volume>(<issue>2</issue>):<fpage>1455</fpage>, PMID: 36674971, <pub-id pub-id-type="doi">10.3390/ijms24021455</pub-id>.<pub-id pub-id-type="pmid">36674971</pub-id><pub-id pub-id-type="pmcid">PMC9861916</pub-id></mixed-citation></ref><ref id="c88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Esteban</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Casta&#241;o</surname><given-names>A</given-names></string-name></person-group>. <year>2009</year>. <article-title>Non-invasive matrices in human biomonitoring: a review</article-title>. <source>Environ Int</source><volume>35</volume>(<issue>2</issue>):<fpage>438</fpage>&#8211;<lpage>449</lpage>, PMID: 18951632, <pub-id pub-id-type="doi">10.1016/j.envint.2008.09.003</pub-id>.<pub-id pub-id-type="pmid">18951632</pub-id></mixed-citation></ref><ref id="c89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sexton</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Needham</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Pirkle</surname><given-names>J</given-names></string-name></person-group>. <year>2004</year>. <article-title>Human biomonitoring of environmental chemicals: measuring chemicals in human tissues is the &#8220;gold standard&#8221; for assessing people&#8217;s exposure to pollution</article-title>. <source>Am Sci</source><volume>92</volume>(<issue>1</issue>):<fpage>38</fpage>&#8211;<lpage>45</lpage>, <pub-id pub-id-type="doi">10.1511/2004.1.38</pub-id>.</mixed-citation></ref><ref id="c90"><label>90.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Bingham</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Cohrssen</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Powell</surname><given-names>CH</given-names></string-name></person-group>. <year>2001</year>. <source>Patty&#8217;s Toxicology</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Wiley</publisher-name>.</mixed-citation></ref><ref id="c91"><label>91.</label><mixed-citation publication-type="webpage"><collab>ECHA (European Chemicals Agency)</collab>. <year>2022</year>. <article-title>Methylcyclohexane</article-title>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://echa.europa.eu/substance-information/-/substanceinfo/100.003.296" ext-link-type="uri">https://echa.europa.eu/substance-information/-/substanceinfo/100.003.296</ext-link> [accessed <date-in-citation content-type="access-date">10 April 2023</date-in-citation>].</mixed-citation></ref><ref id="c92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Waidyanatha</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rappaport</surname><given-names>SA</given-names></string-name></person-group>. <year>2005</year>. <article-title>Investigation of cysteinyl protein adducts of benzene diolepoxide</article-title>. <source>Chem Biol Interact</source><volume>153-154</volume>:<fpage>261</fpage>&#8211;<lpage>266</lpage>, PMID: 15935825, <pub-id pub-id-type="doi">10.1016/j.cbi.2005.03.033</pub-id>.<pub-id pub-id-type="pmid">15935825</pub-id></mixed-citation></ref><ref id="c93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>QF</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>ZN</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>XJ</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>ZR</given-names></string-name>, <etal>et al.</etal></person-group><year>2020</year>. <article-title>Influence of benzene exposure, fat content, and their interactions on erythroid-related hematologic parameters in petrochemical workers: a cross-sectional study</article-title>. <source>BMC Public Health</source><volume>20</volume>(<issue>1</issue>):<fpage>382</fpage>, PMID: 32293364, <pub-id pub-id-type="doi">10.1186/s12889-020-08493-z</pub-id>.<pub-id pub-id-type="pmid">32293364</pub-id><pub-id pub-id-type="pmcid">PMC7092548</pub-id></mixed-citation></ref><ref id="c94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lin</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Meza-Wilson</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Devasurendra</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Godwin</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>SK</given-names></string-name>, <etal>et al.</etal></person-group><year>2023</year>. <article-title>Volatile organic compounds in disposable diapers and baby wipes in the us: a survey of products and health risks</article-title>. <source>Environ Sci Technol</source><volume>57</volume>(<issue>37</issue>):<fpage>13732</fpage>&#8211;<lpage>13743</lpage>, PMID: 37683294, <pub-id pub-id-type="doi">10.1021/acs.est.3c02862</pub-id>.<pub-id pub-id-type="pmid">37683294</pub-id><pub-id pub-id-type="pmcid">PMC11714667</pub-id></mixed-citation></ref><ref id="c95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hart</surname><given-names>LB</given-names></string-name>, <string-name name-style="western"><surname>Lightsey</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Golder</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Vassy</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Sundstrom</surname><given-names>B</given-names></string-name></person-group>. <year>2022</year>. <article-title>A comparison of personal care product use between undergraduate students attending military and non-military universities: possible implications for exposure to endocrine-disrupting chemicals</article-title>. <source>J Hazard Mater Adv</source><volume>7</volume>:<elocation-id>100117</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.hazadv.2022.100117</pub-id>.</mixed-citation></ref><ref id="c96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Stanfield</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Setzer</surname><given-names>RW</given-names></string-name>, <string-name name-style="western"><surname>Hull</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Sayre</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Isaacs</surname><given-names>KK</given-names></string-name>, <string-name name-style="western"><surname>Wambaugh</surname><given-names>JF</given-names></string-name></person-group>. <year>2024</year>. <article-title>Characterizing chemical exposure trends from NHANES urinary biomonitoring data</article-title>. <source>Environ Health Perspect</source><volume>132</volume>(<issue>1</issue>):<elocation-id>017009</elocation-id>, PMID: 38285237, <pub-id pub-id-type="doi">10.1289/EHP12188</pub-id>.<pub-id pub-id-type="pmid">38285237</pub-id><pub-id pub-id-type="pmcid">PMC10824265</pub-id></mixed-citation></ref><ref id="c97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Min</surname><given-names>HS</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>Choe</surname><given-names>SA</given-names></string-name></person-group>. <year>2023</year>. <article-title>Occupational differences in personal care product use and urinary concentration of endocrine disrupting chemicals by gender</article-title>. <source>J Expo Sci Environ Epidemiol</source><volume>33</volume>(<issue>2</issue>):<fpage>312</fpage>&#8211;<lpage>318</lpage>, PMID: 35414680, <pub-id pub-id-type="doi">10.1038/s41370-022-00436-7</pub-id>.<pub-id pub-id-type="pmid">35414680</pub-id></mixed-citation></ref><ref id="c98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Marchese</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Arciola</surname><given-names>CR</given-names></string-name>, <string-name name-style="western"><surname>Barbieri</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Silva</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Nabavi</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Sokeng</surname><given-names>AJT</given-names></string-name>, <etal>et al.</etal></person-group><year>2017</year>. <article-title>Update on monoterpenes as antimicrobial agents: a particular focus on p-cymene</article-title>. <source>Materials (Basel)</source><volume>10</volume>(<issue>8</issue>):<fpage>947</fpage>, PMID: 28809799, <pub-id pub-id-type="doi">10.3390/ma10080947</pub-id>.<pub-id pub-id-type="pmid">28809799</pub-id><pub-id pub-id-type="pmcid">PMC5578313</pub-id></mixed-citation></ref><ref id="c99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cao</surname><given-names>XL</given-names></string-name>, <string-name name-style="western"><surname>Sparling</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dabeka</surname><given-names>R</given-names></string-name></person-group>. <year>2019</year>. <article-title>P-cymene, a natural antioxidant, in Canadian total diet foods: occurrence and dietary exposures</article-title>. <source>J Sci Food Agric</source><volume>99</volume>(<issue>12</issue>):<fpage>5606</fpage>&#8211;<lpage>5609</lpage>, PMID: 31206173, <pub-id pub-id-type="doi">10.1002/jsfa.9854</pub-id>.<pub-id pub-id-type="pmid">31206173</pub-id></mixed-citation></ref><ref id="c100"><label>100.</label><mixed-citation publication-type="journal"><collab>European Food Safety Authority</collab>, <person-group person-group-type="author"><string-name name-style="western"><surname>Comandella</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Bignami</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>F&#252;rst</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Grob</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Mengelers</surname><given-names>M</given-names></string-name>, <etal>et al.</etal></person-group><year>2024</year>. <article-title>Technical Report on the need for re-evaluation of the safety of hexane used as an extraction solvent in the production of foodstuffs and food ingredients</article-title>. <source>EFSA Supporting Publications</source><volume>21</volume>(<issue>9</issue>):<elocation-id>EN-9001</elocation-id>, <pub-id pub-id-type="doi">10.2903/sp.efsa.2024.EN-9001</pub-id>.</mixed-citation></ref><ref id="c101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Verner</surname><given-names>M-A</given-names></string-name>, <string-name name-style="western"><surname>McDougall</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Johanson</surname><given-names>G</given-names></string-name></person-group>. <year>2012</year>. <article-title>Using population physiologically based pharmacokinetic modeling to determine optimal sampling times and to interpret biological exposure markers: the example of occupational exposure to styrene</article-title>. <source>Toxicol Lett</source><volume>213</volume>(<issue>2</issue>):<fpage>299</fpage>&#8211;<lpage>304</lpage>, PMID: 22677344, <pub-id pub-id-type="doi">10.1016/j.toxlet.2012.05.024</pub-id>.<pub-id pub-id-type="pmid">22677344</pub-id></mixed-citation></ref><ref id="c102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sari-Minodier</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Truchon</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Charest-Tardif</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>B&#233;rub&#233;</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tardif</surname><given-names>R</given-names></string-name></person-group>. <year>2009</year>. <article-title>The effect of workload on biological monitoring of occupational exposure to toluene and n-hexane: contribution of physiologically based toxicokinetic modeling</article-title>. <source>J Occup Environ Hyg</source><volume>6</volume>(<issue>7</issue>):<fpage>415</fpage>&#8211;<lpage>432</lpage>, PMID: 19384711, <pub-id pub-id-type="doi">10.1080/15459620902928141</pub-id>.<pub-id pub-id-type="pmid">19384711</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>